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This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.
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Crude, but Effective

v y

►

The titles of three papers that appear
in this issue of the Journal caught my
attention for what seemed at first to
be very different reasons. After read
ing the three articles and reflecting on
what enticed me, I became aware that,
for all their divergence of topic, they
provoked an “ethical” feeling regard
ing the importance and problems of
testing and reporting what we do for
our patients.
Gahhos and colleagues (page 613)
have reported a detailed, carefully
designed, prospective, randomized,
double-blind, clinical comparison of
two antibiotics given prophylactically
to patients scheduled to undergo elec
tive colectomy. They have made a
careful assessment of several para
meters. In current jargon, this work
may justifiably be called “an elegant
study”. Part of my interest was
stimulated when I simultaneously
received the Sept. 16, 1982 issue of
the New England Journal of Medicine,
wherein I read Arthur Schafer’s “The
ethics of the randomized clinical
trial”.1 Schafer raises many important
issues relating to whether patients
should know they will be selected on
a random basis for one or another
mode of treatment; whether such trials
sacrifice the patient’s right to com
pletely individualized treatment for the
benefit of scientific progress; and how
we can balance traditional patientcentred medicine against the potential
wider social benefits of strict random
ization. Unfortunately, without the
rigour of the double-blind, random
ized trial, truth may not be served.
Although these and other consider
ations are important, they do not con
cern me in connection with the study
by Gahhos and associates. What
bothers me is that I do not use either
form of treatment tested. Moreover,

I am afraid that I may be fooled by
differences, albeit small, that were
likely due to chance. In fact, in the
study of Gahhos and colleagues, the
only difference between the two
groups that was statistically significant
was the number of Bacteroides organ
isms remaining in the gut; neverthe
less, I cannot avoid noticing that no
body receiving clindamycin had a
wound infection whereas three pa
tients who received metronidazole did.
On the other hand, I worry about
pseudomembranous colitis and find
myself in a kind of ethical dilemma
regarding which treatment my patients
should receive. My biggest problem
is, how do I compare this careful
study of two prophylactic regimens
that I am not using with my own ex
perience and with the many other
careful and not-so-careful studies of
other treatment regimens? What we
all long for is a good, big, healthy . . .
difference! The problem seems to be
that we have so finely tuned things
that such differences will be hard to
come by.
The article by Crabtree and col
leagues (page 644) describes a lethal
complication, necrotizing choledochomalacia, quite likely due to the use
of monooctanoin. It would not be
described as an elegant study. It is,
in fact, the type of report that inertia
and perhaps a sense of dismay dis
courage us from publishing. The sti
mulus to share such an experience is
more an ethical thing. It certainly does
not come from some sense of victory.
However, such a report serves the
medical fraternity and our patients
well. Whether such a tragedy is a
never-to-be-repeated fluke or a per
vasive danger, we must all now take
this event into consideration. Perhaps
this kind of report would fit what

Ralph Nader has called “blowing the
whistle”. It is not elegant. Rather, it
is “crude, but effective”.
I found the paper by Martin and
Gelfand on mid-trimester abortion
(page 641) difficult to read because
I was distracted by my own emotional
and religious bias against abortion for
sociologic reasons, even though this
issue is not discussed in the paper. F or
me, the ethical dilemma related to a
conflict in my mind between the H ip
pocratic commitment to the health and
life of my patient versus the Hippo
cratic commitment to respect all life
from conception. Interestingly, the
only mortality in the experience re
ported was a patient for whom a mid
trimester abortion was performed to
try to save her life. From a purely
professional point of view, I am
concerned that decisions regarding
“health” in the sociologic realm are
being made, at least in my community,
by gynecologists who may have little
or no training in evaluating sociologic
criteria. The report nevertheless im
pressed me as a useful contribution
by outlining the carefully documented
experience of mid-trimester abortions
in one hospital.
As members of the surgical com 
munity, we find the ethical climate
blows with many winds. We must try
to evaluate quickly and carefully the
benefits of what is new (monooc
tanoin), and need to report to one
another the problems; we are pres
sured by society’s desires and mores
(liberalized abortion), which may con
flict with our own perception of the
professional mandate; and we are con
fronted by a barrage of data obtained
by agonizingly difficult studies that
are sometimes expensive, that possibly
intrude on patients’ rights, and that
may, discouragingly, reveal only small
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differences. In such a climate I believe
that we must maintain an open, ami
cably critical, communication and con
tinuing review of all that we do and
intend to do for our patients and for
society. We should not only receive
and evaluate spoken and published re
ports but we, ourselves, should also
contribute by voice and print with de
termined candour and precision —

whether our contribution be elegant or
controversial, or crude but effective.
R .J . B l a n c h a r d ,

m d , f r c s [c ]

Member,
Editorial Board
Reference
1. S chafer A : T he ethics of the random ized
clinical trial. N Engl J M ed 1982; 307: 719-

The Unstable Ankle
It is quite some time since the subject price to pay is some loss of inversion
of ankle stability was discussed in which may be an inconvenience when
these pages.1-3
walking on uneven ground. Pieron in
The problems of knee stability arise this issue (page 672) presents a new
because of the complex nature of the approach, that of leaving the tendon
hinge mechanism which allows (nay, of the peroneus brevis attached to the
demands) rotation and mediolateral muscle belly to create a dynamic re
motion in addition to flexion and ex pair that should obviate the 1o„j of
tension. The ankle is closer to a pure inversion. Unfortunately, when a ten
hinge in which only a small amount of don is passed through a long tunnel in
rotation and inversion-eversion motion bone, especially cancellous bone, it
are possible in addition to dorsi- and will adhere to the walls of the tunnel,
plantar-flexion. Inversion and eversion effectively cancelling the pull of the
occur mainly at the subtalar joint. Ac muscle. The tendon does not slide in
quired symptomatic instability is usu the bone. This was proven in two of
ally the result of rupture of the lateral the author’s patients who required re
ligaments, which are really a com operation, but was not demonstrated
bination of ankle and subtalar in the other patients. The presence of
elements.
a sclerotic border seen in the roent
The osseous part of the ankle joint genogram is not proof of sliding of the
is more stable than that of the knee. tendon. The pulley described by Lip
The mortise of the ankle is much deep scomb and associates4 for the thumb
er than the quite shallow cups of the is not a bony, but a tendinous one.
tibial plateaux. As in the knee, the Sliding does occur around a tendinous
medial and lateral ligaments are the pulley, but not within a bony canal.
strong ones and account for the stab
What Pieron has described is a
ility afforded by the soft tissue com tenodesis operation which no doubt
ponent. The knee is really two unequal works well, as do the other tenodesis
joints, separated by the cruciate liga operations long established.
ments; the ankle is not complicated
by such an arrangement. The fact that J o s e p h L. S h u g a r , m d , f r c s [c ]
the tenon of the ankle, the dome of
the talus, is narrower in the back than Senior associate editor
in the front does not complicate the
action too much.
Thus, the repair of ruptured lateral References
ankle ligaments, done immediately or 1. C lark BL, D erby AC, P o w er G R I: Injuries
late as a reconstruction, is not plagued
o f the lateral ligam ent of the ankle. C on
servative vs. operative repair. Can J Surg
by the problems that befall repairs of
1965 ; 8: 358-63
the knee ligaments. Most of the many 2. L a u r in C A , O u e l le t R, St - J acques R : T alar
and subtalar tilt: an experim ental investiga
already described reconstructions are
Can J Surg 1968; 11: 270-9
a combination of ankle and talocalca 3. Gtion.
r oss AE, M a c in t o s h D L : Injury to the
neal repair, using the peroneus brevis
lateral ligam ent of the ankle: a clinical study.
J Surg 1973; 16: 115-7
tendon, usually left attached to the 4. LCan
ipsc o m b PR , E l k in s EC , H e n d e r s o n E D :
base of the fifth metatarsal. It is of
T endon transfers to restore function of
hands in tetraplegia, especially after fractureadequate length and strength. The
dislocation of the sixth cervical v e rte b ra on
operation is usually satisfactory and
the seventh. J Bone Joint Surg [Am] 1958;
40: 1071-80
the ankle becomes stable. Often the
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“STEMETIL"
(prochlorperazine)

stops nausea, helps keep
the patient calm and alert
Indications: nausea and vomiting of various
etiologies: gastrointestinal disorders, drug
intolerance, motion and radiation sickness,
post-operative conditions, pregnancy, vertigo and
migraines.
Dosage: Adults, oral route - Usual effective
dosage is 5 to 10 mg, 3 o r4 times daily; in very
mild cases, a single dose of 5 to 10 mg is often
adequate. This dosage may be increased as
required by increments of 10 mg every 2 or 3 days
until symptoms are controlled. For maintenance
therapy the dosage should be reduced to the
minimum effective dose. Rectal route - The
suggested adult dose is 20 to 50 mg daily.
Children: oral and rectal routes - up to 10 mg
per day in divided doses according to body weight.
Parenteral route (not to exceed 40 mg per day) In general practice: 5 to 10 mg I.M., 2 or 3 times a
day. In surgery: 5 to 10 mg I.M., 1 to 2 hours
before anesthesia. Repeat once during surgery if
necessary. Post-operatively, same dose of 5 to 10
m gl.M ., repeated every3 to 4 hours. M aybe
given I.V. during and after surgery in the infusion
solution at a concentration of 20 mg per litre. In
obstetrics: 10 mg I.M. during first stage of labor:

Contraindications: comatose or deeply de
pressed states of the CNS due to hypnotics,
analgesics, narcotics, alcohol, etc.;
hypersensitivity to phenothiazines; blood
dyscrasias; bone marrow depression; liver
damage.
Warnings and precautions: etiology of vomiting
should be established before using the drug as its
antiemetic action may mask symptoms of
intracranial pressure or intestinal obstruction.
Patients with a history of convulsive disorders
should be given an appropriate anticonvulsant
while on therapy. Tardive dyskinesia may occur in
patients on long-term therapy. If used with CNS
depressants, the possibility of an additive effect
should be considered. Use with great caution in
patients w ith glaucoma or prostatic hypertrophy.
The drug may impair the mental and/or physical
abilities required for the performance of potentially
hazardous tasks such as driving a car or operating
machinery, especially during the first fe w days ot
therapy. Keep in mind that all medications should
.
be used cautiously in pregnant patients, especially
during the first trimester.
Side effects: extrapyramidal reactions, disturbed
temperature regulation and seizures have been
encountered. Other side effects due to
phenothiazine derivatives should be borne in mind;
for complete list, see product monograph.
Overdosage: no specific antidote; symptomatic
treatment. If a pressor agent is required,
norepinephrine may be given (not epinephrine as it
may further depress the blood pressure).
Dosageforms: tablets 5 and 10 mg; ampoules
2 m L /IO m g; liquid 5 mg per teaspoonful (5 mL);
suppositories 5 and 10 mg
Full prescribing information available on
request.
References: 1. Int. Rec. Med., 170; 469, 1957.
2. Curr. Ther. Res., 14 (9): 590-598, 1972.
3. Today’s Drugs, Brit. Med. J., 481, 1970.
4. Antiseptic, 73: 16, 1976.

RHONE POULENC PHARMA Inc.
8580 Esplanade
Montreal, Quebec
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REVIEW ARTICLE

Hyperthermia as a Treatment for Neoplasia
A. D r ezn ik , m d , R E. F alk , m d , fr c s [c ], V. H oward , L. M akowka , m d and D. V e n t u r i

The use of hyperthermia to treat
malignant neoplasms is currently a
“hot” issue. It has been demonstrated
that heating tumour cells to 42°C or
above leads to their self-destruction
by decreased cellular metabolism and
aerobic respiration. The selective
accumulation of heat in the malignant
tissue at 42° to 44°C, compared with
the temperature of normal tissue, is
probably related to the different blood
supply within the tumour. The
historical background and the
experimental and clinical results of
hyperthermia are reviewed. The
advantages and disadvantages of the
different thermotherapy techniques
currently in use are discussed.
Hyperthermia is probably more efficient
if combined with other antitumour
treatment modalities.
L'utilisation de I'hyperthermie dans le
traitement des neoplasies malignes
fait presentement I'objet d’une
controverse “chaudement” debattue.
II a ete demontre que le chauffage
des cellules tumorales a 42°C ou plus
entraine leur autodestruction par une
diminution du metabolisme cellulaire
et de la respiration aerobie.
L'accumulation selective de chaleur
entre 42° et 44°C dans le tissu
tumoral, comparativement a la
temperature dans le tissu normal,
est probablement reliee a I'apport
sanguin different a I’interieur de la
tumeur. On revoit le contexte
historique de meme que les resultats
experimentaux et cliniques de
I'hyperthermie. Les avantages et
desavantages des differentes
techniques d'hyperthermie presente
ment en utilisation sont discutes.

From the Goldie Rotman oncology unit,
Toronto General Hospital, Toronto,
Out.
Accepted for publication June 17, 1982
Reprint requests to: Dr. R.E. Falk,
1-140 Gerrard Wing, Toronto General
Hospital, Toronto, Ont. M5G 1L7

L'hyperthermie est probablement plus
efficace lorsqu’elle est associee a
d’autres therapies antitumorales.

The development of cancer cells can
be prevented by avoiding exposure to
known carcinogens such as tobacco,
sunlight and some industrial chem
icals; but once cancer cells have de
veloped, the treatment is limited to
surgical, chemical and physical meas
ures. An unresectable or disseminated
malignant neoplasm can be treated
with chemotherapy, radiotherapy, im
munotherapy or hormonotherapy.
Hyperthermia as a treatment for
malignant neoplasms was mentioned
in the medical literature as early as
the 19th century. In recent years, an
interest in hyperthermia as a cancer
treatment has arisen because new and
accurate appliances have been devel
oped that have a high degree of se
lective tumour hyperthermia and
cause only minimal damage to sur
rounding and superficial tissues.
Experimental in vitro and in vivo
studies using local, regional or total
body hyperthermia with different
heating systems show a high degree of
tumour necrosis when the temperature
is above 42°C. A limited number of
clinical trials, with promising results
in treating malignant neoplasms by
hyperthermia alone and in combina
tion with chemotherapy or radiother
apy have been reported.
Historical Review

The original interest in “fever ther
apy” is usually attributed to Busch.1
In 1866 he described a complete cure
of histologically proven sarcoma in a
43-year-old woman after an accident
ally acquired erysipelas. Coley,2 in
1893, published the results of inten
tionally produced erysipelas for the
treatment of malignant tumours. He
reported complete recovery in TO of
34 patients (29%). This interesting
phenomenon led Coley to prepare an

extract of different types of bacteria,
mainly Streptococcus pyogenes and
Bacillus prodigiosus. This preparation,
called mixed bacterial toxins (MBT),
was given to induce fever in patients
with cancer.
The side-effects following inocula
tion of MBT, the lack of standardiza
tion and the different biologic be
haviour of various malignant tumours
made this treatment unpredictable.
Clowes3 found in 1906 that malig
nant cells heated to 45°C were irre
versibly damaged and attempts to in
oculate them in other animals failed.
In 1921 Rohdenburg and Prime'1 noted
that diathermy and irradiation poten
tiated each other and it made no dif
ference which was given first. Warren5
reported encouraging results in the
treatment of terminal cancer patients
with whole body hyperthermia, main
taining the rectal temperature at
41.5°C. He found an immediate im
provement in 29 of 32 patients, but
not in prognosis. Johnson,6 using
short radio waves, was the first to
emphasize the different temperatures
recorded at the core and the periphery
of the malignant tumour.
Some investigators713 have demon
strated the efficacy of hyperthermia
alone or in combination with other
antitumour treatment modalities. It
was also shown by Dickson and Suzangar14 and LeVeen and associates15
that malignant tumour cells are irre
versibly damaged when heated to
42°C or more.
Despite the vast experimental in
terest by many scientists, only limited
clinical trials have been carried out.
Effect of Thermotherapy
on Malignant Tumours

There is mounting evidence that hy
perthermia has a destructive effect
upon malignant tumours.16,17 Heating
malignant cells causes: (a) impaired
DNA and protein synthesis, probably
related to enzymatic destruction, (b)
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impaired RNA synthesis due to de
creased incorporation of uridine into
the nucleolar pre-RNA, (c) an increase
in cellular membrane permeability
that allows low-molecular-weight sub
stances access into the cells and (d)
increased tumour cell antigenicity,
either by structural changes of the cel
lular membrane or by a release of
antigens as a result of tumour cell
necrosis. These are probably weak
antigens that could evoke increased
antibody formation. The dividing
cells, especially during the synthesis
and mitosis phases, seem to be more
susceptible to heat. This preferential
heat sensitivity has clinical and ther
apeutic implications, since both phases
are resistant to radiotherapy.
Dickson and Oswald18 found that
heating malignant cells to 47°C
caused cell respiration and glycolysis
to decrease by 50% and 70% respec
tively compared with the values at
38°C. Cessation of oxygen consump
tion and carbon dioxide production
was found after heating to 50°C for
2 hours.
Herman and associates19 found re
cently that the dihydrofolate reductase
activity decreased to about 50% of
the control values after heating at
43 °C for 4 to 5 hours. The reaction
of tumour tissue to hyperthermia dif
fers from that of normal tissue. Heat
ing a tumour to 42° to 44 °C produced
a selective accumulation of heat in
the malignant tissue.7,20'23 This differ
ence is probably related to the blood
supply within the heated structure.
Cancer cells begin their growth as a
nest of cells between normal blood
vessels. As the tumour cells grow they
push aside the normal blood vessels.
Urbach24 and Gullino and Grantham25
found that malignant cells produce an
angiogenic factor that causes a rapid
proliferation of capillaries. Unlike
normal organs, the tumour does not
generally possess a single major ar
terial or venous supply, but merely a
capillary network and sinuses con
nected with the peripheral capillary
system.26 At the periphery of the tu
mour, physiologic, if not anatomic,
arteriovenous communications are
formed. As a result, malignant tu
mours have only 5% to 10% of nor
mal tissue blood flow.2’ This has also
been demonstrated by the use of ra
dioactive microspheres.27 The reduced
blood supply, absence of major blood
vessels and the thermoregulatory sys
tem in tumour tissue prevent the dis
sipation of heat that occurs in normal
organs.
Tumour cell acidosis, caused by de
creased oxygen tension and increased
604

anaerobic metabolism in which lactic
acid is accumulated, may be respon
sible in part for the increased sensi
tivity to hyperthermia. Intravascular
coagulation necrosis caused by the
hyperthermia prevents further dissipa
tion of heat28 and may also contribute
to intratumoral heat conservation.
Amount of Heat and Tumour Necrosis

Tumour cells are more sensitive to
heat than normal cells at temperatures
of 42° to 44°C.28 Heating to 45°C or
more may also cause irreversible dam
age to normal cells.7,21,23,29'31 Selective
heating creates a core tumour temper
ature of 45° to 50°C with demon
strable tumour necrosis but spares the
normal surrounding tissue.15,32"34 The
lethal effect of hyperthermia on can
cer cells depends on the intensity and
duration of treatment. For every
1°C increase in temperature above
42 °C, the time required to produce
tumour necrosis with hvperthermia is
halved.15,23,33,34 Dickson35 noted from
the results of in vitro and in vivo
studies that to produce cell death,
more than 30 hours at 42°C, 3 to 4
hours at 45 °C and only a few minutes
at 50°C were necessary. The differ
ence between the tumour core tem
perature and its peripheral tempera
ture was 2° to 3°C.
Histologic Changes Produced by Heat

The histologic changes that heat
produces in malignant tumours were
studied in detail by Sugaar and LeVeen.36 They examined the changes in
primary lung cancer heated before
operation and compared them to those
of 15 untreated primary lung cancers.
Three stages can be discerned fol
lowing repeated local treatment with
radiofrequency hyperthermia.
• Stage I. There are early, variable
degenerative changes accompanied by
focal aggregation of granulocytes. The
stromal interstitium is extensively in
filtrated with plasma cells and there
is hyperplasia of regional lymph ag
gregates. Acute congestive changes
are present in the surrounding lung
parenchyma. These alterations are not
specific to thermotherapv and might
also occur in tumour tissue treated
by other methods.37-14
• Stage II. There are focal areas
of fibrinoid necrosis in the capillary
stromal wall while the tumour tissue
is profuselv infiltrated with small lym
phocytes. These changes are charac
teristic after hyperthermia treatment
and are comparable to some of the
histologic changes present during the
course of acute allograft rejection.38

• Stage III. Focal areas of coagu
lation necrosis are present around the
necrotic vessels at the core of the
tumour. The capillary wall shows mas
sive infiltration with small lympho
cytes surrounded by pools of lympho
cytes, necrotic tumour tissue and he
mosiderin deposits.
Storm and associates28 also observed
that heating at 45° to 50°C caused
vascular and tumour necrosis with fo
cal hemorrhage. They postulated that
vascular thrombosis could contribute
to the selectivity of the tumour heat
ing by preventing the dissipation of
heat from the tumour mass to circu
lating blood. Moreover, these vascular
changes may prevent the absorption of
necrotic tissue, which is therefore re
placed by fibrotic tissue without ap
preciable change in the size of the
neoplastic lesion.
Methods of Producing Hyperthermia
for Malignant Tumours

Clinically, there are three main
ways of giving thermotherapy: by
whole body, regional and local hyper
thermia.

Whole Body Hyperthermia
A variety of means have been used
to increase total body temperature.
These include: inhalation of hot air,
hot water baths, hot wax, infrared
rays, thermally controlled “space-suits”
and extracorporeal circulation.
Pettigrew and associates39-40 treated
82 patients with advanced metastatic
disease under general anesthesia, using
molten paraffin wax. Clinically, 49
patients improved but 4 died as a re
sult of cardiac arrythmias, dissemin
ated intravascular coagulation and
burns. Because of the advanced state
of the disease, responses were difficult
to evaluate.
Larkin41 reported the results of 77
patients treated with a heated mod
ified water blanket'under general an
esthesia for 2 hours. He found either
subjective or objective responses in
58%. Five patients died as a result
of cardiac arrythmias, pulmonary
edema and severe burns.
Bull and associates42 treated pa
tients with the combination of total
body hyperthermia and Adriamycin
for metastatic sarcoma. Evidence of
tumour shrinkage was seen in only
two patients. Ventricular arrythmias,
which responded to lidocaine infusion,
were noted. Whole body hyperthermia
with the use of radiofrequency waves
is being investigated but no clinical
data are yet available. All the tech-
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niques for whole body hyperthermia
have serious side-effects and are cost
ly and time consuming. Results of ini
tial studies at various institutions may
provide a simple and easy method for
whole body thermotherapy with min
imal side-effects, but most investiga
tors regard this as unlikely.
Regional Hyperthermia
In this method a limb is isolated
and perfused with heated solutions.
Stehlin and colleagues43,44 used region
al thermotherapy with .melphalan to
treat malignant melanomas. They pro
duced a 5-year survival rate of 74%
compared with 22% in a historical
control group. No amputations were
necessary in patients treated with re
gional hyperthermia. Moricca and as
sociates45 reported regression of mela
nomas and sarcomas treated by re
gional heated perfusion to 43 °C for
up to 8 hours.
Local Hyperthermia
Three main types of local hyper
thermia are currently in clinical use:
(a) Ultrasonic heat transfer. This has
been investigated mainly by the Stan
ford University and the MIT groups.
The major advantage of this method
is the precise localization of the ap
plied energy to depths of 10 to 15 cm
and effective heating of deep-seated
tumours. The disadvantages are those
related to the difficulty of heating
lung tumours and those located behind
bony structures. Since the magnitude
of ultrasonic energy required for heat
ing adipose tissue, muscle, skin and
bone increases for each tissue, and
since the absorption coefficient of ul
trasound waves is constant, skin cool
ing is essential, (b) Microwave heat
transfer. Microwave absorption in the
usable frequency ranges of 2.9 to 200
MHz is determined by the specific re
sistance of the tissue. As a result,
fatty tissue, due to its relative specific
resistance will heat to a point of fat
necrosis. Beneath the skin level, tem
perature distribution will depend upon
the amounts of fatty tissue to be
traversed. With this method there are
theoretical advantages to heating su
perficial tumours or tumours derived
from muscle. This method of heating
may be suitable for local but not
whole body use. (c) Radiofrequency
hyperthermia. By this method heat is
generated through electromagnetic
fields. There are two general modes
of radiofrequency heating: capacitive
coupling and inductive heating. Capa
citive coupling may be used to pro

duce current field to generate heat in
tumour tissues. Since skin and fatty
tissue absorb little of the heat it can
be used in obese patients. The use of
intratumour core thermistor probes
does not change the temperature read
ing during the treatment. Inductive
heating has the advantage of heating
larger volumes than the capacitive
type, but it lacks the concentration
and localization of the dispersed heat.
Several basic requirements are nec
essary for adequate local heating, (a)
The amount and intensity of energy
have to be high enough to heat every
part of the tumour, (b) In treating
deep-seated tumours dispersal of en
ergy by, as well as damage to, super
ficial structures should be avoided,
(c) The energy supply in different
parallel body sections should be con
stant. (d) Low-frequency beams are
necessary, since these are most effi
cient.48 In spite of the high level of
technical development of heat gener
ating instruments for medical pur
poses, there is still no standardization
of dielectric constants for conductivity
of different tissues. Atkinson47 found
that several physical characteristics of
tumour tissue are necessary for op
timal response to thermotherapy. They
are electric conductivity, heat conduc
tivity, ability to be heated and per
fusion rate.
Experimental and Clinical Results

The methods of production of hy
perthermia for the treatment of malig
nant tumours include the use of the
whole electromagnetic spectrum —
from conventional diathermy using a
frequency of 1 MHz for Crocker tu
mours in mice48 to microwaves with a
frequency of 200 MHz for hepatoma
223 in rats.49 The main hazard of
heating deep tumours is the relatively
high absorption of heat by superficial
tissues.50
Westermark,23 in treating superficial
Jensen tumours in rats with hyperther
mia, found considerable damage to
the skin and subcutaneous tissue at
temperatures above 46 °C. The tumour
was not heated uniformly and its peri
phery was colder than its core. Cavaliere and associates7 studied the effect
of hyperthermia on Walker and Jen
sen tumours and found no damage to
the superficial tissues at temperatures
below 47 °C. Overgaard and Overgaard12 treated tumours in mice with
microwaves of 27.12 MHz frequency
and found 25% tumour cell necrosis
at tumour core temperatures of 46°
to 47 °C without damage to superfi
cial tissue. The use of hyperthermia

gained renewed attention only in the
last decade as a result of experimental
and clinical investigations.10’12-23,51 This
method was used alone or in com
bination with chemotherapy or irradi
ation.62,53 Most of the clinical studies
were limited to superficial tumours
using relatively low intensity hyper
thermia20 or during operation in order
to avoid superficial tissue damage.
Storm and associates28 studied the ef
fect of hyperthermia on normal and
tumour tissue in animal models and in
clinical trials. Using the inductive type
of radiofrequency heating, they found
first degree burns at 42 °C, second
degree burns at 46 °C and full-thick
ness skin and muscle necrosis at and
above 50°C. Heating internal organs
for 15 minutes at 42° to 45 °C did
not produce any clinical evidence of
internal organ injury; however, pro
longed, continuous heating at even
this temperature universally produced
fatal cardiac arrythmias. These au
thors tried to define the thermal death
time of different human cancers.54
Treatment of 44 tumours in 32 pa
tients was carried out and repeated
tumour biopsy specimens were exam
ined. They found that short duration
thermotherapy at 50 °C resulted in
20% to 100% tumour cell necrosis;
2 to 3 weeks at 45° to 50°C were
necessary to provoke 70% to 100%
tumour cell necrosis and double that
time was necessary at temperatures
between 40° and 45°C. Treatment
was on an outpatient basis; no seda
tion was used. The recorded tumour
temperatures were high and sideeffects were negligible.
LeVeen and associates55 reported
their clinical retrospective experience
with hyperthermia between 1974 and
1977. In 6 of 32 patients with lung
cancer treated with hyperthermia the
disease was eradicated. Regression of
tumour was noted in 11 of 32 patients
and 27 patients reported subjective
improvement. The physiologic changes
resulting from local thermotherapy are
usually of minor importance. There is
an increase of systolic blood pressure
of 20 to 25 mm Hg with only a mod
erate increase in diastolic pressure.
The average pulse rate increases 8.5
beats/min with each degree increase
in temperature. These manifestations
are temporary and occur as a result
of the gradual increase of heat. They
tend to stabilize with stabilization of
the temperature.
Immunologic Aspects
of Hyperthermia

Circumstantial evidence shows that
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the immune system is involved in tu
mour regression following thermo
therapy. The immunologic response to
hyperthermia is indicated by local in
filtration of macrophages and by non
specific cellular and humoral re
sponse.56 An indirect observation of
immunologic activity is indicated by
the disappearance of secondary lesions
after heating the primary tumour.
This is called the “abscopal antitu
mour effect” and was noticed in hu
man cancers as well.45,57 It was also
found that animals which were cured
were immune to challenge with tu
mour cell inocula many times greater
than those of untreated animals. In
rabbits bearing bilaterally implanted
Brown-Pearce carcinoma, thermother
apy of the tumour in one testis was
followed by regression of the contra
lateral tumour. Following tumour
heating a rise of antitumour antibody
titres occurred. The titres increased to
about 1:100 by 2 to 3 weeks after
heating. They were maintained for the
following 3 to 4 weeks and then de
creased to zero after 3 to 4 months.58
Cured rabbits were immune to chal
lenge with Brown-Pearce carcinoma
and inoculation of their sera into nor
mal rabbits produced rejection of fur
ther tumour challenge while injection
of the immune sera into tumour-bear
ing animals led to tumour regression.
The immunologic enhancement of
hyperthermia has led some, such as
Moricca and associates45 and Stehlin
and associates,59 to perform a delayed
amputation, 4 to 12 weeks after re
gional thermotherapy. They believe
that during this period antigens are
released from the necrotic cells. These
antigens lead to an increased anti
tumour response that destroys metastases.58
Microwave heating to 43 °C of
Guerin epithelioma in rats caused im
munologic stimulation with indirect
cellular and humoral responses asso
ciated with increased lymphoid toxi
city and macrophage infiltration.
These results suggest that, as a result
of hyperthermia, an immunologic re
sponse is produced that may play a
prominent role in the destruction of
malignant tumours.60 The mechanism
that provokes the immunologic reac
tion as a result of hyperthermia is not
yet known. Several authors have pos
tulated that changes in the cell mem
brane may increase its immunogenicity.61 In support of this theory,
Jasiewicz and Dickson62 found that tu
mour cells heated at 42°C caused an
increased reaction with specific anti
tumour serum. The changes in the cell
membrane facilitate the action of an
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tibodies against the surface antigens.
These hypotheses are related to local
thermotherapy. The influence of
whole body hyperthermia on the im
munologic system is not yet known.
Dickson and Muckle29 reported better
results after treating VX2 carcinomas
in rabbits with local hyperthermia than
with whole body hyperthermia. They
suggest that whole body hyperthermia
causes depression of the immune sys
tem. Other investigators noticed an
increase in the number of metastatic
lesions as a result of whole body hy
perthermia, probably due to immuno
suppression.16,63
For many reasons the immune re
sponse to local and whole body hyper
thermia is difficult to assess: (a) chem
ically induced tumours in experimental
animals behave differently from spon
taneous human tumours, (b) many
experimental tumours are known to
be immunogenic, enhancing the host’s
immunologic response56 and (c) there
is no laboratory evidence of immuno
logic suppression as a result of whole
body thermotherapy.
Combined Hyperthermia
and Irradiation

The combination of thermotherapy
and irradiation to treat malignant neo
plasms has been utilized by several
groups.64,65 An increased tumour cell
killing effect was noticed when this
combination was used.66"68 Cells that
are in radioresistant S-phase are fre
quently sensitized and killed by
heat.6970 Heat also inhibits the repair
of radiation damage. Ben-Hur and
associates71 demonstrated that the re
pair of sublethal radiation damage was
inhibited by hyperthermia. Experi
mental studies performed on TED.™
tumours showed that the radiation
dose necessary to cause tumour necro
sis decreased by 50% if combined
with local hyperthermia.72,73 These
methods combined were more efficient
than either modality alone in treating
malignant melanoma.74 Marmor and
Hahn75 compared the results of com
bined hyperthermia and irradiation
with irradiation alone for the treat
ment of metastatic superficial tu
mours. In the same patient, different
areas were treated either with radio
therapy alone or in combination with
hyperthermia at 43 °C for 45 minutes.
In 7 of 15 patients a better response
was observed with the two modalities
combined than with irradiation alone.
The tumour regressed completely in
four patients using both methods of
treatment. Two patients did not re
spond to either modality and in two

others only a partial response was
noted.
Combined Hyperthermia
and Chemotherapy

In vitro studies have demonstrated
increased efficiency of some chemo
therapeutic agents when combined
with hyperthermia.76 Only limited in
vivo studies have been done, and even
fewer clinical reports are available.
Increased efficacy has been noted
with the combination of hyperthermia
and BCNU (bischloroethyl nitro
sourea), bleomycin and cis-platinum.
The clinical use of BCNU seems to
be most favourable at 41° to 42°C
while bleomycin exerts its maximal
effect at 42° to 43°C.77 Hyperthermia
probably increases the efficacy of
chemotherapeutic drugs by increasing
absorption of alkylating agents by ma
lignant cells. Hyperthermia is syner
gistic with several chemotherapeutic
agents.78"81 Drugs considered inefficient
in the treatment of various tumours,
such as amphotericin and misonidazole, became effective when given in
combination with hyperthermia.82"84 It
was found also that the synergistic
effect of thermotherapy was not spec
ific for chemotherapeutic agents be
longing to any one class of activity
but increased the effectiveness of
drugs of various groups.
The combination of chemotherapy
with irradiation is generally associated
with increased toxicity.85,86 No such
increase in toxicity has been reported
when chemotherapy is given in com
bination with hyperthermia. Recorded
tumour core temperature during ther
motherapy facilitates the use of con
comitant chemotherapeutic agents
which exert their major activity at
40°C and above. Hyperthermia may
delay or prevent tumour resistance to
certain chemotherapeutic drugs; as far
as is known, no tumour resistance to
hyperthermia has been recorded. Sev
eral studies reported the possibility of
“thermal tolerance”.87,88 This pheno
menon is probably a result of sublethal heating of tumour cells and is
always reversible. No data has yet
been published about the combination
of local hyperthermia with local ar
terial infusion chemotherapy.
Future Prospects

The different modalities used in
cancer therapy demonstrate the lack
of one effective treatment. Hyperther
mia represents an additional relatively
nontoxic therapeutic maneuver. It is
apparent that regional thermotherapy
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is safer and has fewer complications
than whole body hyperthermia. Hy
perthermia evidently yields the best
results when combined with other an
titumour treatments. The effectiveness
of thermotherapy is not related to the
histologic type of the tumour and is
as efficient for treating superficial as
deep-seated tumours. It is difficult to
predict the exact future clinical im
plications of hyperthermia; however,
considering the negligible side-effects
and the initial promising results, it is
probable that hyperthermia has a
place in cancer therapy. Regional hy
perthermia induced by radiofrequency
offers the best and most controlled
form of therapy. Further work will be
necessary to develop equipment to
permit rapid, consistent and safe
heating.
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CANADIAN ASSOCIATION OF CLINICAL SURGEONS

Elective Colon Surgery:
Clindamycin versus Metronidazole Prophylaxis
Fivos N. G ahhos, md , G eoffrey K. R ichards, md , frc path , frcp [c],
E. J ohn H inchey, md, facs, frcs[c] and J ohn J. P rentis , fimls

Orally administered clindamycinneomycin as a prophylactic antibiotic
in patients scheduled to undergo
colon surgery was compared to
orally administered metronidazole-neo
mycin. Clindamycin levels of the colon
contents and the mucosa were 8 to
10 times higher than the serum levels.
Three of the 43 patients who received
metronidazole had wound infection
whereas none of the 38 patients who
received clindamycin did. Clindamycin
may help to prevent staphylococcal
infection, a known problem associated
with metronidazole use. It may also
play a role in preventing infection at
the anastomosis in patients who
undergo colon resection.
L'administration par voie orale de
clindamycine et de neomycine a titre
d'antibiotherapie prophylactique a ete
comparee a l'administration par voie
orale de metronidazole et de neomycine
chez des patients qui devaient subir
une chirurgie du colon. Les taux de
clindamycine dans le contenu et la
muqueuse coliques etaient 8 a 10 fois
plus eleves que les taux seriques.
Trois des 43 patients qui avaient
recu du metronidazole ont eu des
infections de plaie comparativement
a aucun des 38 patients sous
clindamycine. La clindamycine peut
contribuer a prevenir les infections
staphylococcique, un probleme identifie
avec I'usage du metronidazole. II peut
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aussi jouer un role preventif a I’egard
des infections d’anastomose chez
les patients qui subissent une resection
du colon.

patients admitted to the Montreal
General Hospital for elective colon
surgery. Patients were included in the
study if the bowel was incised at oper
ation. Excluded were those who had
The frequency of wound infection received antibiotics during the 2
following operations on the colon is weeks preceding operation, who had
reduced by the preoperative admin evidence of infection before surgery,
istration of appropriate antibiotics. leukopenia (leukocyte count less than
Without antibiotic prophylaxis, the 2.5 X 109/1), thrombocytopenia, renal
wound infection rate ranges from disease (serum creatinine value greater
32% to 58% ' and the rate of infec than 114.9 ^umol/l or creatinine clear
tious complications is as high as ance less than 50 ml/min), or active
75% .2 The combination of neomycin degenerative neurologic disease. Fully
and metronidazole given orally has informed, written consent was ob
been shown to reduce markedly the tained from each patient. Patients
incidence of wound infection follow were assigned to two groups by a
ing operations on the colon3'5 and the pharmacist, using a table of random
incidence of anaerobic infection falls numbers. The codes were known only
towards zero. These drugs are almost to the pharmacist.
entirely free of serious side-effects.6'8
Patients in both groups received
In recent studies3’5 at the Montreal clear fluids and 30 ml of magnesium
General Hospital, involving 138 pa citrate for 2 days before operation.
tients who received metronidazole, Enemas were administered the night
orally or intravenously, in conjunc before the operation until the return
tion with neomycin orally as prophy was clear.
laxis, there were six wound infections;
Group 1 received metronidazole,
five were staphylococcal and one was 750 mg orally three times and neo
due to bacteria originating in the in mycin, 1 g orally three times on the
testine. Since the antibacterial activity day before operation. Group 2 re
of metronidazole is confined to anae ceived clindamycin, 450 mg orally
robic organisms, we decided to study three times and neomycin 1 g orally
clindamycin, which is effective against three times on the day before surgery.
anaerobes such as Bacteroides sp.7 as No antibiotics were given postoperwell as aerobes such as staphylococci. atively.
Clindamycin is present in wound fluid
The wounds were inspected for evi
in adequate concentrations following dence of infection on days 4 and 8
preoperative administration.9
after operation and on the day of dis
A prospective, randomized, double charge. Infection was defined as in
blind, clinical trial was, therefore, flammation and induration in the
undertaken to compare the effective wound with the discharge of pus, re
ness of metronidazole to that of clin gardless of the culture results.
damycin, orally administered, as part
All patients were checked daily for
of a prophylactic regimen in elective signs of elevated body temperature,
colon surgery. Anergy testing was per tachycardia and diarrhea. Patients
formed perioperatively.
who had diarrhea (three or more li
quid stools a day or, in patients with
Patients and Methods
a colostomy, an effluent in excess of
500 m l/d) after or during the admin
Clinical Study
istration of the drugs, underwent the
The study population consisted of following investigations: proctosig-
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moidoscopy with biopsy and the
testing of stools for the presence of
Clostridium difficile cytotoxins.
Anergy Testing
Delayed hypersensitivity skin test
ing was performed perioperatively,
using six recall antigens (purified pro
tein derivative, histoplasmin, Varidase, Candida, Trichophyton, dinitrochlorobenzene) injected intradermally. Injection sites were examined
after 48 hours. The skin test was con
sidered to be positive if two or more
of the six recall antigens produced an
induration of 5 mm or more. The pa
tient was considered relatively anergic
if only one of the antigens reacted
and anergic if none of the antigens
produced induration of 5 mm or
more.
Microhiologic Studies
Quantitative bacteriologic cultures
were made of feces before antibiotic
administration and of colon contents
and peritoneal fluid obtained at the
time of operation. Decimal dilutions
of the material were inoculated onto
the surface of selective and nonselective media using a calibrated multiple
loop applicator.3 Surface viable counts
were recorded for total aerobes, en
terobacteria (coliforms), Streptococcus
faecalis (enterococci), staphylococci,
Candida sp, Pseudomonas aeruginosa,
lactobacilli, bifidobacteria, Bacteroides
sp, clostridia, anaerobic cocci and total
facultative anaerobes.
Qualitative cultures of infected
wounds were made for both aerobes
and anaerobes. Biologic assays of
metronidazole and clindamycin in
blood, colon content and separated
colon mucosa and muscularis muco
sae, obtained at the time of operation,
were carried out using the variable
volume and plate diffusion tech
nique.10 All samples for assay were
first screened to ensure the absence of
unsuspected interfering antibiotics.
The carriage rate of Staphylococcus
aureus was determined by cultures of
abdominal skin and nose made before
the administration of antibiotics.
Statistical analysis was carried out
using the unpaired, Student’s f-test.
Results

Clinical
One hundred and three consecutive
patients entered the trial. Twenty-two
patients were rejected for reasons
listed in Table I, leaving 81 patients
614

eligible for study. When the code was
broken, a number of factors were ex
amined to validate the randomization
carried out by the hospital pharma
cist. There were 43 patients in group
1 (metronidazole) and 38 patients in
group 2 (clindamycin). The following
characteristics of the patients in both
groups were similar: age distribution,
disease process, type of operation,
operating surgeon, duration of opera
tion, duration of hospital stay preand postoperatively, drainage of
wounds and type of anastomosis (hand
versus stapler). There were no differ
ences between the two groups in the
extent of primary disease or associated
systemic disease (such as diabetes mellitus). All wounds were closed pri
marily.
Of the 43 patients in group 1, 3
had wound infections. Two infections
were associated with aerobic fecal or
ganisms (coliforms) and one was sta
phylococcal (S. aureus). There were
no abdominal wound infections in the
38 patients in group 2. This difference
in the number of wound infections in
each group is not statistically signif
icant. No wound infections developed
during a 6-month period following
discharge from the hospital. Thirtyseven patients were tested preoperatively for delayed hypersensitivity
reactions according to the method of
Pietsch and Meakins.11 In group 1, 11
of 23 patients tested were anergic, 4
were relatively anergic and 8 were
normal. In group 2, 3 of 14 patients
tested were anergic, 2 were relatively
anergic and 9 were normal. These dif
ferences were not significant. In the
three infected patients, one was aner
gic and one was relatively anergic; the
third patient was not tested. Our study
population contained a majority of pa
tients having cancer (38 in group 1
and 32 in group 2) and some had mal
nutrition which is a known depressant
of delayed hypersensitivity.11
Two types of bowel anastomosis
were used: hand and stapler. In group
1, 27 anastomoses were done by hand,
the stapler was used in 12, and for
group 2 the figures were 28 and 5,
respectively. In the three infected pa
tients, anastomosis was carried out by
hand in two and with a stapler in the
third. These differences were not
significant. The mean duration of hos
pital stay after operation was 12.9
days (standard deviation ± 3 . 2 days)
in group 1 and 14.4 days (± 5.7 days)
for group 2, a difference that is not
statistically significant. In the infected
patients, the mean duration of hospital
stay was 19.3 days (± 6.4 days).
Ten group 1 patients were drained

through a separate stab wound and 5
through the operative incision while
the remaining 28 patients were not
drained. In group 2, of 38 patients, 5
were drained through a separate stab
wound, 12 through the operative inci
sion wound while 21 patients were not
drained. Of the three infected pa
tients, two were drained through a
separate stab wound while no drainage
was employed in the third. These dif
ferences were not significant. A 2.5cm Penrose drain was used in each
case.
Adverse effects from the drugs
were minimal. Two patients in group
1 and one in group 2 vomited more
than one dose of the antibiotics. One
patient in group 2 had pseudomem
branous colitis postoperatively, diag
nosed by sigmoidoscopy and biopsy.
The organism isolated was heat re
sistant Clostridium perfringens and no
C. difficile was identified. The colitis
resolved quickly with a 10-day course
of metronidazole and no relapses were
noted during the 6 months of follow
up.
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Bacteriologic Findings
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Carriage rate of S. aureus.—In
group 1, 6 of 26 patients (23%) had
S. aureus in the pretreatment feces,
an average of 103'4 organisms per
gram, and 3 of 40 patients (7.5%)
had S. aureus in nose or abdominal
skin, or both.
In group 2, 8 of 36 patients (22%)
carried S. aureus in the admission
pretreatment specimen of feces, an
average 1035/g, and 11 of 33 patients
(33%) had this organism in the nose
or abdominal skin cultures, or both.
No clinical infections with S. aureus
were noted.
Pretreatment feces.—No significant
differences were noted between clin
damycin and metronidazole for any
of the bacterial populations examined
(log. normal distribution: unpaired
two-tailed Student’s f-test) (Table II).
Colon contents.—Twenty-eight sam
ples of colon content were analysed
for the clindamycin group (group 2)
and 35 samples for the metronidazole

H

u
A. 4

A
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Table I- R e a s o n for Exclusion of Patients
Reason for exclusion

No. of
patients

No bowel incision
Other preoperative antibiotics
Postoperative antibiotics
No preoperative antibiotics
Code broken

10
2
6
1
3

Total

22
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group (group 1). There was no statis
tical difference between the two groups
for coliforms, the median concentra
tion being nil (less than lOVg). In
group 2, only 2 of the 28 samples
were positive for Bacteroides fragilis,
at a concentration of 102/g (a level
regarded as biologically not signif
icant).3,3 For group 1 patients, the scat
ter was greater, 6 of 35 samples being
positive for B. fragilis, with concen
trations ranging from lOVg to 106/g.
Two of these samples exceeded
1O'5/g, a figure previously regarded
as a critical level for biological sig
nificance.3,5 A statistical comparison
of the bacterial data for the two
groups gave a single tail P value of
0.03 consistent with a marginal su
periority of clindamycin in eliminating
anaerobes in the colon, under the con
ditions of this trial (Table III).
Peritoneal fluid.-—Twenty-two sam
ples of peritoneal fluid in group 2
yielded coliforms (102/g), 1 yielded
enterococci (lOVg) and 20 were bacteriologically sterile. No patients were
clinically infected.
Of 30 samples in group 1, 1 yielded
coliforms (103/g),
1 enterococci
(lOVg) and the remaining 28 samples
were bacteriologically sterile.

Assays of serum and colon content.
—Seventeen samples of serum were
assayed for clindamycin, yielding a
mean of 2.2 /xg/ml (± 1.7 /xg/ml).
Twenty-seven samples of colon con
tent yielded a mean of 19.2 /xg/ml
(±16.9 /xg/ml). The mean level in
the colon was approximately nine
times higher than in serum.
Twenty-four samples of serum were
assayed for metronidazole, yielding a
mean of 11.2 /xg/ml (±7.3 /xg/ml).
Thirty-five samples of colon content
had a mean concentration of metro
nidazole of 12.3 /xg/ml (±12.3
Ug/ml). Seven samples were below
the threshold of sensitivity of the test
(3 /xg/ml). The mean level of anti
biotic in the colon approximated that
in serum.
Tissue assays.—Seven samples of
colonic mucosa and muscularis mu
cosae were assayed for clindamycin.
They yielded a mean concentration of
the antibiotic of 15.9 /xg/g of tissue
(±17.3 /xg/g) and 3.7 /xg/g (±1.9
/xg/g) respectively.
Five similar samples, assayed for
metronidazole, yielded a mean of 8.8
/xg/g of tissue (±12.6 /xg/g) and 13.6
/xg/g (±18.9 /xg/g) respectively.
The ratios of antibiotic concentra

Table II-Bacteriology: Pretreatment Feces
Count,
log. 10/g
Nil
102
103
10*
10s
106
107
108
108
Mean

Coliform organisms
Clindamycin

Bacteroides organisms

Metronidazole

2

Clindamycin

1

—

3
9
10
4
_
—

4.7

_

1

_

_

6
8
5
6
4
3
-

_

_

5
4
3
9
6

9
9
6
7
3
1

5.3
__ I

1

Metronidazole

1

6.2

6.6
__ |

1

P = 0.3

P = 0.3

Table III-Bacteriology: Colon
Count,
log. 10/g
Nil
102
103
104
105
106
107
Mean

Coliform organisms
Clindamycin

Bacteroides organisms

Metronidazole

23
3
2

28
—

3
2

—

_

_
_

1
1
1.3

1.7

Clindamycin
26
2

29
2
1
1
1
1

_
_
_
_

-

1.1

1____

L-

P == 0.2

Metronidazole

1.5

P = 0.03 (single tail)

tions were determined in each patient
for serum to mucosa, mucosa to mus
cularis mucosae and serum to muscu
laris mucosae. The metronidazole ra
tios were compared with the clinda
mycin ratios using one-tailed Student’s
/-test to determine if they were of
the same order. Comparison of the
mucosa to muscularis mucosae ratios
for the two antibiotics gave a P value
of 0.04, while the serum to muscu
laris mucosae ratios gave a P value
of 0.025 and for serum to mucosa
ratios the P value was 0.005.
Metronidazole appears in mucosa
in concentrations similar to those
found in serum. By contrast, clinda
mycin appears to accumulate actively
in the mucosa. The reason for this
is not known.
Discussion
Bacterial concentrations of 10” to
10” cfu/g are found in the colon.”
Anaerobic bacteria make up 99.9%
of the fecal flora. The dominant or
ganism in the colon is B. fragilis in a
concentration of 109 to 1010/g of feces
in healthy individuals.” Leigh13 re
ported pure growths of B. fragilis in
half the wounds that became infected
following intestinal operations. A
complication of oral antimicrobial
prophylaxis against anaerobes is the
overgrowth of Candida sp. and sta
phylococci.14 We found, in a series of
138 patients3-5 treated with metronida
zole and neomycin, that five out of
six wound infections were staphylo
coccal alone and only one was due
to bacteria of intestinal origin. Anti
biotics that are effective against anae
robes, particularly B. fragilis, include
clindamycin, metronidazole, rifamycin, lincomycin, erythromycin and
chloramphenicol. We chose clinda
mycin because of its activity against
staphylococci and anaerobic gram
positive cocci in addition to its effi
cacy against B. fragilis.” Wagner and
associates16 found that after adminis
tering a single 250-mg dose of clinda
mycin, the mean half-life of the anti
biotic was 2.3 hours. Only 6.4% of
the dose is excreted in the urine”
while high concentrations are found
in the bile.18
As in previous studies with metronidazole3'5’14 no anaerobic infections
were found in our series, as was the
case with clindamycin, which has not
previously been tested in elective
bowel preparation. No infections were
noted with clindamycin in this study
while three patients in the metronida
zole group had wound infections (two
coliform, one staphylococcal). De-
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spite the fact that, when statistically
analysed, the distribution of infection
is not significant, our quantitative
cultures show a significant difference
(P = 0.03) between the two drugs in
eliminating anaerobes in the colon,
clindamycin being more effective.
This may be secondary to high levels
of clindamycin in colonic mucosa and
contents, as shown by our tissue as
says. This is in agreement with the
work of Berger and associates19 who
found high penetration of clindamy
cin into inflamed appendices.
Clindamycin protected against sta
phylococcal infections despite the fact
that 11 of 33 patients were carriers
in nose or skin, or both, compared
with 3 of 40 in the metronidazole
group. This could be due to the ac
tivity of clindamycin against staphy
lococci and also to its high concentra
tion in wound fluid.9 Clindamycin has
also been found to be more effective
in the treatment of anaerobic lung
abscesses than metronidazole.20
When the findings of this study were
combined with those of our previous
studies3,5 in 181 patients who received,
as prophylaxis, metronidazole orally
or intravenously in conjunction with
orally administered neomycin, there
have been nine infections (4.9%), of
which six were staphylococcal and
three were due to bacteria of gut
origin, compared with no infections
in the 38 patients who received clin
damycin and neomycin orally.
Responding to reports that diarrhea
and pseudomembranous colitis oc
curred relatively frequently among pa
tients who received clindamycin,21 we
followed all our patients carefully for
development of diarrhea. In one pa
tient who had anterior resection for
peridiverticular abscess and ulcerative
colitis, pseudomembranous colitis de
veloped; it was confirmed by sigmoid
oscopy and biopsy. However, only C.
perfringens was isolated, and for tech
nical reasons we were unable to check
for C. difficile toxins in stool. This
patient had received clindamycin as
bowel preparation. Clostridium dif
ficile is known to be responsible for
the majority of cases of pseudomem
branous colitis.22,23 Clindamycin as
the cause of this condition has been
disputed both in prospective23 and
retrospective24,25 studies. Any antimi
crobial drug capable of altering the
normal intestinal flora can be respon
sible for precipitating pseudomem
branous colitis.25 Diarrhea has not
been reported after a 1-day course of
clindamycin, which is in agreement
with our data. Two patients receiving
metronidazole and one receiving clin
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damycin vomited more than one dose
of antibiotics but no nausea, maculopapular rash, urticaria, transient ab
normality of liver function tests,
transient leukopenia or eosinophilia
was reported in either group.
Conclusions

The results of a prospective, ran
domized, double-blind, clinical trial,
assessing the relative effectiveness of
metronidazole-neomycin and clinda
mycin-neomycin as a preoperative
bowel preparation, indicate no signif
icant difference in the reduction of
aerobic bacteria of feces and colon
content between the two groups.
There was, however, a significantly
greater reduction in anaerobic bac
teria in the feces of patients receiving
clindamycin. Tissue assays showed ac
cumulation of clindamycin in the
colonic mucosa, while the colon con
tent to serum drug level ratio was
9:1.
Both clindamycin and metronida
zole are equally effective in reducing
postoperative wound sepsis, but clin
damycin may aid in preventing sta
phylococcal infection, a known resid
ual problem in metronidazole pro
phylaxis.
The accumulation of clindamycin
in such high concentration in the wall
of the colon may play a significant
role in preventing infection at the
anastomotic site.
We thank Dr. Shirley Chou for carry
ing out the tissue assays for clindamycin
and metronidazole.
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Variations of Cardiac Rate and Hemodynamic
Criteria of Rejection
R obert P arent, b sc, Gilles D ucharme, m
Since heart rate influences the values
of many hemodynamic parameters, the
authors have examined the effect of
heart rate variations noted after cardiac
transplantation on the hemodynamic
criteria of rejection. They have
undertaken serial studies at intrinsic
rate and at a paced atrial rate of
150 beats/min in 11 resting
homotransplanted dogs. The authors
analysed cardiac index, stroke volume,
peak velocity, acceleration, stroke
power and stroke work. Results at
intrinsic and paced atrial rates were
compared during each of three phases
of postoperative evolution: phase II
(2 to 3 days after transplantation),
phase III (4 to 5 days) and phase IV
(6 to 7 days postoperatively).
Phase II, being the period of maximum
recovery, served as a baseline for
comparing the cardiac parameters
in phases III (the initial phase of
rejection) and phase IV (24 hours
before death).
The authors found that the patterns
of change were similar at intrinsic
and paced atrial rates and concluded
that heart rate variation does not
significantly influence the hemodynamic
criteria of rejection.

sc, P aul Stanley, md and C laude

rythme auriculaire stimule de 150
pulsations/min, chez 11 chiens au
repos, porteurs d'une homogreffe. Les
auteurs ont analyses I’index cardiaque,
le debit systolique, la velocite
maximum, (’acceleration, la puissance
de contraction et le travail systolique.
Les resultats a rythme intrinseque
et a rythme auriculaire stimule ont
ete compares pour chacune des trois
phases devolution postoperatoire: la
phase II (2 a 3 jours apres la greffe),
la phase III (4 a 5 jours) et la phase
IV (6 a 7 jours apres I'operation).
Comme la phase II correspond a la
periode de retablissement maximum,
elle a servi de valeur de depart pour
comparer les parametres cardiaques
en phase III (la phase initiale de rejet)
et en phase IV (24 heures avant la
mort).
Les auteurs ont decouvert que les
caracteristiques de changement etaient
les memes, que ce soit a rythme
intrinseque ou a rythme auriculaire
stimule. Ils concluent que les variations
du rythme cardiaque n'influencent pas
de facon significative les criteres
hemodynamiques de rejet.

Hemodynamic criteria of acute car
diac rejection have been reported pre
viously,1 and it was found that the
Puisque le rythme cardiaque influence
plusieurs parametres hemodynamiques,
hemodynamic measurements in which
les auteurs ont etudies les effets d’une
velocity was a component were ex
variation du rythme cardiaque apres
tremely sensitive and revealing in the
greffe cardiaque sur les criteres
detection of the initial phase of re
jection. However, variations of cardiac
hemodynamiques du rejet. Ils
ont entrepris des etudes en
rate from one subject to another and
from one postoperative phase to an
serie, a rythme intrinseque et a un
other
were observed.
From the division of cardiovascular
Aware
of the effects that variations
surgery, Centre de Recherche
in
cardiac
rate can have on the hemo
Pediatrique, Hopital Ste-Justine,
dynamic parameters used to indicate
Universite de Montreal and McGill
the initial phase of rejection,2-4 we de
University, Montreal, PQ
cided to assess the importance of
Presented at the 86tli annual meeting
of the Canadian Association of Clinical these variations, to establish their
Surgeons, eastern division,
functional effects on the parameters
Ottawa, Ont., May 15, 1982
mentioned above and to verify our
Supported by Medical Research Council diagnostic criteria of early rejection.1
of Canada grant 4391, Fondation
We undertook a series of experi
Alexandre de Seve, Fondation
ments in the orthotopic transplanted
Canadienne des Maladies du Coeur
heart to evaluate the effects of daily
and Fondation des Clubs Sociaux
changes in cardiac rate on the hemo
de Montreal
Accepted for publication Aug. 18, 1982 dynamic measurements used in the
diagnosis of rejection. Serial studies
Reprint requests to: Dr. Claude
of
ventricular function were per
Chartrand, Section de chirurgie
formed in dogs at intrinsic rate and
cardio-vasculaire, Hopital Ste-Justine,
3175, chemin Ste-Catherine, Montreal, at a rate of 150 beats/min, controlled
PQ H3T 1C5
by auricular pacing. Our aim was to

C hartrand,
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verify if the evolution curves of ven
tricular function were identical at
intrinsic and at controlled heart
rates.
M aterial an d M eth o d s

Eleven mongrel dogs, weighing
from 15 to 29 kg, were chosen in ac
cordance with our biochemical and
hematologic normograms.5 Following
induction of anesthesia with pentobar
bital sodium (25 mg/kg), left thora
cotomy was carried out, peripheral
vessels were cannulated and the dog
was connected to the heart-lung ma
chine and perfused according to the
techniques previously reported.®
Orthotopic homotransplantation of
the heart was performed following the
technique of Lower, with modifica
tions.1,7 During the ischemic period
(53.5 minutes) the heart was protected
with a cooling bag.8 Following com
pletion of the anastomoses, circulatory
assistance was continued for a period
of 1 hour to allow functional recovery
of the graft and insertion of instru
ments for measuring the hemodynamic
status: suture of conduction wires
to the left atrial wall, insertion of
an electromagnetic flowmeter probe
around the ascending aorta (Gould
Statham Flo-Probe Blood Flow Trans
ducer Model SP75115; Gould Stat
ham. Oxnard, Calif.), introduction of
no. 8 French catheters through the
left subclavian artery into the aortic
arch and into the right atrium through
the left jugular vein. The left atrial
wires, the transducer cables and the
catheters were exteriorized at the base
of the dog’s neck dorsally.
This experimental preparation al
lowed for daily evaluation of the car
diac function of the nonsedated, rest
ing animal at intrinsic rate and at a
rate of 150 beats/min stabilized by
left atrial pacing. The following data
were recorded during each study:
heart rate, electrocardiographic find
ings, cardiac index, stroke volume in
dex, maximum systolic flow index,
peak velocity, maximum acceleration
index, stroke work index, stroke pow
er index, and systolic, diastolic and
mean arterial pressures; the methods
of recording, conversion, calculation,
indexation and analysis that have been
reported previously in detail were fol
lowed.1
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Only the dogs that remained well
were retained in the study. Experi
mental conditions were identical in
both groups, thus allowing valid com
parisons. The dogs were grouped ac
cording to the heart rate (intrinsic or
stabilized) and to the period of evolu
tion as defined previously.1 These pe
riods correspond to the phases of
postoperative evolution that are ident
ified in terms of both time lapse and
functional status of the animal.
Phase II (days 2 and 3 after opera
tion) corresponds with a plateau of
cardiac performance that is never sur
passed in the later periods. The ab
solute data of this period are used as
reference points for comparison with
the later periods. In phase III (days
4 and 5 after operation) there are
signs of decreased ventricular perfor
mance corresponding to the functional
initial stage of rejection. Phase IV
(days 6 and 7 after operation) is ac
companied by a severe deterioration
of all the parameters of ventricular
function and, in total rejection, oc
curs in the 24 hours preceding death.
Comparisons between the different
postoperative phases were carried out
at intrinsic and at stabilized rates. The
data obtained in all phases were used
for comparison and statistical anal
ysis by one-way analysis of variance.
Multiple comparisons were performed
using the paired Student’s f-test cor
rected for the Bonferonni inequality.9

Ta b le 1 -C om pa rison o f P hase II and P hase III
at Intrinsic H eart Rate*
Phase
M ea su rem e nt
H eart ra te, beatslm in
(n = 9)
Cardiac in d e x, l/min ■m 2
(n = 9)
S troke v o lu m e index, ml/m2
(n = 9)
M a xim u m sys to lic f lo w index,
m ils ■m 2 (n = 9)
Peak v e lo c ity , cm/s ■m 2
(n = 9)
M a xim u m acceleration index,
cm/s2 ■n r 2 (n = 9)
S troke p o w e r index,
103 erg/s • m '2 (n = 8)
S troke w o r k index,
103 d yn -c m fm 2 (n = 8)
S ystolic arterial pressure.
m m Hg (n = 8)
Diastolic arterial
pressure, m m Hg (n = 8)
M ean a rterial pressure.
m m H g (n = 8)

ll-lll
(absolute values)!

III
(% change)

132.7 ± 6.6

6.9 ± 7.1

5468.6 ± 527.3

1065.9 ± 330.1

-1 9.5 *

41.22 ± 3.19

5.86 ± 1.69

-14.2*

355.29 ± 24.33

43.57 ± 13.24

-12.3*

192.14 ± 10.49

23.78 ± 7.56

-12.4*

4003.0 ± 256.8

873.6 ± 148.2

-2 1.8 §

63 954.0 ± 5634.0

12 352 ± 2712.2

-19.34!

7377.2 ± 650.3

1540.8 ± 284.5

-2 0 .9 §

133.26 ± 5.05

8.77 ± 7.87

-6 .6 (NS)

87.87 ± 3.89

8.34 ± 6.76

-9 .5 (NS)

109.47 ± 4.36

8.69 ± 6.04

-7 .9 (NS)

-5 .2 (NS)

'V a lu e s are m ean ± standard erro r o f mean.
tD iffe re n c e b e tw e e n absolute va lu e s o f phases II and III.
* P < 0.05.
§ P < 0.005.
H P < 0 .0 1 .
N S = not significant (P > 0.05).

Results

Ta ble 11-C om parison o f Phase II and P hase III
at Rate Stabilized b y A trial Pacing

The dogs survived an average of
6.4 days. We accepted no other data
than those obtained in the animals
in which the atrial pacing at 150
beats/min could be induced and main
tained during the whole hemodynamic
study and in which total rejection was
confirmed at autopsy.
Tables I and II show the hemody
namic data obtained in phases II and
III. Comparison of these results shows
that during phase III there is a signif
icant decrease of ventricular perform
ance indices at both intrinsic and
stabilized rates. The most important
changes were in maximum accelera
tion index, stroke power index and
stroke work index. Arterial blood
pressure decreased slightly but not
significantly.
It is noteworthy that the decrease
in ventricular performance both at in
trinsic (Table I) and stabilized (Table
II) rates was identical in spite of the
variations in frequency. However, the
variations in intrinsic rate were slight.
The results of the tests in phase
IV, 24 hours before death, showed
that there was a severe deterioration
618

II
(absolute values)

Phase
M e a su rem e nt
H eart rate, beatslm in
(n = 9)
Cardiac in d e x, l/min •m 2
(n = 9)
S tro k e vo lu m e index, ml/m2
(n = 9)
M a xim u m s ys to lic f lo w index,
ml/s ■n r 2 (n = 9)
Peak ve lo c ity, cm/s •m 2
(n = 9)
M a xim u m acceleration index,
cm/s2 ■m 2 (n = 9)
S tro k e p o w e r index,
103 erg/s ■m 2 (n = 8)
S tro k e w o r k index,
103 dyn-cm /m 2 (n = 8)
S ysto lic arterial pressure ,
m m Hg (n = 8)
Diastolic arterial
pressure, m m H g (n = 8)
M ea n arterial pressure ,
m m Hg (n = 8)
*P
tP
*P
NS

<
<
<
=

II
(absolute values)

H ill
(absolute values)

150 ± 0

0

5630.3 ± 395.4

781.8 ± 229.4

N o test.
Controlled
rate
-13.9*

36.43 ± 2.65

4.10 + 2.17

-11.3 (NS)

340.49 ± 23.50

37.62 + 9.24

-ll.O t

184.09 ± 29.93

20.46 ± 5.41

-11.1*

3837.1 ± 247.0

667.04 + 86.04

-17.4*

61 864.0 ± 4872.0

9872.5 + 1688.6

-1 6.0 *

6797.9 ± 481.9

1286.1 ± 229.5

-18.9*

136.23 ± 6.17

7.81 ± 5.71

-5 .7 (NS)

94.05 ± 4.61

5.38 ± 4.03

-5 .7 (NS)

112.03 ± 5.31

6.56 ± 4.55

-5 .9 (NS)

III
(% change)

0.05.
0.01.
0.005.
not significant (P > 0.05).
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of ventricular function secondary to
acute rejection (Tables III and IV).
Moreover, there was a significant drop
in the blood pressures. During phase
IV, as in phase III, the decreases in

the values were similar during intrin
sic (Table III) and stabilized (Table
IV) rates in spite of a more notable
change in frequency of the intrinsic
cardiac rate.

Table III-Comparison of Phase II and Phase IV
at Intrinsic Heart Rate
II
(absolute values)

Measurement
Heart rate, beatslmin
(n = 8)
Cardiac index, llmin - m 2
(n = 8)
Stroke volume index, mllm2
(n = 8)
Maximum systolic flow index,
m l/s-nr2(n = 8)
Peak velocity, cmls ■m 2
(n = 8)
Maximum acceleration index,
cmls2- m 2(n = 8)
Stroke power index,
103 erg/s-m 2(n = 7)
Stroke work index,
103 dyn-cm/m2 (n = 7)
Systolic arterial pressure,
mm Hg In = 7)
Diastolic arterial
pressure, mm Hg (n = 7)
Mean arterial pressure,
mm Hg (n = 7)
*P < 0.005.
tP < 0.05.
NS = not significant (P > 0.05).

Phase
ll-IV
(absolute values)

IV
(% change)
-10.9 (NS)

137.1 ± 5.3

14.93 ± 11.07

5055.5 ± 449.9

3259.3 ± 203.0

-64.5*

36.86 ± 2.79

21.85 ± 1.44

-59.3*

330.40 ± 18.77

165.20 ± 8.42

-50.0*

175.59 ± 9.37

88.17 ± 5.14

-50.2*

3716.5 ± 270.2

2050.4 ± 194.2

-55.2*

57 324.4 ± 4971.2

32 299.7 ± 2350.2

-56.3*

6320.8 ± 584.3

3988.9 ± 248.0

-63.1*

129.61 ± 6.87

25.71 ± 6.65

-19.8t

87.17 ± 4.77

30.58 ± 4.45

-35.1*

104.04 ± 7.17

33.98 ± 5.02

-32.7*

Table IV-Comparison of Phase II and Phase IV
at Rate Stabilized by Atrial Pacing
Phase
Measurement
Heart rate, beatslmin
(n = 8)
Cardiac index, llmin - m 2
(n = 8)
Stroke volume index, mllm2
(n = 8)
Maximum systolic flow index,
m lls-m 2(n = 8)
Peak velocity, cmls ■m 2
(n = 8)
Maximum acceleration index,
cmls2 ■m 2 (n = 8)
Stroke power index,
103 ergls ■m 2 (n = 7)
Stroke work index,
103 dyn-cmlm2 (n = 7)
Systolic arterial pressure,
mm Hg (n = 7)
Diastolic arterial
pressure, mm Hg (n = 7)
Mean arterial pressure,
mm Hg (n = 7)
*P < 0.005.
IP < 0.05.
*P < 0.01.

II
(absolute values)

HIV
(absolute values)

150 ± 0

0

5208.0 ± 394.4

3089.89 ± 257.7

IV
(% change)
No test.
Controlled
rate
-59.3*

34.72 ± 2.63

20.60 ± 1.72

-59.3*

315.26 ± 20.33

146.12 ± 12.12

-46.3*

167.82 ± 10.65

77.77 ± 6.15

-46.3*

3644.1 ± 276.5

1837.0 ± 176.5

-50.4*

54773.7 ± 5431.1

27 622.9 ± 1720.0

-54.3*

5994.1 ± 560.9

3676.0 ± 283.9

-61.3*

130.78 ± 8.16

19.99 ± 6.19

-15.3t

90.65 ± 6.37

25.16 ± 5.69

-27.8*

108.04 ± 6.94

25.48 ± 4.85

-23.6*

Discussion

It is well known that variations in
cardiac rate can modify the absolute
values of certain measures of ventri
cular function, particularly those in
which velocity is a component.2-4 It
has been shown that the changes dif
fer, depending on the amplitude of
these variations. For example, with
only slight variations (a range of
110 to 150 beats/ min), Nobel and as
sociates10 have observed, in the con
scious dog under atrial pacing, a slight
decrease in the ventricular end-dia
stolic pressure and volume and in
stroke volume and work. In man, at
rates ranging from 60 to 180 beats/
min, Benchimol and Ligget11 reported
a progressive and moderate increase
of cardiac index, tension time index,
dP/dt (rate of rise in ventricular pres
sure) and arterial pressure and a pro
gressive and moderate decrease of
stroke index, stroke power, stroke
work, systolic ejection time and mean
systolic ejection rate.
In a previous publication in which
we reported on the hemodynamic
signs of rejection in dogs with ortho
topic heart transplants,1 the para
meters of ventricular performance,
where velocity was a component, were
very sensitive in detecting the initial
phase of rejection. However, during
those experiments we had observed
variations in cardiac rate from one
animal to another and from one post
operative phase to another. Aware of
the fact that the velocity indices could
be affected by variations of the heart
rate, we questioned the validity of our
diagnostic criteria of rejection and un
dertook the present series of experi
ments to test this.
Since each dog served as its own
reference and since the experimental
conditions were identical at both in
trinsic and stabilized rates, our com
parisons were reliable and controlled.
The results of the serial hemody
namic studies at intrinsic rate and at
stabilized rate can be superimposed
and are expressed in phase III by a
substantial decrease of 10% to 20%
of the ventricular functional para
meters and in phase IV by a marked
fall of at least 40% in all functional
indices.
This similarity allows us to con
clude that the variations in intrinsic
rate did not influence the hemodyna
mic indices. However, it must be
noted that the variations in cardiac
rate were only 5.2% in phase III and
10.9% in phase IV and that they may
be insufficient to modify ventricular
function indices.
However, if important daily varia-
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tions of cardiac rate occur in a pa
tient, comparison of the hemodynamic
indices would most likely not be re
liable and the functional consequences
of rejection would not be detectable.
In such an event, stabilization of the
rate by atrial pacing would allow more
valid comparison.
Comparison of the overall hemo
dynamic tables shows that the drop
in cardiac performance is a little less
severe when the atrial rate is stabil
ized at 150 beats/m in. This observa
tion suggests a beneficial effect of
pacing during rejection.
In conclusion, analysis of the serial
hemodynamic results shows that func
tional evolution curves at intrinsic
and stabilized rates are superimposable. Thus, the variations in cardiac
rate observed in the unpaced heart did
not have significant repercussions on
the cardiac performance indices, pos
sibly because these variations were
slight. W e conclude from this study
that the results obtained at the stabil
ized rate reflect the hemodynamic ex
pression of cardiac rejection and that
our diagnostic functional criteria of
rejection already described remain
valid.
We gratefully acknowledge the tech
nical help of Gaston Angrignon, Suzanne
Chartrand, Lise Langevin, and Gaetan
Lagace and the secretarial help of
Jocelyne Vachon and Sylvie Tasse.
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Treatment of Pancreatitis Associated with Pancreas
Divisum by Dorsal Duct Sphincterotomy Alone
Roger G. K eith ,

md , frcs [c ], frcs, facs,*
AND F R E D R IC

Of 480 patients seen with pancreatitis
at the Sunnybrook Medical Centre,
Toronto, in the past 5 years, 5 had
pancreas divisum, demonstrated by
pancreatography. Clinical presentations
included recurrent acute pancreatitis,
chronic pancreatitis and recurrent
subcutaneous fat necrosis with
steatorrhea. Pancreatography
demonstrated dorsal pancreatic
drainage through the duct of Santorini
in all cases. The luminal diameter at
the orifice of the duct of Santorini,
assessed at operation, was inadequate
to provide normal drainage from the
gland.
Sphincterotomy of the duct of
Santorini alone, without surgery to
the duct of Wirsung or sphincter of
Oddi, was performed in four patients.
This relieved the pain of chronic
pancreatitis, eliminated recurrent
attacks of acute pancreatitis and
curtailed recurrences of subcutaneous
fat necrosis and steatorrhea during
follow-up periods of 51, 27, 17 and
28 months respectively. One patient
who refused operation continued to
have recurrent pancreatitis 41 months
after diagnosis.

G.

T heodore F. Shapero,

md,

F R C P [c]f

S A IB IL , M D , F R C P [ c ] f

canal pancreatique accessoire a ete
etabli a I'operation et il s'est revele
insuffisant pour assurer le drainage
normal de la glande.
Une sphincterotomie du canal
pancreatique accessoire, sans chirurgie
du canal de Wirsung ou du sphincter
d’Oddi, a ete pratiquee chez quatre
patients. Cette intervention soulagea
la douleur de la pancreatite chronique,
elimina les recidives de pancreatite
aigue et ecourta les recidives de
necrose des tissus adipeux
sous-cutanes et de steatorrhee aux
examens de controle effectues apres
51, 27, 17 et 28 mois respectivement.
Un patient qui refusa I'operation
souffre toujours de pancreatite
recidivante 41 mois apres le diagnostic.

but the mechanism is unexplained. It
has been postulated that drainage of
secretions at the orifice of the dorsal
duct (Santorini) is inadequate.
This report describes the manage
ment of five selected cases of pan
creatitis associated with pancreas divi
sum. Operative findings and follow-up
results support the use of dorsal duct
sphincterotomy alone to provide ade
quate drainage of the dorsal pancreas
and thus prevent recurrent disease.
Patients

During 5 years beginning in 1976,
480 patients were seen with pancrea
titis at the Sunnybrook Medical
Centre in Toronto. Not all underwent
endoscopic retrograde cholangiopan
creatography. Five patients without
alcoholism or biliary tract disease
were found to have pancreas divisum.
In four the diagnosis was suggested
by the findings of endoscopic pan
creatography and confirmed by
operative pancreatography. In one
case endoscopic pancreatography was

By the seventh embryologic week, the
ventral pancreas, along with the bile
duct, has rotated posterior to the gut
and fused with the dorsal pancreas.
Normally, union of the ventral and
dorsal ducts occurs, with secretions
entering the gut through the orifice of
the ventral duct (Wirsung). The dorsal
duct (Santorini) persists in communi
cation with the ventral duct in over
85% of cases; however, the commu
Des 480 patients souffrant de
nication with the duodenum at the
pancreatite qui ont ete vus au cours
minor papilla is quite variable.1
des 5 dernieres annees au Sunnybrook
As early as 1910 Opie2 recognized
Medical Centre de Toronto, 5
that ventral and dorsal ducts may not
avaient une separation du pancreas
unite; secretions of the dorsal gland
demontree a la pancreatographie. Le
(cephalad head, body and tail) enter
tableau clinique comprenait pancreatite
the duodenum through the minor ori
aigue recidivante, pancreatite
fice of the dorsal duct (Santorini). The
chronique et necrose recidivante des
parenchyma is not cleaved and the
tissus adipeux sous-cutanes avec
caudad head and uncinate process
steatorrhee. Dans tous les cas, la
drain through the ventral duct at the
pancreatographie mettait en evidence
papilla of Vater (Fig. 1). Opie coined
un drainage dorsal du pancreas par
the term pancreas divisum to describe
le canal pancreatique accessoire. Le
this anatomic variant.
diametre a I'orifice de la lumiere du
Anatomists, using various injection
techniques, have found the incidence
of pancreas divisum, in an unselected
From the departments of *surgery and
population at autopsy, to be from 5%
t medicine, University of Toronto and
Sunnybrook Medical Centre, Toronto,
to
10%.1,3,4 Endoscopic pancreato
O nt.'
graphy has defined the anatomic vari
ant in large series of selected cases,
Presented at the 86th annual meeting
of the Canadian Association of Clinical in which the incidence varied from
Surgeons, eastern division, Ottawa,
3% to 6%.5-8 Whether this anatomic
Ont., May IS, 1982
abnormality can predispose to pan
Accepted for publication July 20, 1982
creatic inflammation remains contro
FIG. 1—Fusion of ventral and dorsal
Reprint requests to: Dr. Roger G. Keith, versial. Possibly some cases of idio
pathic, recurrent acute pancreatitis pancreas. Nonunion of ducts results in
Sunnybrook Medical Centre, 2075
Bayview Ave., Toronto, Ont. M4N 3M5 can be related to pancreas divisum pancreas divisum.
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Unsuccessful and the diagnosis was
established at operation.
Case Reports

Case 1.—A 22-year-old man had had
chronic recurrent pancreatitis since he
was 15 years old. A background of dull,
constant pancreatic pain was complicated
by multiple recurrences of severe pain
associated with elevation of the serum
amylase level. There was no history of
alcoholism. No family members had pan
creatitis.
Serum glucose, calcium, lipid and tri
glyceride levels and liver function were
determined; all were normal. A secretin
test showed normal volume but a bor
derline low level of bicarbonate (90
mmol/1). Cholecystography and ultra
sonography indicated a normal biliary
tract. An endoscopic retrograde cholangiopancreatogram failed to show the pan
creatic duct.
T ransduodenal operative pancreato
graphy revealed pancreas divisum. The
ventral duct (Wirsung) (orifice diameter
1 mm) was short and did not commu
nicate with the dorsal duct (Santorini).
The minor duct papilla was 2.5 cm prox
imal to the papilla of Vater. The dorsal
duct (orifice diameter 0.5 mm) was 4 mm
in diameter, coursing to the tail of the
gland, without changes suggestive of
chronic pancreatitis.
A sphincterotomy of the dorsal duct
orifice enlarged its diameter to 4 mm.
No surgical procedure was performed on
the sphincter of Oddi or the orifice of
the ventral duct.
Case 2.—On three occasions in the
previous 4 years this 59-year-old man
had required hospitalization for acute
pancreatitis. Notable amylasemia was as
sociated with severe abdominal pain on
each occasion. Elevation of the alkaline
phosphatase level without jaundice was
noted on the last admission. There was
no history of alcoholism.
Biochemical investigations indicated
normal glucose, calcium, lipid and tri
glyceride levels. Oral cholecystography
and abdominal ultrasonography demon
strated a normal gallbladder without
stones.
Intravenous
cholangiography
showed a normal extrahepatic biliary
tract. Endoscopic retrograde cholangio
pancreatography confirmed the normal
biliary tree, but only a small ventral pan
creatic duct was shown by pancreato
graphy. The minor papilla was identified
but could not be cannulated.
The patient refused operation. He was
followed up over the next 36 months.
Three episodes of acute pancreatitis
necessitated hospitalization during this
period. Transient jaundice, with maximal
elevation of serum bilirubin to 90.6
nmol/1, was noted on the last admission.
He continues to refuse operative treat
ment.
Case 3.—A 58-year-old woman had
been admitted to hospital with acute pan

creatitis on five occasions in the previous
3 years. Fourteen years before, she had
undergone cholecystectomy. She never
drank alcohol. Liver function studies
gave normal results. Serum lipid, tri
glyceride and calcium levels were nor
mal. Fasting blood glucose values ranged
from 3.33 mmol/1 to 5 mmol/1. Further
studies failed to show organic hypoglyce
mia. Abdominal ultrasonography demon
strated a normal extrahepatic biliary
tract. Pancreas divisum was suggested
when endoscopic retrograde cholan
giopancreatography visualized a small
duct in the ventral pancreas but no com
munication with the dorsal duct. A
secretin test gave a low bicarbonate value
(69 mmol/1) and reduced volume (1.5
ml/kg).
At operation the head of the pancreas
appeared atrophic. The body and tail
were fibrotic. Transduodenal cannulation
of the ventral pancreatic duct at the
papilla of Vater enabled operative pan
creatography to be carried out; it con
firmed the endoscopic findings. The
orifice of the ventral duct measured 3 mm
in diameter. The minor papilla of the
dorsal duct was identified 3 cm proximal
to the papilla of Vater. Difficult cannula
tion, using lacrimal duct probes, proved
that the orifice was 0.5 mm in diameter.
Pancreatography confirmed that the dor
sal duct (Santorini) ran from the tail to
this minor orifice. Sphincterotomy of the
dorsal duct orifice enabled a 3-mm probe
to be passed which corresponded to the
luminal diameter of the duct itself.
Case 4.—A 48-year-old woman had a
12-month history of intermittent abdom
inal pains of sufficient severity to require
hospitalization on three occasions. No
elevation of the serum amylase level was
recorded. A cholecystectomy had been
done 2 years previously. She did not
drink alcohol. Extensive investigations
failed to define a gastrointestinal cause
for the pain. Liver function, and serum
calcium, lipid and glucose levels and all
routine gastrointestinal films were nor
mal. Abdominal ultrasonography also
gave normal results. An endoscopic retro
grade cholangiopancreatogram showed a
normal common bile duct, but only the
short noncommunicating ventral duct of
the pancreas. A secretin test gave a low
bicarbonate value (69 mmol/1) and low
volume (0.3 ml/kg). Provocative testing
with secretin/morphine reproduced the
pain without elevation of the amylase
level.
At operation, the pancreas appeared
fibrotic. Transduodenal pancreatography
indicated that the ventral duct commu
nicated with only a small segment of
the gland in the head. The bile duct was
normal. The ventral duct orifice meas
ured 2 mm in diameter. The orifice of
the dorsal duct (Santorini) was located
1.5 cm proximal to the papilla of Vater
and measured 0.5 mm by lacrimal duct
probing. Pancreatography demonstrated
that the dorsal duct drained the entire
gland. The duct was not dilated.

Sphincterotomy of the minor duct
orifice increased the diameter to 3 mm.
Case 5.—For 30 months this 66-yearold man had had recurrent subcutaneous
fat necrosis. Twelve separate lesions oc
curred spontaneously on both arms, chest
and abdomen at intervals of up to 3
months. Biopsies confirmed the fat ne
crosis and suggested pancreatic disease.
The patient also had an 8-monfh history
of steatorrhea, which responded to sup
plementation with pancreatic enzyme. He
also had a history of peptic ulcer dis
ease.
The secretin test result was abnormal.
Ultrasonography and computerized to
mography demonstrated a normal gall
bladder but an enlarged pancreas. Endo
scopic retrograde cholangiopancreato
graphy revealed a normal biliary tract,
but only a small ventral pancreatic duct
was visualized, indicating pancreas divi
sum (Fig. 2).
At operation a fibrotic pancreas was
seen. Transduodenal pancreatography
confirmed that the dorsal duct drained
the entire gland through the minor papil
la, located 2 cm proximal to the papilla
of Vater. The duct appeared normal.
The dorsal duct orifice was 0.5 mm in
diameter compared with the 1.5 mm dia
meter of the ventral pancreatic duct ori
fice. Sphincterotomy of the orifice of the
dorsal duct enlarged it to 3 mm, the
diameter of the duct itself.
Surgical Technique

The operation was designed to con
firm the diagnosis and perform the
appropriate procedure to prevent re
current disease. Laparotomy requires
thorough examination of the liver and
biliary tract, stomach and duodenum,
colon and retroperitoneum in order to
rule out unexpected causes of “pan-

FIG. 2— Endoscopic retrograde chol
angiopancreatography shows normal bili
ary tree but small ventral pancreatic
duct (arrow).
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creatitis-like” pain. The pancreas is
examined in its entirety by division of
the gastrocolic ligament and kocherization of the duodenum and head of
the gland. Gross features of pancreatic
disease are recorded.
A transverse duodenotomy is made
opposite the papilla of Vater, palpable
through the intact duodenal wall. Ex
posure of the papilla of Vater is fol
lowed by location of the minor papil
la, indicating the orifice of the dorsal
(Santorini) duct. Lacrimal duct probes,
graded from size 0000 to 8 (corre
sponding to diameters ranging from
0.45 mm to 1.75 mm) are used to
define the dorsal duct orifice and
record its diameter (Fig. 3). The
largest probe that passes readily
through the orifice determines this.
Similarly, the orifice of the ventral
(Wirsung) duct is probed and the
diameter recorded. Thereafter, oper
ative pancreatography of both ducts
is performed (Figs. 4 and 5).
The sphincter of Oddi and the ori
fice of the ventral duct are left in
tact. The orifice of the dorsal duct
is carefully dilated to the diameter
of the duct itself. An incision is made
1.5 cm long, positioned vertically at
the superior margin of the duct ori
fice (Fig. 6). Duct epithelium and
duodenal mucosa are not sutured. The
duodenotomy is closed transversely
with adjacent drainage.
The gallbladder was not removed
or the biliary tract incised in any
case.

Follow-up
There were no surgically related
deaths and only one subcutaneous
wound infection. The mean duration
of hospitalization postoperatively was
12 days. In case 1, the sphincterotomy
relieved the patient of the constant
pain of chronic pancreatitis. He had
no exocrine or endocrine insuffi
ciency. Thirteen months after opera
tion he was hospitalized with acute
pancreatitis. Twenty-three months
later another attack of pancreatitis
necessitated admission and he had
three further episodes over the next
year; on each of these occasions, as
sociated excessive alcohol intake was

documented. This had not been the
case before operation or in the early
follow-up period.
In case 2, the patient with recur
rent acute pancreatitis who refused
operation, three hospital admissions
were required to manage episodes of
acute pancreatitis occurring during
the 41-month follow-up. Transient extrahepatic cholestasis was observed
during the last episode.
Two patients (cases 3 and 4) have
been followed up for 27 months and
17 months, respectively, since opera
tion for recurrent acute pancreatitis.

FIG. 5— Operative
pancreatogram
showing normal dorsal duct which
drained at minor papilla.

FIG. 3— Lacrimal duct probe (size
000) inserted into dorsal duct orifice.

Results
Operative Findings (Table I)
In all cases, the pancreas was firm
but not calcific. The parenchyma was
moderately well preserved and no
peripancreatic inflammation was ob
served.
The orifices of the ventral duct
ranged from 1 to 3 mm (mean 2 mm).
The ventral duct was from 4 to 6 cm
long, running in a transverse or superomedial direction. Branching of the
duct was noted on pancreatography
but no signs of chronic pancreatitis
were demonstrated. The diameter of
each duct was equivalent to that of
its orifice.
The orifice of the dorsal duct in
all four patients who were operated
on was only 0.5 mm in diameter. The
dorsal duct diameters measured be
tween 3 and 4 mm. Pancreatography
showed that the dorsal duct extended
to the tail of the gland in all cases.
It did not communicate with the ven
tral duct and there was no evidence
of chronic pancreatitis (Fig. 5).
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FIG. 4— Catheters placed in dorsal
and ventral ducts for operative pancrea
tography.

FIG. 6— N o. 6 lacrimal duct probe in
intact ventral duct orifice below and
no. 8 probe in dorsal duct orifice above,
following sphincterotomy.

Table 1 - Operative Findings in Pancreas Divisum
Case
no.
i
2

3
4

Condition
of pancreas
Fibrotic
Head atrophic;
body and tail
fibrotic
Fibrotic
Fibrotic and
enlarged

Dorsal orifice
diameter, mm

Dorsal duct
diameter, mm

Ventral orifice
diameter, mm

0.5

4

1

Normal

0.5
0.5

3
3

3
2

Normal
Normal

0.5

3

1.5

Normal

Pancreatogram
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The first (case 3) has been pain free
and has no evidence of pancreatic dis
ease. After 11 months the other pa
tient (case 4) had a single episode of
abdominal pain without amylasemia
or other features of pancreatitis.
During the 28 months since sphinc
terotomy, the last patient (case 5) has
had no recurrence of subcutaneous fat
necrosis. His stools are not steatorrheic and he has not needed pancre
atic enzyme supplements. He has had
no pancreatic pain and no diabetes.
Discussion

Mitchell and associates,9 studying a
series of 449 endoscopic retrograde
cholangiopancreatograms,
observed
that pancreas divisum occurred equal
ly with and without pancreatitis. They
concluded that the anatomic variant
did not predispose to pancreatitis.
Others5'7'8,10 have also found that the
frequency of pancreas divisum in pa
tients suspected of having pancreatitis
is no greater than that found at autop
sy in an unselected group.
The 1% incidence of pancreas divi
sum in this series cannot be consid
ered significant as pancreatography
was not carried out in many cases.
However, its association with idio
pathic recurrent pancreatitis in all
cases is important. Analysis of other
series, separating cases of idiopathic
recurrent pancreatitis, indicates a
strong association with pancreas divi
sum. Cotton8 reported an incidence of
25.6%, while Richter and colleagues11
noted a 12% incidence. Others10'12
have found recurrent acute pancrea
titis in 75% to 100% of their cases
of pancreas divisum.
A 20% incidence of chronic pan
creatitis has been attributed to pan
creas divisum in a report by Kruse.7
The diagnosis was based on pancreatic
insufficiency (Lundh test meal), but
was not confirmed in the majority of
patients by an abnormal pancreato
gram, nor was correlation with alco
holism stated. Four of our patients
with recurrent pancreatitis had ab
normal secretin test results. Cotton8
described abnormal dorsal duct pan
creatograms in 7 of 19 patients with
pancreas divisum and nonalcoholic
recurrent pancreatitis. None of his pa
tients underwent exocrine function
tests. No reports associate pancreas
divisum with nonalcoholic, calcific
pancreatitis.
Operative pancreatography in our
treated cases showed normal dorsal
ducts without signs of chronic pan
creatitis. Cooperman and associates10
found no evidence of chronic pan

creatitis in five patients who were
operated on; however, pancreato
graphy showed a dilated dorsal duct
in one case. Richter and associates11
described slight dilatation of the dor
sal duct in two of six patients who
underwent operative pancreatography
for acute pancreatitis.
In view of the established (chem
ical) pathogenesis of chronic alcoholic
pancreatitis,13 it is difficult to accept
similar pathologic and clinical effects
from an incomplete obstruction to
the flow of normal pancreatic secre
tion (mechanical) produced by pan
creas divisum. It is more plausible to
entertain such a mechanism for re
current acute pancreatic inflammation.
We established that the diameter
of the dorsal duct orifice in the four
natients who underwent operation was
0.5 mm. The diameter of the duct
itself was 3 to 4 mm. in keening with
the normal diameter of the fused
ventral duct (Wirsuna).14 Reflux of
duodenal contents into the dorsal duct
would be extremelv unlikelv through
such a minute orifice. Disconnection
from the bile duct precludes biliarv
calculus or crvstal obstruction and
avoids bile regurgitation into the dor
sal duct. There were no abnormalities
of calcium or lipid and no alcohol
abuse in the patients operated on.
Operative pressure or flow studies
would be affected bv the dilatation
necessarv to introduce a flow probe.
None the less, inadeauate secretion
from the gland is indicated bv con
sistently low flow and bicarbonate
concentrations on secretin testing of
our patients. In case 5 operative cannulation of the dorsal duct for pan
creatography allowed egress of cloudv
secretions with white (noncalcific)
precipitates.
We believe that episodes of acute
parenchymal inflammation of the dor
sal pancreas occur when intraductal
secretory pressure rises excessively
behind the minute orifice — produc
ing microductal rupture and acinar
disruption. This process may occur
more frequently if plugging of the
orifice occurs from abnormal protein
precipitates.
Sphincterotomy of the dorsal duct
orifice will increase its diameter to
that of the duct itself. Impedance to
flow of dorsal gland secretion disap
pears and remission from further epi
sodes of parenchymal inflammation
should follow. This report describes
the first four consecutive cases in
which such a procedure was the sole
surgical treatment for recurrent pan
creatitis associated with pancreas div
isum. Although one patient had late

alcohol-associated recurrence of pan
creatitis, the results in the other three
were gratifying. Of particular import
ance is the purely objective monitor
of freedom from recurrence of sub
cutaneous fat necrosis 28 months after
operation. Continued remission be
yond 12 months without clinical
evidence of restenosis in all cases in
dicates the permanence of the sphinc
terotomy. Follow-up endoscopic pan
creatography and secretin studies will
be performed.
Encouraging results have been pre
sented by Cooperman and associates10
and Richter and associates.11 Both
series described dorsal duct sphinctero
plasty for pancreatitis associated with
pancreas divisum in six and four cases
respectively. However, in both the
procedure was complemented by chol
ecystectomy and sphincteroplasty of
the common bile duct and ventral
pancreatic duct (Wirsung). The good
results cannot be ascribed to a single
aspect of this multifaceted technique.
Cotton15 has reported preliminary
results in two patients following en
doscopic papillotomy of the minor
papilla. However, cannulation of the
dorsal duct at endoscopy is difficult.
Highly qualified endoscopists reported
success in 4 of 15,5 10 of 27° and
20 of 63s cases. Therefore, the appli
cation of this technique and the lon
gevity of the decompression require
further evaluation.
It has been suggested that pancrea
tectomy or pancreaticojejunal an
astomosis be considered when dorsal
duct pancreatography indicates that
chronic pancreatitis is present.5,8,10
Considering the most common patho
genesis of chronic pancreatitis, a dili
gent search for alcoholism is advised
before major pancreatic surgery is
performed.18
Conclusions

Pancreas divisum should be con
sidered in cases of idiopathic recur
rent acute pancreatitis. The diagnosis
can be established by secretin testing
and endoscopic retrograde pancreato
graphy.
The orifice of the dorsal duct (San
torini) is likely inadequate to drain
dorsal gland secretions effectively.
Parenchymal inflammation results
from sustained high intraductal pres
sure, possibly affected by abnormal
protein precipitates.
Dorsal duct sphincterotomy affords
relief from the pain of recurrent
acute pancreatitis, improved fat diges
tion and remission from fat necrosis,
which have been sustained for 17 to
28 months.
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Evidence is less convincing that
pancreas divisum is a predisposing
condition in the pathogenesis of
chronic pancreatitis.
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Possible intra-abdominal injuries were
sought in 101 patients admitted with
blunt abdominal trauma. The serum
amylase level was measured in the
first 12 hours after the accident.
Twenty-five patients had hyperamylasemia; 18 underwent laparotomy
and 7 w ere treated conservatively.
At laparotomy all 18 patients exhibited
at least one serious intra-abdominal
lesion, and there was a total of
28 lesions in the whole group (including
only four pancreatic injuries).
The mean value of the serum
amylase for those who had laparotomy
was 1190 IU, while it was only
363 IU for those not operated upon.
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The authors conclude that hyperamylasemia in blunt abdominal trauma
is not specific to pancreatic injury,
but may suggest the presence of a
serious intra-abdominal lesion.
Cent un patients admis pour
traumatismes abdominaux fermes ont
eu un dosage d’amylasemie dans les
12 premieres heures consecutives
a leur accident. Vingt-cinq patients
presentaient une amylasemie elevee;
18 de ces patients ont ete operes
et 7 observes. Tous les patients
operes etaient porteurs d'au moins
une lesion intra-abdominale severe
et, au total, 28 lesions furent
retrouvees (incluant quatre ruptures
pancreatiques).
L'amylasemie moyenne du groupe
opere etait de 1190 IU, et celle du
groupe non opere de 363 IU.
Les auteurs concluent que
I'hyperamylasemie dans les cas de
traumatismes abdominaux fermes
est souvent un temoin d'une lesion
intra-abdominale severe. Elle ne reflete
cependant aucune specificite quant au
type de lesion intra-abdominale
retrouvee (en particulier les lesions
pancreatiques).

Elevation of the serum amylase level
in patients with blunt abdominal
trauma was thought in the past to
indicate pancreatic injury.1-3 Recently,
however, this opinion has not been

m d , fa c s ,

f r c s [c ]J

shared.4-5 Olsen4 in 1973 found that
only 8% of patients with hyperamylasemia had pancreatic injuries, while
33% of patients with hyperamylasemia had no serious intra-abdominal
injuries. Moretz and associates5 in
1975 reached the same conclusion and
stated that elevated serum amylase
levels correlated poorly with pancrea
tic injury in blunt abdominal trauma.
Both papers stated that serum amylase
levels measured within a few hours of
blunt trauma to the abdomen had
little prognostic significance.
We decided to re-examine the diag
nostic value of elevated serum amyl
ase levels in blunt abdominal trauma,
to determine: (a) whether admission
serum amylase levels correlate with
the presence, severity and type of in
tra-abdominal injuries and (b) whether
hyperamylasemia in the recently in
jured patient should be an indication
for immediate abdominal exploration.
Patients and Methods
Over a period of 2Vz years, 101
patients with blunt abdominal trauma
seen in the emergency room of the
Hopital du Sacre-Coeur in Montreal
were investigated for possible intra
abdominal injuries. Studies included
the clinical, radiologic and laboratory
investigations used for all trauma pa
tients. In addition, the serum amylase
level was measured in the first 12
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hours after the accident, but before
laparotomy. Serum amylase determin
ation was by the iodometric or amyloclastic technique and its value was ex
pressed in international units (IU);
the normal value ranges from 80 to
170 IU.
Results

Of the 101 patients, 29 had a serum
amylase value greater than 170 IU.
Four patients with facial injuries,
which may have involved the parotid
gland, a possible source of serum
amylase, were excluded from the
study. So 25 patients with hyperamylasemia form the basis of this report.
We reviewed the management of
these 25 patients and found that 18
had undergone emergency laparotomy,
while 7 had been treated conservative
ly. The decision to perform the emer
gency laparotomy was based on clin
ical criteria.
The 18 patients treated surgically
had a substantially higher level of
serum amylase than those treated con
servatively. The mean value for this
group was 1190 IU; 3 patients had
a serum amylase value between 200
and 400 IU, 5 patients had a value
between 400 and 600 IU and 10 pa
tients had a value higher than 600
IU (Table I). The serum amylase lev
el of the seven patients who were
treated conservatively was only slight
ly elevated (Table II) and the mean
value was 363 IU. Five of these pa

tients had a serum amylase value be
tween 200 and 400 IU and two pa
tients had a value between 400 and
600 IU; thus, all seven patients who
were treated conservatively had se
rum amylase levels lower than 600
IU.
All 18 patients operated on exhibited at least one intra-abdominal
lesion at laparotomy; in total there
were 28 lesions: 5 hepatic lacerations,
4 ruptured spleens, 8 bowel lacera
tions (of which 2 were located in the
duodenum), 7 severe retroperitoneal
hematomas (2 associated with kidney
lacerations and 1 with a ruptured
aorta) and 4 pancreatic injuries (Table
I).

Discussion

In investigating the patient with
multiple trauma for possible intra
abdominal injuries, clinical, radiologic

and laboratory data are analysed be
fore an emergency laparotomy is un
dertaken. The laboratory changes as
sociated with abdominal injuries might
be in the form of a drop in hemo
globin level, leukocytosis, elevated
sedimentation rate, increase in the
serum levels of transaminases and
possibly of amylase.
The value of serum amylase de
termination in blunt abdominal trau
ma has long been a controversial
issue. White and Benfield6 believed
that an elevation of the serum amylase
level was a good indicator of pan
creatic injury and that operation was
indicated despite unremarkable find
ings on physical examination; however,
normal serum amylase levels do not
exclude the possibility of pancreatic
injury and the decision whether or
not to operate must then be made on
other grounds. Olsen4 and Moretz and
associates5 considered that determina-

Table II-Serum Amylase Levels and the Distribution of
Lesions (+1 in Seven Patients Who Were Treated Conservatively
Patient
no.

Amylase.
IU

1

206
340
242
551
313
496
395

2
3
4
5
6
7

Thorax

Spine
and
pelvis

Extremities

+
+

+
+

+

+

+

+

Head
injury

+
+
+
+
+

+
+

Table 1-Serum Amylase Levels and the Distribution of Lesions (+)
_________in the 18 Patients Who Underwent Laparotomy
Patient
no.

Amylase,
IU

i

695

2
3
4
5
6

545
2695
1326
304
3325

7
8

402
1150

9
10
11
12
13

350
855
342
3678
448

14
15
16
17

1415
405
2209
470

18

810

Pancreas

Liver

Spleen

+

Bowel
+

+
+
+

Retroperitoneal
hematoma
+
(aorta)
+

+
+
(duodenum)
+
+
(duodenum)

+
+

+

+
+

+
+

+

+
+
(kidney)
+

+
+
+

+

+

+

+

Head
injury

+

+

+
+

Extremities

+

+

+
+

Thorax

Spine
and
pelvis

+
+
(kidney)

+

+
+

+

+

+

+

+

+
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tion of the serum amylase level in
blunt abdominal trauma has little
prognostic importance, since it can
neither identify nor exclude a pan
creatic injury.
In our series, 25 patients with blunt
abdominal trauma had hyperamylasemia; 7 were treated conservatively,
while 18 had an emergency lapa
rotomy with the discovery of 28 se
rious intra-abdominal lesions in the
whole group. Only four pancreatic
lacerations were found, an incidence
of 16% of all patients with hyperamylasemia. In this study, a serum
amylase level of 500 IU was critical,
since only one patient with a serum
amylase level above 500 IU (Table
II) was treated conservatively.
From our data, hyperamylasemia
in the recently injured patient is ap
parently not specific to pancreatic
injury, but can often suggest the pres
ence of a serious intra-abdominal le
sion. However, hyperamylasemia in
the absence of other signs (clinical or
radiologic) of intra-abdominal injury
does not constitute an indication for
laparotomy.
With blunt abdominal trauma, hy
peramylasemia may appear within a
few hours of the accident, despite the
absence of pancreatic injury, possibly
resulting from extrapancreatic release
of amylase. It is believed that several
organs other than the pancreas can
produce amylase: for example, the
liver, striated muscle, adipose tissue

and Fallopian tubes, and trauma to
these organs can cause elevation of
amylase levels.4-7
To improve the clinical specificity
of serum amylase, measurement of
amylase isoenzymes has been sought.
Using various methods (chiefly elec
trophoresis, isoelectric focussing and
column chromatography) it is believed
that serum amylase can be fraction
ated into two principal isoenzymes:8
the pancreatic type (P-type) and the
salivary type (S-type). The S-type iso
amylase may arise not only from sali
vary gland tissue but from many dif
ferent tissues and thus lacks organ
specificity.8-9 The P-type isoamylase
is considered to arise solely from the
pancreas. Hence, it may serve as a
marker for pancreatic lesions.8'10 How
ever, wide clinical use of isoamylase
analysis in evaluating blunt abdominal
trauma will require a test less com
plex and time-consuming than those
available now.
Conclusions
In blunt abdominal trauma hyper
amylasemia is not specific to pan
creatic injury, but can often suggest
the presence of a serious intra-abdom
inal lesion. However, hyperamylase
mia in the absence of other signs of
intra-abdominal injury does not con
stitute an indication for emergency
operation. The measurement of serum
amylase in conjunction with other in

vestigations, such as abdominal tap
and peritoneal lavage, could be of
help in selecting patients for early
laparotomy.
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SESAP III Question
241. Subungual melanoma often
(A)
(B)
(C)
(D)
(E)

involves the fingers but not the toes
occurs as a vertical pigmented band under the nail
is accompanied by a pigmented halo on the eponychium
migrates distally with the growth of the nail
is effectively treated by early local excision

For the incomplete statement above select the one answer that is best of the five given.
For the critique of Item 241 see page 649 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and SelfAssessment Program No. 3. For enrolment in the Surgical Education and Self-Assess
ment Program No. 3, please apply to the American College of Surgeons, 55 East
Erie St., Chicago, IL 60611.)
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Osteoid Osteoma of the Cervical Spine:
Case Reports and Literature Review
T.J. Z w im p f e r ,* W.S. T ucker , md , FRCs[c]f and J.F. F aulkner , md , FRCsfc]t

Osteoid osteoma, a benign
osteoid-forming tumour, may be found
in any bone in the body. Approximately
10% of cases involve the spine,
the lumbar region being the most
common site and the cervical region
the second commonest site for
spinal osteoid osteomas. Two new
cases of cervical spine osteoid
osteoma are presented and the 21
previously reported cases are
reviewed.
This cervical spine tumour should
be considered as a possible diagnosis
in any young person complaining
of neck or upper back pain, especially
if the pain is worse at night, is
relieved by salicylates and is
accompanied by tenderness, neck
stiffness and scoliosis of rapid
onset. Detailed radiologic investigation
aids in the diagnosis and accurately
locates the lesion. Surgery is the
definitive treatment and complete
resection of the tumour results
in rapid and permanent relief of pain.
L'osteoide-osteome, une tumeur
osteoide-formatrice benigne, peut
affecter n'importe quel os de
I'organisme. Dans environ 10% des
cas, il y a atteinte de la colonne
vertebrale, les regions lombaire et
cervicale etant, dans I'ordre, les
localisations les plus frequentes des
osteoides-osteomes spinaux. Deux
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nouveaux cas d'osteoi'des-osteomes de
la colonne cervicale sont presentes
et les 21 cas deja decrits sont passes
en revue.
Cette tumeur de la colonne cervicale
devrait etre consideree comme un
diagnostic possible chez toute
personne jeune qui se plaint d'une
douleur au cou ou au haut du dos,
surtout si la douleur est plus vive
durant la nuit, si elle est soulagee
par les salicylates et si elle est
accompagnee d'une sensibilite et d’une
raideur du cou ainsi que d'une
scoliose d'apparition rapide. L'examen
radiologique pousse aide au diagnostic
e t permet de localiser la lesion
de facon precise. La chirurgie offre
une cure definitive et la resection
complete de la tumeur donne un
soulagement rapide et permanent
de la douleur.

Osteoid osteoma was first described
by Jaffe1 in 1935 as a “benign osteo
blastic tum our composed of osteoid
and atypical bone”. It has been found
in every bone of the body, with over
50% of reported cases involving the
femur or tibia.2 About 10% of these
tumours are localized to the spine,
with the lumbar region being the most
common site, followed by the cervical,
thoracic and sacral regions in decreas
ing order of frequency.3 In this paper
we restrict our discussion to osteoid
osteomas of the cervical spine, pre
senting two new cases and reviewing
the clinical data of 21 previously re
ported cases.
Case Reports
Case 1
A 23-year-old man was seen in Oc
tober 1974. He complained of neck pain
that had persisted since a wrestling in

jury to his neck in 1972. The left-sided
pain extended from the superior nuchal
line to the upper border of the left scapu
la, occasionally radiating into the left
shoulder. Although the pain was constant
it became much worse at night, making
sleep very difficult without Aspirin,
which was the only type of analgesic
that produced appreciable pain relief.
The pain was aggravated by stress and
tension as well as neck movement. He
had been able to keep working full time
during the previous 2 years.
All neck movements were limited by
pain, but extension, rotation to the left
and lateral flexion to either side were
especially painful. There was marked ten
derness over the spinous processes of
C2 and C3. There was no neurologic
deficit and the findings on general physi
cal examination were otherwise normal.
The patient was admitted on Oct. 2.
1974 with suspected occipital neuralgia. A
block of the C2 and C3 nerve roots pro
vided partial but only temporary pain re
lief. Plain films of the cervical spine and a
myelogram were reported to be normal.
Tomograms revealed a small circular
radiodense area, about 1 cm in diameter,
arising from the left lamina of C2 and
surrounded by a radiolucent rim of bone.
This area showed increased uptake on
the nuclear bone scan, suggesting an
active, bone-forming lesion. A provisional
diagnosis of osteoid osteoma of the left
lamina of C2 was made. At operation
on Nov. 18, a red, circular tumour, 1.5
cm in diameter, was found arising from
the inferior and deep surfaces of the left
lamina of C2. It had extended into the
interlaminar space between C2 and C3
but was still covered by a thin layer of
cortex. The lesion was removed in one
piece along with a small part of the
lamina of C2. There was no involvement
of the C3 vertebra. No instability of the
C2-3 joint was anticipated and no fusion
was required.
Grossly, the excised specimen con
tained multiple fragments of firm, pur
plish material that appeared calcified in
some areas. Histologically, there were

VOLUME 25, NO. 6, NOVEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY

637

many large trabeculae of woven bone
and osteoid surrounded by numerous, ac
tive osteoblasts. The trabeculae were ar
ranged within a stroma comprised of
multinucleated giant cells amid a collec
tion of vascular spaces (Fig. 1). This con
firmed the diagnosis of osteoid osteoma.
The patient’s postoperative course was
smooth and he left hospital 1 week after
the operation. At follow-up 3 months
later, the neck pain had totally disap
peared and all neck movements were
pain free. A few degrees of extension and
rotation in both directions were lost. He
was considered cured.
Case 2
A 19-year-old man had had neck pain
for 2 years. The pain was worse on the
left side and had gradually worsened.
One year before admission, following a
game of racquetball, the pain became
much more severe and a few weeks later
he noted pain in both upper extremities
extending to the middle digits of both
hands, involving the left side more than
the right. The pain was particularly
severe at night. Although worse than the
arm and hand pain, the neck pain was
better relieved by analgesics; Aspirin
was the most effective. There was no
neurologic problem. His past medical his
tory was unremarkable.
On physical examination cervicothoracic scoliosis was noted with a head tilt
to the left. Neck movements were normal
and pain free except for extension and
rotation to the left which made the pain
worse. No neurologic deficit was de
tected.
Plain films of the cervical spine re
vealed no abnormalities, but a nuclear
bone scan showed an area of increased
uptake in the neural arch of C6 (Fig. 2).
Tomograms showed a lytic area in the
left inferior facet of C6, with some cal
cification. The bone surrounding this
lesion, as well as the superior facet of
C7, showed some sclerotic changes (Fig.
3). A myelogram appeared normal. Os
teoid osteoma of the left inferior arti
cular facet of C6 was suspected.
At operation the left inferior facet of
C6 was enlarged in a bulbous manner
but was still covered by bone. The in
ferior facet was decorticated and the
lesion was found to involve both the in
ferior facet and the pedicle of C6. The
superior facet of C7 appeared normal
and was left intact. The purple lesion,
measuring about 1.5 cm in diameter,
consisted of friable bone-like material.
The tumour was completely curetted with
some of the normal bone surrounding it.
Because the C6-7 joint seemed to be
unstable, a posterior fusion was per
formed using bone grafts from the right
iliac crest. Histologic examination of the
lesion confirmed the diagnosis of osteoid
osteoma.
The patient was fitted with a Forrester
neck brace. At follow-up 2Vi months
after the operation, his condition was
much improved. He complained of mild
638

neck pain and intermittent shoulder and
arm pain on both sides. He felt the qual
ity of the neck pain had changed and
that it had been steadily improving.
He held his head rigidly but with no
evidence of scoliosis. The findings on
neurologic examination were normal.
Postoperative plain films of the cervical
spine revealed the defect in C6 and the
fusion of C6-7. There was no scoliosis
and no evidence of tumour.
Review of Previously Reported Cases
Table I1,4'18 gives the relevant de
tails of 21 patients (18 males, 3 fe
males) with osteoid osteoma of the
cervical spine, previously reported in
the literature. They ranged in age
from 8 to 34 years (mean 14.5
years). The majority of patients were
in the second decade of life.
Location
In 19 patients the lesion was located
only in the posterior elements of the
vertebra. Both the posterior elements
and the body were involved in one
case. The tum our was found only in
the body of the vertebra in one pa
tient.9
In 20 cases only one vertebra was
involved, with no evidence of inter
vertebral spread. One 34-year-old pa
tient had multilevel involvement. Since
the lesion was probably of much long
er standing than the others, there
would have been ample time for such
extensive spread.

Symptoms
Neck pain, usually localized over
the tumour site, was the major com
plaint in all cases. Eight patients also
experienced pain at sites distant from
the tumour.
The pain followed a characteristic
pattern, starting as a mild, intermit
tent ache that slowly increased in se
verity and frequency, eventually be
coming constant, at which stage most
patients sought medical advice. In half
of the patients, the pain was particu
larly bothersome at night.
Many types of analgesics were tried
but the only group that consistently
gave good pain relief were the salicyl
ates. Of the 10 patients who used sali
cylates, 7 obtained notable relief.
Physical Signs
Tenderness, localized over the tu
mour site, was a prominent physical
finding in 14 patients.
Scoliosis, rapid in onset and usually

FIG. 2 —Nuclear bone scan showing
circular area of increased radionuclide
uptake (arrow) on left at C6-7.

FIG. 1— Case 1. Trabeculae of woven
bone and osteoid surrounded by active
osteoblasts and multinucleated giant
cells. Stroma contains numerous vascular
spaces (heniatoxylin-phloxine-saffron
stain, reduced by 50% from x80).

FIG. 3—Tomogram of cervical spine
shows radiolucent area (arrows) of ero
sion of left inferior facet of C6. Sur
rounding bone shows sclerotic change.
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associated with paravertebral muscle
spasm on the side of the lesion, was
reported in nine patients. It usually
was accompanied by torticollis. In all
cases the convexity of the curvature
pointed away from the side of the le
sion, suggesting that unilateral muscle
spasm was the underlying cause of
the scoliosis. Neck stiffness with some
limitation of movement was reported
in most cases.
The neurologic examination gave
normal results in 16 patients, abnor
mal findings in 4 and was not re
ported in 1. Weakness and atrophy of
the muscles of the shoulder and arm
were reported in three of the four
patients and in two there was depres
sion or absence of the deep tendon
reflexes of the upper extremity. Sen
sory changes in the upper extremities
were found in two, one with hypesthesia, the other with paresthesia.

Diagnosis
The time between the onset of
symptoms and diagnosis in the 19 pa
tients for whom this information was
reported ranged from 6 to 48 months
(mean 14 months). The other diag
noses most frequently considered were
herniation of a cervical disc, cervical
strain, arthritis, scoliosis and bone ab
scess.

Radiologic Findings

Treatment

Plain films of the cervical spine
in all 21 patients gave positive find
ings in only 10 on initial examina
tion. Other radiologic techniques used
to identify the lesion were nuclear
bone scanning, tomography, angio

All patients were treated surgically
once an osteoid osteoma was diag
nosed. The procedure consisted of
complete removal of the tumour,
either by en bloc excision or curettage.
Before the correct diagnosis was made

graphy and myelography. On plain
films the lesion appeared as a circular
radiolucent area surrounded by a rim
of sclerotic bone. In several cases, radiodense spots representing calcifica
tion were found within the radiolucent
region. Myelograms were obtained in
four of the eight patients who com
plained of radicular pain but were
negative in two, suggesting a cause
other than irritation of the nerve root
for the distant pain.

some patients underwent other forms
of treatment, such as bed rest, cervical
traction or fusion, which resulted in
partial but only temporary relief. In
a few patients, such treatments re
sulted in an increase in the pain. Total
removal of the tumour was the only
treatment that produced complete and
permanent pain relief. Two patients
required fusion because of extensive
removal of the articular facets and
instability.
Follow-up of 16 patients was re
ported and generally the results were
good. Most reported complete relief
of pain within a few months of oper
ation, while the remainder noted a
great decrease in the severity of the
pain with continuing improvement.
There was no tumour recurrence up
to 4 years after operation. All nine
patients who had scoliosis or torticollis
had improvement, many returning to
normal within several months. Two
patients complained of residual neck
stiffness with some limitation of neck
movement, but they believed this was
improving with physiotherapy. Of the
four patients who had had neurologic
findings, two became normal while
the other two continued to have some

Table 1--R eported C a se s of Osteoid Osteoma o f C e rvica l Spine
Age,
A uthor and year

yr

Sex

Vertebra
involved

Portion

Ja ffe , 19351

16

M

C7

Spinous
process

Hamilton, 19454
Sobel, 1946s
Cam pos, 19466

19

M

C2

13
11

M
F

C6
C4

Pedicle
Lamina

W alker. 19527

14

F

C5

Spinous
process
Spinous
process

14

M

W ard, 1957s

11

M

C5
C5

Fett and Russo, 1959s
Freiberger, I9 6 0 10

9 ’ /z
12

M
M

C3
C7

Fountain and Burge, 196111
Gelberm an and Olson, 197412

11
11

M
M

C5
C1

P ed icle
Spinous
process

8
9

M

C6

M

C5

Lamina
Lam ina and

-

M

-

M

Cl
C7

-

M
M

C6
C5

G oldstein and associates, 197715

27

M

C7

Glasauer, 1979’ 6
Banna, 197917

12
12

M
F

C6
C7

Conley and associates, 197918

34

M

C4 to

Keim and Reina, 197513

Fielding and associates, 197714

Ped icle
Transverse
process
Body
Lamina

pedicle
Lam ina
Spinou s and
articular
processes
Lamina
Lam ina and
pedicle
Lam ina and
pedicle
Lamina
Spinous
process and
lamina
C7 N eural arch
and body

Night
pain

Yes
No

R adicular
pain

A sp irin
relief
_

No

S c o lio s is

Yes

No

No

No
No

Yes
Yes

_

No

No

-

-

_

No

No

__

No

No

_
_

No

No

Yes

No
No

N eurologic
signs

Y es

Yes
No

Yes
No

T en derness

_

No

No

No
No

No
No

Yes

Yes

Yes

Yes
No

No

_

No

Yes

No
No

Yes

Yes

Y es

Yes

Yes
No

Yes
Yes

No

No
No

Yes
No

No

Yes
Yes

No
No

No
Yes

No
Yes

No
Yes

Y es
Yes

No
No

Yes

Yes

No

Yes

Yes

No

Yes

Yes
Yes

Yes
Yes

Yes

Yes
Yes

Y es
Y es

No
No

Yes

Yes

Yes

Yes

Y es

No

_

—

_

_

_

—
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residual arm and shoulder weakness
and depressed reflexes.
Pathologic Features
In all patients the lesion consisted
of a well-circumscribed, reddish mass
that was hard and gritty and appeared
vascular and hemorrhagic. Microsco
pically, the tumour consisted of trabe
culae and islands of uncalcified os
teoid and atypical, immature bone, set
in a vascular and cellular stroma. Ac
tive osteoblasts and osteoclasts were
the major cell types.
Discussion

It is clear that osteoid osteoma of
the spine has some characteristic
features and knowledge of them
can be invaluable in diagnosing the
cause of obscure, persistent pain in
the neck or upper back, when plain
films show a normal appearance.
The patients are most commonly
males in the second or third decade of
life. The sex incidence for spinal os
teoid osteomas favours males in a pro
portion of 6 to 1 compared to the
2 to 1 male predominance for osteoid
osteomas involving all bones.3,19
Osteoid osteoma of the cervical
spine is quite rare. In Dahlin’s2" re
view of 3987 primary tumours of
bone, there were 28 osteoid osteomas
involving all bones, an incidence of
less than 1%.20,21 This rarity may ac
count for the frequent delay in diag
nosis and treatment.
Pain in the neck or upper back is
the major complaint of almost all
patients. It is usually well localized
and increases progressively in severity
and frequency. The pain is often more
severe at night. Analgesics of the sali
cylate group are particularly effective
in relieving the pain. This feature is
so characteristic of osteoid osteoma,
involving any bone, that it alone should
suggest the diagnosis. It is not under
stood why salicylates produce such
dramatic pain relief but one theory
proposed by Saville22 is that tumour
cells produce arachidonic acid, which,
in the presence of cyclo-oxygenase, is
metabolized, forming products that
create and promote pain and bone re
sorption. Aspirin, a cyclo-oxygenase
inhibitor, prevents the formation of
such products.
Saville also presented a case in
which a 10-month regimen of Aspirin
resulted in complete pain relief for
lVi years after the medication was
stopped and in radiologic healing of
the lesion.
Sherman and McFarland23 in 1965
proposed another theory. They found
nerves accompanying the blood vessels
640

Treatment consists of complete sur
as they entered the tumour. They pos
tulated that these nerves are derived gical removal of the lesion with fusion
from the autonomic nervous system if instability is expected. Because most
and that vascular compression causes patients undergo operation, the na
the pain.
tural history of osteoid osteoma has
Local neck tenderness, stiffness and not been extensively studied, but
limitation of neck movement are the Simm in 197528 reported on 20 pa
usual physical findings. Rapidly devel tients with suspected osteoid osteomas,
oping scoliosis of the cervical spine is involving all bones, who were not
also sometimes seen. After surgical re operated upon. He found that over
moval of the lesion the scoliosis usual many years, the pain decreases and
ly disappears within a few months but eventually disappears but that the ra
if the lesion is left untreated, over diologic features may persist and the
many years the scoliosis can become lesion may never totally heal.
structural and irreversible, especially
Osteoid osteoma, if removed com
in growing children. For this reason, pletely, rarely recurs and very rarely
it is important that osteoid osteoma be undergoes malignant degeneration.6
suspected in any child or young adult Complete surgical resection of the tu
complaining of neck pain or backache, mour is usually possible and the prog
especially if it is accompanied by nosis is good. The patient’s signs and
scoliosis of rapid onset.13
symptoms disappear or at least de
Characteristically, the findings on crease substantially allowing return to
neurologic examination are normal, a relatively normal life.
but compression of nerve roots or the
spinal cord can result in weakness and Conclusions
atrophy of the upper extremity, as
The signs and symptoms of osteoid
well as sensory changes and depres
osteoma of the cervical spine are so
sion of the reflexes.17
Once osteoid osteoma is suspected characteristic that it should be possible
it is important that detailed radiologic to make the diagnosis from the history
investigation be performed for accu and physical examination alone. The
rate localization. Plain films of the commonest presentation is neck or
cervical spine frequently are normal. upper back pain, more severe at night,
If so, a nuclear bone scan should be that is dramatically relieved by anal
done; osteoid osteoma appears as an gesics of the salicylate group. Neck
area of increased radionuclide uptake, stiffness and limitation of movement,
which suggests increased bone acti local tenderness and scoliosis are com
vity.24'26 A bone scan is an excellent mon. Radiologic investigation should
screening test for osteoid osteoma but include plain films, a nuclear bone
it is not diagnostic,
somore specificscan and tomograms of the cervical
spine. If these are inconclusive, angio
tests are required! Tomograms can
pick up very subtle lesions that are graphy or myelography may prove
easily missed on plain films. If tomo helpful. The treatment of choice is ^
grams are inconclusive, angiography complete surgical removal. The prog
can be helpful. Selective angiography nosis is good.
of the artery supplying the involved
We thank Dr. J.M. Bilbao, depart
vertebra
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Mid-Trimester Abortions:
a Decade in Review
M a rkus C. M a r t in ,

md, c m

,
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At the Sir Mortimer B. Davis-Jewish
General Hospital in Montreal, the
total number of abortions increased
over the 10-year period Jan. 1, 1970
to Dec. 31, 1979 but the percentage of
mid-trimester abortions performed
fell after 1974 to 2.1% at the end
of the study period. The authors
reviewed the records of 1422 patients
who underwent mid-trimester
abortions over the 10 years of the
study to determine which technique
was the safest, the quickest and
the most commonly performed. Initially,
saline instillation was the commonest
method but this has been replaced
by injection of prostaglandin F2„,
which was found to be the quickest
acting of the fluids used. Hysterotomy
and hysterectomy were associated
with higher complication rates than
other methods, confirming the
authors' belief that they should be used
only under exceptional circumstances.
A I'hopital General Juif-Sir Mortimer
B. Davis de Montreal, le nombre
total des avortements s ’est accru
durant la periode de 10 ans allant du
ler janvier 1970 au 31 decembre 1979
alors que le pourcentage des
avortements pratiques au cours du
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M o r r ie M . G e l f a n d ,

deuxieme trimestre s'abaissait apres
1974 pour atteindre 2.1% a la fin
de la periode etudiee. Les auteurs
ont passe en revue les dossiers
de 1422 patientes qui ont subi un
avortement du deuxieme trimestre
au cours de ces 10 annees afin
de determiner quelle technique etait
la plus sure, la plus rapide et la
plus frequemment employee. Au debut,
I’instillation d'une solution saline
etait la methode la plus couramment
utilisee mais elle fut remplacee
par I'injection du prostaglandine F2„
qui s ’avera la plus rapide des
preparations utilisees. L’hysterotomie
et I’hysterectomie etaient reliees a
un taux de complications plus eleve
que les autres methodes, ce qui
confirme I’opinion des auteurs que ces
interventions ne devraient etre
utilisees que dans des circonstances
exceptionnelles.

m d , c m , f r c s [ c ],

FAc o g ,

facs

Menstrual extractions and suction cu
rettages are common in many hospi
tals in Canada. In Quebec, however,
because of the religious concerns in
most hospitals, abortions are primari
ly limited to the English, non-Catholic hospitals of Montreal. Elective
mid-trimester abortions are less fre
quently carried out in all institutions.
We, therefore, wished to review our
experience in the 1970s in order to
plan for the 1980s.
Patients and Methods

We analysed 1422 consecutive mid
trimester pregnancy terminations car
ried out between Jan. 1, 1970 and
Dec. 31, 1979 at the Sir Mortimer B.
Davis-Jewish General Hospital.
The technique used in the majority
of cases was intra-amniotic instillation
or injection of abortifacients. The

Table 1 - P ro ce d u re s U se d (N = 1422)
Procedure

No.

%

Instillation of saline alone
Instillation o f saline w ith
dilatation and curettage
Injection o f prostaglandin F2o
alone

507

35.7

347

24.4

94

6.6

98
3
13
300

6.9
02
09
21.1

11

0.8

48
1

34
0.1

Injection o f prostaglandin F2o
w ith dilatation and curettage
Instillation of 5 0 % glucose
H ysterotom y alone
H ysterotom y and tubal ligation
H ysterectom y, w ith or w ithout
bilateral salpingo-oophorectom y
Dilatation and evacuation or
dilatation and curettage
Other
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solutions used were 20% saline, pros
taglandin Fta and 50% glucose. A
number of patients also underwent
hysterotomy. A few underwent dilata
tion and evacuation.
All fetuses were of at least 13 weeks’
gestational age, confirmed by examin
ation of specimens, ultrasonography
or clinical dating. All terms and def
initions used are in concordance with
those used by the American College
of Obstetricians and Gynecologists.1

A

>

A

■*

\

Results
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Table I and Fig. 1 detail the proce
dures used in the study period. Intraamniotic instillation of saline was the
most common method being carried
out in 854 cases (60.1%), but by the
f i g . 1__Procedures by year. D + E /D + C = dilatation and evacuation or
end of the decade we were using only
dilatation and curettage.
prostaglandin injection (13.5%). The
second commonest procedure was hys
terotomy performed in 313 cases
(22%); this was done with tubal liga
tion in 91% of the 313 women.
As abortions became more avail
able they were more commonly car
ried out in the first trimester. There
was a concomitant marked decrease
in the number of second trimester
abortions, although the total number
of abortions increased (Fig. 2).
Abortions were performed predom
inantly in the younger age groups.
Teenagers constituted the largest
group by the late 1970s (Fig. 3) and
had a higher percentage of more ad
vanced pregnancies before their ter
mination than older age groups (Table
II).
The recidivism rate of 8.3% was
not high (Fig. 4); those who needed
another abortion rarely waited until
the mid-trimester. The contacts for an
early abortion had already been estab
FIG . 2— Comparison of frequency of mid-term (black circles) and all abortions
(white circles).
lished.
Table III shows the interval be
tween instillation or injection of the
various solutions and abortion. Both
for nulliparous and multiparous pa
tients, prostaglandin gave the shortest

X
A
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%

/

o
4
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FIG. 3— Percentage o f abortions by age group.
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interval. Furthermore, whereas prosta
glandin took the same time regardless
of parity, saline took longer to be ef
fective in the nulliparous patient. Oxy
tocin infusion was usually started
within 12 hours of the instillation to
shorten abortion time.
Complications
Postoperative complications are de
tailed in Table IV. Retained products
of conception was the commonest
problem, occurring in over half (51%)

of our prostaglandin injections. Al
though common with saline, this prob
lem occurred in only 40% of our pa
tients. Prostaglandin injection also
failed more commonly (4.2%) than
saline instillation (3.4%) but was asso
ciated with a lower incidence of infec
tion and blood loss requiring trans
fusion.
Hysterectomy gave the highest in
cidence of complications. Hysterotomy
gave a high incidence of postoperative
morbidity.
There was one maternal death due

Table II- -Gestational Age and Patient Age
Gestational age, w k
Total no.
of patients

Patient age, yr

13-15

16-18

19 -20

21 +

12-19
2 0 -2 4
25 -29
30 -34
35 -39
40+

117
191
167
109
89
53

164
159
109
87
56
32

16
17
22
8
5
6

1
5
5
1
3
-

298
372
303
205
153
91

Total

726

607

74

15

1422

Table III- -P a rity and Interval between Instillation or Injection and Abortion
Interval betw een procedure
and actual abortion
Parity
Nulliparous
Saline
Prostaglandin
Glucose
Multiparous
Saline
Prostaglandin
Glucose
Total
Saline
Prostaglandin
Glucose

No.

Range, h

M ean, h

455
122
3

9-151
8-6 6
3 1 -4 8

34.47
21.92
41 33

311
74
-

6-121
5 -1 0 0

30.22
21 69

766
196
3

6-151
5 -1 0 0
3 1 -4 8

32.73
21.83
41.33

to cardiomyopathy, an incidence of
0.07%. The procedure, a hysterot
omy, was done to try to save the life
of a woman with severe heart disease.
Discussion and Conclusions
With the liberalization in 1969 of
the Canadian abortion law, the total
number of abortions increased pro
gressively over the 10 years analysed.
Simultaneously, there was a marked
decrease in mid-trimester abortions.
Our largest group was made up of
teenagers, a group with a slowly ris
ing abortion rate in Canada.2 Their
pregnancies also tended to be more
advanced than those of other age
groups.3
Analysis of the complication rates
confirms previous statements that
“major surgery for abortion should be
restricted to unique circumstances”.4
Prostaglandin acts most quickly but
is associated with a greater proportion
of retained products of conception
resulting in subsequent curettage.
Many centres are now performing
mid-trimester abortions at up to 16
weeks by dilatation and evacuation
after insertion of a laminaria tent.5
Due to the impressive decline at our
institution in mid-trimester abortions,
our own experience with this method
has been limited.
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Table IV Number (and %) of Complications Associated w ith Various Procedures

Complication
Fever
Endometritis
Urinary tract infection
Wound infection
Ileus
Retained products of
conception*
Blood loss requiring
transfusion
Cervical injury
Laminaria tent required
Otherf

Dilation and
evacuation or
curettage
1 (2.1)

2 (4 .2 )
1 (2.1)
1 (2.1)

Instillation
of saline

Injection of
prostaglandin F,„

25 (2.9)
15 (1.8)
6 (0.7)

1 (0.5)
2 (1.0)

347 (40.6)

98 (51.0)

46 (5.4)
1 (0.1)
9 (1.1)
7 (0.8)
netained more than 2 h, necessitating a subsequent curettage.
tAnem ia, phlebitis, pyelonephritis, septicemia, pneumonia, pelvic inflammatory disease,

8 (4 .2 )
1 (fL5)
1 (0.5)
3 (1.6)

Hysterotomy
38
5
32
9
6

(12.1)
(1.6)
(10.2)
(2.9)
(1.9)

Total abdominal
hysterectom y
2 (18.2)
2 (18.2)
1 (9.1)
-

1 (0.3)
10 (3.2)

4 (1.3)

-

3 (27.3)

1 (9.11

diarrhea, seizure, suicide attem pt, lysis of adhesions.
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Necrotizing Choledochomalacia after Use of
Monooctanoin to Dissolve Bile-Duct Stones
T S. C rabtree , md , R. D ykstra , md , frcs [ c ], J. K elly , m b , mrc path , fr c p [c ] and
R.M. P reshaw , m d , frcs [c]

-<>
A 72-year-old man with choledocholithiasis, demonstrated radiologically,
was treated by constant perfusion
through the gallbladder of mono
octanoin (glyceryl-1-monooctanoate)
following cholecystostomy for a
perforated gallbladder. The mono
octanoin was given at a rate of
7.5 m l/h and monitored to ensure
that delivery pressure did not rise
above 20 cm H20 . Perfusion was
carried out for 60 hours, but could
not be continued because of abdominal
pain, nausea and vomiting. This
was followed by progressive jaundice,
anorexia and fever. The patient
was treated with penicillin G
and cefoxitin intravenously and
metronidazole orally, but he died
5 weeks after the perfusion.
Autopsy showed acute pancreatitis
and cholangitis, and a biliary tree
filled with pus and a black biliary cast.
No calculi were present. The authors
consider the possible causes for
this patient's death.

et montra des voies biliaires remplies
de pus et d’un residu biliaire noir.
On ne releva pas la presence de
calculs. Les auteurs commentent les
causes possibles ayant pu entrainer
le deces du patient.

Monooctanoin (predominantly glyce
ryl-1-monooctanoate and glyceryl dioctanoate), a commercial emulsifying
agent, has been used to dissolve bileduct stones when a T-tube allows ac
cess to the biliary tree.1 Perfusion of
the bile ducts with monooctanoin in
rhesus monkeys caused no obvious ab
normality in contrast to other sub
stances.* Furtherm ore, monooctanoin
is a normal product of digestion of
medium-chain triglyceride. In contrast
to these studies, another group3 has
reported the development of cholan
gitis, papillitis, and possibly acute pan
creatitis in anesthetized cats when the
biliary tree was perfused with mono
octanoin. We report here a case of
necrotizing choledochomalacia after
the use of monooctanoin.

Case Report
A 72-year-old white man suffered
acute abdominal pain for 48 hours. At
laparotomy there was biliary peritonitis
secondary to gallbladder perforation. A
Foley catheter was placed in the gall
bladder after the evacuation of several
small yellowish calculi. These calculi
were not analysed. It was not possible
to determine if pancreatitis was present,
the liver appeared normal to inspection
and no attempt was made to perform
intraoperative cholangiography. Post
operative pulmonary infection was treated
with cloxacillin. He was discharged 38
days after operation; a cholangiogram
at that time demonstrated choledocholithiasis. On discharge his serum bilirubin
level was 0.8 mg/dl (13.7 pmol/1) (nor
mal less than 1.0 mg/dl [17.1 [j.mol/1])
and the alkaline phosphatase value was
160 IU/1 (normal less than 85 IU/1).
Over the next 5 months, the cholecys
tostomy catheter was allowed to drain
freely into a plastic drainage bag. Biliary
volumes varied from 50 to 300 ml/24 h
suggesting incomplete and intermittent
From the gastrointestinal research unit
and departments of pathology and
obstruction of the distal duct. Because
surgery, Faculty of Medicine, University he seemed unwilling and unable to
of Calgary, Calgary, Alta.
manage the biliary fistula by himself,
Accepted for publication Mar. 22, 1982 the patient was readmitted for an
attempt to dissolve the calculi by the
Reprint requests to: Dr. R.M. Preshaw,
use of monooctanoin.
Department of surgery, Faculty of
A cholangiogram again demonstrated
Medicine, Health Sciences Centre,
choledocholithiasis (Fig. 1). He was
University of Calgary, Calgary, Alta.

Un homme de 72 ans atteint d'une
choledocholithiase, mise en evidence
a la radiographie, a ete traite par
perfusion continue de la vesicule
biliaire avec du mono-octanoi'ne
(glyceryl-1-monooctanoate) apres une
cholecystostomie pour une perforation
de la vesicule. Le mono-octanoi'ne fut
administre a la vitesse de 7.5 m l/h
et surveille de fapon a s’assurer que
la pression de perfusion ne depasse
pas 20 cm H.,0. La perfusion s’etendit
sur 60 heures, mais elle dut etre
interrompue en raison de douleur
abdominale, nausee et vomissement.
Ceci fut suivi d’un ictere evolutif,
d’anorexie et de fievre. Le patient
recut de la penicilline G et de la
cefoxitine par voie intraveineuse et
du metronidazole par voie orale, mais
il mourut 5 semaines apres la
perfusion. L’autopsie revela une
pancreatite aigue et une cholangite
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afebrile, alert and on a normal diet.
The serum bilirubin level was 0.6 mg/dl
(10.3 u.mol/1), alkaline phosphatase 240
IU/1 and serum glutamic oxaloacetic
transaminase 102 IU/1 (normal less than
200 IU/1).
Monooctanoin (Capmul 8210; StokelyVan Camp, Capital City Products Co.,
Columbus, Ohio) was perfused by syringe
pump through a sterile system containing
a 0.45 n cellulose acetate filter and an
open vertical venous pressure manometer,
as suggested by Thistle and associates:1
the perfusion was to be stopped if the
pressure exceeded 20 cm H20 . Mono
octanoin is supplied unsterile, but culture
showed no growth by standard aerobic
and anaerobic methods.
Perfusion at 7.5 m l/h caused anorexia
after 24 hours and intermittent nausea.
However, the perfusion was continued
without interruption for a further 24
hours as similar symptoms had been
observed by Thistle and associates.1 The
patient complained of right-sided abdo
minal pain so the perfusion was stopped
for 12 hours. The pump was then re
started as his symptoms appeared to
improve, but when his serum bilirubin
level rose to 4.5 mg/dl (77 umol 1) the
perfusion was discontinued.
Over the next 5 weeks, progressive
jaundice and pyrexia developed, while
the intermittent nausea and vomiting and
anorexia continued. The cholecystostomy
catheter was kept open throughout, but
the volume of bile produced was only
25 to 100 ml/24 h. Bile cultured on four
occasions by needle aspiration of the
lumen of the catheter was sterile. Initial
blood cultures were sterile, but at 3 and
again at 4 weeks after the perfusion was
stopped, blood cultures grew, respective
ly, Escherichia coli and Enterobacter
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FIG. 1—Cholangiogram showing com
mon duct calculus.
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cloacae. Liver scanning, computerized
axial tomography and other radiologic
studies were not helpful. Because of a
clinical impression of liver abscess or
ascending cholangitis, he was given
metronidazole orally, and penicillin G
and cefoxitin intravenously. His pyrexia
showed slight improvement but the
alkaline phosphatase value rose above
1000 IU/1 and the serum bilirubin level
to 22 mg/dl (376 pmol/1). The serum
amylase level, determined on several
occasions, was not elevated. A cholan-

FIG. 2—Cholangiogram 3 weeks after
monooctanoin perfusion. Appearance is
compatible with biliary cast (arrows):
previously noted calculi are no longer
present.

FIG. 3—Common hepatic duct con
taining black biliary cast. Glass rod is
in cystic duct.

giogram (Fig. 2) showed no calculi in
the duct system, but was interpreted
either as showing hemobilia or a biliary
cast. The patient died from progressive
renal failure and bronchopneumonia
5 weeks after monooctanoin perfusion.
Autopsy was limited to examination
of the abdomen. The peritoneal cavity
contained 2 litres of clear orange fluid.
The gallbladder was 4 cm long and its
wall was thickened. The extra- and intrahepatic bile ducts contained black biliary
casts (Fig. 3) and there were focal
abscess-like collections of turbid yellow
fluid beside large bile ducts. No calculi
were present. Histologically the large
bile ducts were destroyed and their walls
were replaced by casts of bile that re
tained the central lumina. Bile appeared
to have dissected into the duct wall
because some connective tissue was
found near the luminal surface. Bile had
leaked focally into the portal tract to
form small bile lakes or bile-containing
abscesses. The casts contained clumps of
gram-negative rods and were surrounded
by a mixed neutrophil and macrophage
response (Fig. 4). Ducts of less than
500 u diameter were normal in appear
ance as was their epithelium. The liver
was green and histologically showed
marked canalicular and liver cell choles
tasis predominantly centrilobular in dis
tribution. Copper stains were negative.
The portal tracts showed mild lympho
cytic and neutrophilic infiltration and
edema. Neutrophils were not present in
bile-duct lumina and there was no fur
ther proliferation. There were multiple
foci of fat necrosis throughout the lesser
sac and pancreas; acute pancreatitis was
present.
Discussion

M onooctanoin effectively dissolves

cholesterol gallstones when adminis
tered directly into the human biliary
system. Thistle and associates1 re 
ported that their 12 patients frequent
ly had anorexia, nausea and emesis
and abdominal discomfort during ad
m inistration of this substance, but that
these side-effects were probably at
tributable to increased pressure in the
bile ducts and were relieved when the
perfusion was stopped. For this reason
we were not unduly disturbed when
our patient had similar complaints.
The duration of therapy in the
Mayo series varied from 4 to 21 days.
O ur patient had continuous perfusion
for 48 hours and intermittent perfu
sion for a further 12 hours. Adm in
istration of monooctanoin was then
stopped because of a rising serum
bilirubin level.
Despite the finding that monooclanoin did not cause any histologic
changes in the bile ducts of rhesus
monkeys,2 it has been reported to
cause cholangitis and papillitis, and
acute pancreatitis after perfusion of
the biliary tree in anesthetized cats.3
The histologic findings in our case
were those of toxic epithelial necrosis
in the bile ducts.
Thistle and associates1 perfused
monooctanoin into the common bile
duct of their patients by means of in
dwelling T-tubes and interrupted the
perfusion three times daily for periods
of 1 to 2 hours. In our case, we at
tem pted to perfuse continuously for
48 hours and only interrupted the per
fusion when the abdominal pain de
veloped as well as anorexia and nau
sea. Furtherm ore, the monooctanoin

FIG. 4— Biliary cast replacing wall of major intrahepatic duct, with bile leakage
into portal tract connective tissue. There was heavy mixed inflammatory cell response
(hematoxylin and eosin, reduced by 31% from x 100).
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solution was perfused into the gall
bladder by a cholecystostomy catheter
rather than directly into the bile duct.
We find it difficult to attribute the
fatal result in this case to these dif
ferences.
It is possible that perfusion of the
duct system flushed a biliary calculus
into the ampulla and simultaneously
induced acute pancreatitis. The chol
angitis observed would therefore rep
resent a complication of distal biliary
obstruction. Against this argument is
the failure of decompression of the
biliary tree to alter the clinical course
and the repeated failure to culture any

organisms from bile samples. Perhaps
the severe cholangitis represented an
unusual response to one of the anti
biotics administered after the initial
jaundice was noted.
The clinical course and autopsy
findings were consistent with a toxic
choledochomalacia and pancreatitis
induced by 60 hours of perfusion with
monooctanoin solution, although we
cannot exclude the coincidental devel
opment of severe cholangitis. Any
agent capable of making cholesterol
crystals stable might also under some
circumstances disrupt the lipid com
ponent of cell membranes; this occurs

in cats3 and perhaps occasionally in
man, as evidenced by this case.
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Immobilization Hypercalcemia
L owell

van

Z u id en ,

m d , frcs [c ], K.A. A nquist , md , frcs [c ], N.
N. K astelen , md , frcs [c ]

Three cases of immobilization
hypercalcemia are presented and the
incidence, clinical symptoms, laboratory
investigation, pathophysiology and
treatment of this metabolic abnormality
are reviewed. Immobilization hyper
calcemia is more common than has
previously been suspected. Vague
clinical symptoms may not suggest the
diagnosis of hypercalcemia. Laboratory
investigation of these clinical
complaints in the immobilized patient
should include determination of the
serum calcium and total protein levels
and the urinary calcium to creatinine
ratio.
The pathophysiology of this entity
is unknown. Treatment is directed
towards lowering the serum calcium
level using intravenous hydration,
furosemide and salmon calcitonin.
Definitive treatment consists of
mobilizing the patient. Exercises in
bed have not been effective in
preventing or treating immobilization
hypercalcemia.
Cet article decrit trois cas
d’hypercalcemie d’immobilisation
et passe en revue I’incidence, le
tableau clinique, les examens de
laboratoire, la pathophysiologie et le
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traitement de cette anomalie
metabolique. L’hypercalcemie
d’immobilisation est plus frequente
qu'on ne I'a soupponne jusqu'a
maintenant. La symptomatologie vague
peut ne pas suggerer le diagnostic
d'hypercalcemie. Les examens de
laboratoire faits en rapport avec les
plaintes du malade immobilise doivent
inclure la determination des
concentrations seriques du calcium
total et des proteines totales ainsi
que le rapport du calcium et de la
creatinine urinaire.
La pathophysiologie de cette
entite est inconnue. Le traitement
cherche a abaisser la calcemie
par I’administration de solutes
intraveineux, de furosemide et de
calcitonine de saumon. Le traitement
definitif consiste a mobiliser le
patient. Les exercices au lit ne se sont
pas reveles efficaces pour prevenir
ou traiter I'hypercalcemie
d'immobilisation.

Osteoporosis that develops following
partial or complete immobility of the
human skeleton has been recognized
for over a century.1,2 Hypercalcemia,
only recently described in the immo
bilized patient, is a metabolic com
plication of immobilization. The cause
of this type of hypercalcemia is un
known.
Fuller Albright and associates3 pre
sented the first complete description
of this complication, illustrating the
diagnostic and therapeutic problems

Schachar,

md , frcs [c ] and

involved. Their patient, a 14-year-old
boy with a fracture through a cyst in
the neck of femur, was immobilized
in a hip spica. Subsequent clinical and
laboratory evidence of hypercalcemia
suggested a diagnosis of hyperpara
thyroidism. No abnormal parathyroid
tissue was found following exploration
of the neck and anterior mediastinum.
It was assumed that the hypercalcemia
resulted from a lack of stress on the
skeleton. The patient was therefore
mobilized and his symptoms resolved
completely. The blood chemistry
values returned to normal in t month.
Since the report of Albright and
colleagues, this complication has been
described in many clinical situations,
including poliomyelitis,3,4 spinal cord
injury,3 burns,6 acute renal failure7’8
and postoperative immobilization.”
The common factor in each of these
clinical situations is immobility.
The present paper reports three
cases of immobilization hypercalce
mia, occurring at the Alberta Chil
dren’s Provincial General Hospital, in
Calgary, during a 3-month period. A
review of the literature suggests that
hypercalcemia is common in the im
mobilized patient, but that it is fre
quently missed. Further consideration
of the clinical manifestations, as dem
onstrated in the present study, em
phasizes the subtle symptoms asso
ciated with immobilization hypercal
cemia. This may explain the frequent
failure to recognize this complication.
Both urine and serum biochemical
studies may be helpful, but they are
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not diagnostic of immobilization hy
percalcemia. Although the definitive
method of measuring renal calcium
excretion is by 24-hour urine collec
tion, a more recent contribution by
Rosen and associates10 suggests that
the calcium to creatinine ratio is an
easier and more effective indication
of increased renal excretion of cal
cium. However, no further reports
using this test have appeared in the
literature. Biochemical assessment of
the serum total calcium, phosphate
and total protein levels must be in
cluded in the laboratory assessment of
a patient with suspected hypercalce
mia.
This paper also reviews the research
into the pathophysiology of immobil
ization hypercalcemia, discusses vari
ous modes of treatment and concludes
with a treatment plan for this meta
bolic complication of immobility.
Case Reports
Case 1
A 14-year-old boy sustained a supra
condylar fracture of the right femur. Bal
anced skeletal traction with both tibial
anu femoral condylar Steinman pins re
sulted in adequate position.
Four weeks after the injury the boy
was emotionally labile and had mild
abdominal discomfort which slowly sub
sided. The serum calcium level was not
determined. At 7 weeks he had bloodtinged urine and severe flank pain. Uri
nalysis revealed many red blood cells
and a few calcium oxalate crystals. The
total serum calcium level was 12.3 mg/dl
(3.07 amol/1) (normal range, 8.5 to 10.5
mg/dl [2.12 to 2.62 q.mol/1]). Serum
phosphate, total protein and alkaline
phosphatase levels were normal. Fluid
intake was encouraged and acidification
of the urine was accomplished using
ascorbic acid. The patient was rapidly
mobilized and his serum calcium level
returned to, and remained, normal.
Case 2
This 7V5-year-old girl sustained a
closed head injury, renal contusion and
closed fracture of the left femur when
she was struck by an automobile. The
head injury and renal contusion resolved.
The fractured femur was treated with
balanced skeletal traction and immobi
lization.
Four weeks after admission she ex
perienced grumbling abdominal and right
lower quadrant pain. Despite investiga
tion, the diagnosis of hypercalcemia was
not made until 5V4 weeks after admis
sion. At this time her serum calcium level
was 11.3 mg/dl (2.82 jj.mol/1). Urinalysis
demonstrated calcium oxalate crystals
and microscopic hematuria. A urinary
calculus was passed 2 days after the diag
nosis was made. The patient was treated
with hydration and mobilization. Follow

up laboratory studies showed that the
condition had resolved.
Case 3
When she fell from a horse this ^V iyear-old girl sustained a mid-shaft frac
ture of the left femur. The fracture was
treated with balanced skeletal traction.
Five weeks after injury she had mild
abdominal discomfort, anorexia and
slight emesis.
Laboratory examination revealed an
elevated calcium level of 14.2 mg/dl
(3.54 umol/I). Urinalysis and serum
phosphate, total protein, alkaline phos
phatase and parathyroid hormone estima
tions gave normal results. Twenty-fourhour urine collections were used to meas
ure calcium excretion throughout the
course of the illness, but they were found
to be unreliable. Salmon calcitonin
(40 lU /d) given intramuscularly drama
tically reduced the serum calcium to
normal levels and eliminated the symp
toms. Two and a half weeks after the
diagnosis of hypercalcemia, mobilization
with protected weight-bearing of the frac
tured femur was permitted. Follow-up
calcium levels were normal.

served in our patients, symptoms be
gin late in the period of immobiliza
tion. Lethargy, slight alteration in
mood, minor gastrointestinal distress,
nausea or mild anorexia may be the
only symptoms. These nonspecific
complaints are unlikely to suggest a
diagnosis of hypercalcemia. T heir oc
currence late in the period of immo
bility may be dismissed as patient re
action to confinement or a m inor viral
illness.
In children the period of immobil
ization may be only 4 or 5 weeks. The
onset of minimal symptoms may occur
just before their mobilization and the
diagnosis may be missed.
Urolithiasis is a late manifestation
of hypercalcemia. It occurs after
symptoms have been present for some
time. This was evident in our second
patient. It is our opinion that prom pt
clinical and laboratory investigation
of these minor symptoms and treat
ment of the hypercalcemia will pre
vent the development of urinary cal
culi.

Literature Review

Laboratory Assessment

Clinical Assessment

Standard laboratory assessment is
useful but not definitive in the diag
nosis of immobilization hypercalce
mia. The level of ionized calcium in
the blood gives a physiologic repre
sentation of altered calcium dynamics.
However, this test is not available in
most laboratories. M easurement of the
serum total calcium is the most useful
generally available test, but the total
protein level must also be known.
Total calcium may be norm al in pa
tients with elevated ionized calcium
levels;13 therefore, the clinician may
need to rely on the clinical m anifesta
tions and the urinary calcium excre
tion.
Twenty-four-hour urine calcium ex
cretion greater than 250 mg (6.24
mmol) has been defined as abnormal.
This test is awkward to perform and
unreliable. In our third patient, the
24-hour urinary calcium excretion was
normal. Rosen and colleagues10 meas
ured the urinary calcium clearance to
creatinine clearance ratio and found a
good correlation with serum ionized
calcium. If this ratio is equal to or
greater than 0.4:1, then hypercalcemia
is likely.
Other determinations should include
serum phosphate and alkaline phos
phatase levels. In patients with
immobilization hypercalcemia these
values should be norm al.3,10
There is no general agreem ent on
parathyroid hormone levels to be ex
pected in immobilization hypercalce
mia. Parathorm one levels in immo-

The incidence of immobilization
hvpercalcemia is controversial. W olf
and associates” and others12 have
stated that this complication is rare
in the immobilized traum a patient.
Heath and associates13 compared the
serum ionized calcium and urinary
calcium levels of 4 healthy imm obil
ized adult volunteers with 10 adult
patients immobilized for fracture m an
agement. He found elevated ionized
calcium levels in all volunteers and in
7 of the 10 patients. Such abnorm al
ities in immobilized children have
been documented by Rosen and asso
ciates.10 Further clinical confusion is
added by Henke and colleagues,14 who
stated that immobilization hypercal
cemia occurs only in patients with an
underlying disorder of calcium m eta
bolism, such as Paget’s disease and
hyperparathyroidism. The literature
does not substantiate this premise.4,10,15
Furthermore, the cases described here
did not demonstrate any underlying
abnormality.
We conclude that immobilization
does cause an alteration in calcium
dynamics, which may or may not be
come clinically manifest. By careful
consideration of the complaints of
these immobilized patients we may un
derstand why this phenomenon is not
detected more frequently.
Hypercalcemia is a systemic ab
normality, and its metabolic conse
quences have diverse and often subtle
clinical manifestations. As we ob
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bilization osteoporosis of animal
models have been reviewed by Burk
hart and Jowsey.18 Immobilization os
teoporosis did not develop in parathyroidectomized animals. In a further
study of the effects of calcitonin on
immobilized dogs, Chiroff and Jow
sey17 postulated an elevation of para
thormone to account for the minimal
effects of calcitonin on the immobil
ized bone. The role of parathyroid
hormone in this syndrome remains
unclear.
Lerman and associates18 measured
the immunoreactive parathyroid hor
mone level in two patients with im
mobilization hypercalcemia and found
it elevated. Others10'1214 have found a
normal or low immunoreactive para
thyroid hormone level in immobilized
patients with hypercalcemia.
This problem may be resolved by
recent studies on renal function in
hypercalcemic patients.19 Altered glo
merular filtration and loss of urine
concentrating ability of the tubules
has been shown to occur in hyper
calcemia.7'8,10 Parathyroid hormone
metabolism is dependent upon renal
function.19 This may affect parathy
roid hormone levels and account for
the variability of reported levels in
patients with immobilization hyper
calcemia.
Hydroxyproline levels in the urine
are known to be elevated in immobi
lized patients, due to an increased
breakdown of bone-derived colla
gen.13’20 However, this does not appear
to be helpful in the diagnosis and
treatment of immobilization hypercal
cemia.
Most other laboratory studies have
been found useful in experimental
metabolic studies but add little in the
immobilized patient with hypercalce
mia.
Pathophysiology
The pathophysiology of immobiliza
tion hypercalcemia is unknown. A re
lation between disuse osteoporosis and
hypercalcemia has been postulated by
many authors.4’6'7,11'13 Biochemical,21
histologic,22 angiographic23 and radiographic24 investigations have revealed
many complex mechanisms involved in
the development of disuse osteopo
rosis. Uhthoff and Jaworski,25 in a
morphologic investigation of bone loss
in dogs, described three distinct phases
of bone loss (endosteal, Haversian and
periosteal) with a bone envelope-spec
ific response in each phase.
In humans, disuse osteoporosis has
been the subject of recent interest be
cause of space exploration.26 Investiga
tion into calcium dynamics and
648

bilization hypercalcemia is mobiliza
tion of the patient. If the original
problem precludes mobilization, med
ical treatment can be effective in man
aging this complication. Other causes
of hypercalcemia must first be ruled
out. Measurement of the total calcium
level and urinary calcium to creatinine
ratio can be used to follow the pa
tient’s response to treatment.
Initially, the patient should be ade
quately hydrated with saline. Renal
perfusion must be maintained to allow
adequate calcium excretion. Acidifica
tion of the urine with ascorbic acid
will diminish the risk of renal calcif
ication.7 Furosemide enhances calcium
excretion in the loop of Henle and
is effective in lowering the serum
calcium level.29 Complications of furo
semide therapy such as volume deple
tion, hypokalemia and hypomagnese
mia must be avoided.
Diminution of calcium intake is
generally not effective. It becomes im
portant only in those patients already
receiving supplemental calcium or vi
tamin D. In these situations the sup
plement should not be given.
Other therapeutic agents include
phosphates, steroids, anabolic steroids
and calcitonin.
Phosphate has been administered
both orally and intravenously to lower
serum calcium.30 Calcium levels are
lowered without increasing the urinary
excretion of calcium. Metastatic cal
cification, hypotension, hypocalcemia
and death have all been reported with
its use.30
Steroids have been found effective
in lowering serum calcium concentra
tion in patients with hypercalcemia
due to malignant tumours.8 Several
cases of dramatic lowering of serum
calcium in immobilized patients have
also been reported.5,12 The systemic
complications of steroids are well
known. Anabolic steroids have also
been used successfully to treat immo
bilization hypercalcemia.31
Mithramycin has been used to
lower calcium levels in patients with
hypercalcemia due to malignant tu
mours.32
Salmon calcitonin has been effec
tive.10’20,33 Most authors agree that cal
citonin exerts its effect by decreasing
bone resorption. The response to cal
citonin is biphasic; an initial decrease
in osteoclast function accounts for the
early rapid fall in calcium and later,
with continued calcitonin administra
tion, the number of osteoclasts is also
decreased.20 Our third patient gives
further support to the effective use of
Treatment
salmon calcitonin in the treatment of
The definitive treatment of immo immobilization hypercalcemia. Idio-

the effect of bed rest have been
studied.410,13’24 Conclusions from these
studies reveal a loss of mineral and a
tendency to elevated ionized calcium
levels in both the zero gravity and
with bed rest.
In reviewing the literature, four
possible pathophysiologic pathways
emerge for the explanation of hyper
calcemia in the immobilized patient:
1. Mechanical stress applied to
bone has been shown to create a
piezoelectric charge on the bone.27 A
negative charge is established on the
concave surface of bone, where bone
deposition takes place. Bed rest de
creases this stress, altering the charge
in favour of bone resorption. Albright
and associates3 proposed this theory
for the development of immobilization
hypercalcemia, and Becker27 stated
that recent work on electrical prop
erties of bone supports this theory.
2. The vascular response to immo
bilization has been studied by Hardt,21
who found an initial increase in bone
blood flow associated with increased
mineral deposition. A second response,
after 15 days of immobilization, was
a decrease in mineral deposition and
bone blood flow. Geiser and Trueta23
also studied immobilized bone and
showed increased vascularity.
3. Metabolic factors have been im
plicated as the cause of disuse osteo
porosis and hypercalcemia. Altered
metabolism of osteoblasts and osteo
clasts has been proposed21’23 to explain
the difference in pH and carbon di
oxide tension noted in immobilized
bone. The role of osteoblast-osteoclast
coupling in immobilization hypercal
cemia has not been established. Secre
tion of parathyroid hormone in im
mobilized volunteers and patients has
been discussed. Other hormones (e.g.,
thyroid) may be involved directly16 or
indirectly through parathyroid hor
mone.28 The role of the metabolic re
sponse to trauma in the development
of disuse osteoporosis and hypercal
cemia has not been studied.
4. Finally, a neurologic cause for
disuse osteoporosis has been postu
lated.22 The exact effect of denerva
tion on the development of disuse os
teoporosis and hypercalcemia has not
been established. Loss of muscle func
tion and its inherent mechanical load
ing probably account for the osteopo
rosis of denervation.
Hypercalcemia is thus a well-recog
nized complication of disuse osteo
porosis, but no unified pathogenetic
mechanism has yet been described.
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syncratic reactions to calcitonin have
very rarely been described. Mild nau
sea and gastrointestinal upset can oc
cur. No adverse effect of calcitonin
on fracture healing has been de
scribed.20’33 We have found 40 IU of
salmon calcitonin given intramuscu
larly to be effective in the manage
ment of our patients’ hypercalcemia.
Others20 recommend up to 100 IU
daily.
Physical methods have been used
to treat immobilization hypercalcemia.
Several investigations have shown that
neither isometric nor isotonic exer
cises in bed are helpful in lowering
serum calcium levels in immobilized
subjects.5’7,34 We agree that exercise in
bed will not alter the pathophysiologic
process of immobilization hypercalce
mia. Intermittent longitudinal com
pression of limbs does not alter the
negative calcium balance in normal
subjects confined to bed.34 Supple
mental calcium, phosphate, calcitonin
and longitudinal compression all to
gether have been shown to prevent
disuse osteoporosis.34
Definitive management of hypercal
cemia in immobilized patients requires
early diagnosis, rapid mobilization and
medical intervention directed at lower
ing the serum calcium. This is accom
plished effectively by intravenous sa
line, furosemide and salmon calcitonin
given intramuscularly. Careful mon
itoring of clinical symptoms, serum
calcium levels, urinary calcium clear
ance to creatinine clearance ratio and
fluid balance will reflect the response
to treatment.
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SESAP III Critique
ITEM 241
The combination of an area of pigmentation in the nail bed with pigmentation of the
nail fold (Hutchinson’s sign) is diagnostic of subungual melanoma. This lesion occurs
most frequently on the thumb and great toe. It spreads concentrically rather than in a
vertical band. The lesion is in the nail bed, and therefore does not travel with nail
growth. The most important differential diagnosis involves subungual hematoma. The
pigmentation of subungual hematoma migrates distally with nail growth. Treatment
requires amputation.

0
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Is TPN

Mo, not really,
rhere will always be
some patients who
'equire TPN.
However, for the majority
Df patients, those with
a functioning gut, there
is a preferred alternative.
Mvonex® HN, total
\
enteral nutrition, is that
preferred alternative.

Vivonex HN is as effective,
and is safer, easier to handle
and is less expensive
Equally effective
“ It is probable that the nitrogen and body
weight preservation provided by enteral
hyperalimentation equals or exceeds that
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Giant Hemangioma of the Liver
G reta T aitelbaum ,

md ,* E.

J ohn H inchey, md, FRCs[c],f M ilton J. H erba,
J ohn L ough, md , frcp [c]§

Six patients with hemangioma of the
liver larger than 5 cm in diameter
were treated at the Montreal General
Hospital between 1968 and 1981.
Two patients were symptomatic,
complaining of nonspecific right upper
quadrant pain. One man presented
in a dramatic fashion when he bled
from a ruptured hemangioma after
a fall. Arteriography in three of the
patients revealed characteristic
filling of the vascular spaces
commencing in the arterial phase
with persistent dense accumulation
in the venous phase. A timed,
infusion computerized axial tomogram
in one case revealed prolonged
opacification, occurring from the
periphery of the lesion towards
the centre over several minutes.
All six hemangiomas were benign;
they consisted of large blood spaces
separated by fine fibrous septae.
They appeared to expand by
incorporating marginal liver sinusoids.
Organizing thrombus was often
seen; this could account for the
right upper quadrant pain. The patients
were treated by partial or total
hepatic lobectomy to relieve symptoms
and prevent hemorrhage due to
trauma. On two occasions, nodules
of hemangioma were left behind
but none of the six patients showed
evidence of recurrence on follow-up.
Six patients atteints d’un hemangiome
hepatique dont le diametre etait
superieur a 5 cm ont ete traites a
I'Hopital General de Montreal entre
1968 et 1981. Deux patients qui avaient
des symptomes se plaignaient de
douleurs non specifiques au quadrant
superieur droit. Un homme presents
un tableau dramatique alors qu'il se
mit a saigner d’un hemangiome rompu
a la suite d'une chute. Chez trois de
ces patients, I’arteriographie revela
un remplissage caracteristique qui
debutait avec la phase arterielle et
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montrait une accumulation dense
persistante durant la phase veineuse.
Dans un cas, une tomographie
transverse axiale sur ordinateur avec
chronometrage et perfusion montra
pendant plusieurs minutes une
opacification prolongee apparaissant a
la peripherie de la lesion et s ’etendant
vers le centre. Les six hemangiomes
etaient benins; ils consistaient en de
larges espaces sanguins separes par
de fines parois fibreuses. Ils semblaient
s'etendre aux depens des capillaires
sinusoides marginaux du foie. Un
thrombus en voie d’organisation etait
souvent observe, ce qui peut expliquer
la douleur au quadrant superieur
droit. Le traitement a consiste a faire
une lobectomie hepatique totale ou
partielle destinee a soulager les
symptomes et a prevenir les
hemorragies pouvant resulter d'un
traumatisme. En deux occasions, des
nodules d'hemangiomes ont ete laisses
en place mais aucun des six patients
n'a montre de signes de recidive aux
examens de controle.

md ,

FRCp[c]t

and

pain. Spontaneous rupture of the liver
containing a hemangioma has been
reported.
Advances in radiologic techniques
now allow accurate diagnosis of he
mangiomas of the liver. The proper
management of these lesions is still
not clear.
We have reviewed the experience
with giant hemangiomas of the liver
at the Montreal General Hospital, be
tween 1968 and 1981.

Patients (Table I)
Our group consisted of six patients
(four men. two women). Their ages
ranged from 40 to 61 years. Two pa
tients complained of right upper qua
drant pain for which no other cause
could be found. A large liver was
found during the routine physical
examination of one patient and fur
ther investigations were carried out.
In one man the presentation was dra
matic; his hemangioma ruptured when
he fell out of a third floor window.
Two patients were found to have a
hemangioma incidentally during lapa
Hemangioma is the most common be rotomy for gastric ulcer and gallblad
nign tumour of the liver.1 The inci der operations, respectively.
Three patients underwent extensive
dence, from various autopsy series,
ranges from 0.4% to 7.3% .1-3 Because preoperative investigation. Prelimin
they usually do not produce symptoms ary diagnosis of the liver mass was
hemangiomas are generally discovered metastatic carcinoma in one and
incidentally at laparotomy or autop echinococcal cyst in two, both of
sy A3,4 Adam and associates5 found whom had a positive Casoni test. The
that tumours less than 4 cm in dia true nature of the lesion was revealed
meter did not give rise to symptoms. by .arteriography in three and con
Larger growths, which they called firmed by computerized axial tomo
giant cavernous hemangiomas, pro graphy in two.
duced symptoms due to their pressure
on adjacent organs. Rarely, thrombosis Radiologic Investigation
Three of the patients had preopera
occurs in the vascular spaces of the
tumour and leads to severe abdominal tive investigation for a mass in the
Table 1—Clinical Features
Patient
no.

Sex

Age, yr

i

M

44

2

M

60

3

F

32

4
5

F
M

40
58

6

M

61

Presentation
Right upper
quadrant pain
Post-traumatic
rupture
Incidental
operative finding
Asymptomatic
Right upper
quadrant pain
Incidental
operative finding

Size, cm

Treatment

20 x 14

Left lobectomy

10 x 10

Partial right
lobectomy
Partial right
lobectomy
Right lobectomy
Left lobectomy

7x7
10 x 8
15 x 10
14 x 10

Partial left
lobectomy
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liver. Sulfur colloid liver scans showed
the extent and location of the lesions.
An angiogram showed a typical pic
ture. In two patients the vascular
spaces filled during the arterial phase
and dense accumulation of contrast
material persisted well into the venous
phase. The lesions, characteristically,
filled directly from normal-sized intrahepatic arterial branches, as described
in previous reports.6 In the third pa
tient severe stenosis at the origin of
the celiac axis prevented selective

catheterization so the lesion could not
be demonstrated. Arteriography car
ried out before resection clearly out
lined the arterial anatomy. In the case
illustrated in Fig. 1 (patient 4 in Table
1) , the left hepatic artery originated
from the left gastric artery. In the
other patient subselective right and
left hepatic arteriography showed the
precise location and blood supply of
the lesion in the left lobe.
The pattern of contrast accumula
tion in the hemangioma is reflected
by computerized axial tomography;
with infusion, and sequential timed
scans over several minutes, opacifica
tion occurred initially in the periphery
with a gradual increase in density
towards the centre of the lesion (Fig.
2) .

Pathologic Features

FIG . 1— Patient 4. A rteriogram shows
filling of vascular spaces during arterial
phase. Left hepatic artery arises from
left gastric artery. A rea of hemangioma
is indicated by arrows.

The six hemangiomas were similar
in structure. They appeared irregularly
loculated and dark red beneath the
liver capsule and varied in greatest
dimension from 7 to 20 cm. Multi
focal, yellowish areas of organizing
thrombus were sometimes seen on the
sectioned surface. Microscopically,
the hemangiomas had a sponge-like
appearance with blood spaces sepa
rated by fine fibrous septae lined by

endothelium (Fig. 3). The tumours ex
tended irregularly into the adjacent
liver which did not show distortion
by compression or pseudocapsule for
mation. At the edge of the lesion, iso
lated blood lakes were often seen in
the hepatic parenchyma, sometimes
communicating with ectatic sinusoids
in association with atrophy of the
liver cells (Fig. 4). Large arteries and
veins were often present in adjacent
liver. Old and recent thrombosis, with
organization and fibrosis, was found
in every case.
Operation

Hemangiomas of the liver may be
resected by wedge excision, partial re
section of the involved lobe or formal
excision of a complete anatomical
lobe. The operation required is de
termined by the anatomical character
istics of the individual lesion. Formal
lobectomy should only be done for
giant lesions replacing an entire lobe
or for multiple lesions confined to one
lobe. Three of our patients required
formal lobectomy; the other three
were treated by partial lobectomy.
Two patients, who had left lobec
tomies, also had single small heman
giomas in the right lobe. Twelve-year
follow-up by repeat liver scans in one
of these two patients has shown no
change in the size of the residual le
sion.
Discussion

F IG . 2— Patient 4. Computerized axial tom ogram s. (A) Preinfusion scan shows
large hypodense lesion in right lobe. H = h cm an g io m a. (B) Infusion, early scan,
shows increased density at periphery. (C) Infusion, after several minutes, show s
further filling of lesion from periphery tow ards centre of lesion. (D) A fter right
hepatic lobectomy, bowel is located between abdom inal wall and rem ainder o f liver.
Left lobe of liver has undergone considerable hypertrophy.

Cavernous hemangioma of the liver
is discovered at autopsy in about 5%
of cases1-3 and in about 10% of these
there are multiple hemangiomas. They
are considered to be vascular ham ar
tomas rather than true neoplasms.3 Al
though it is uncertain whether these
lesions are congenital or acquired, the
structure, characterized by the pres
ence of irregular blood lakes in ad
jacent liver parenchyma and the ab
sence of a capsule, suggests that giant
hemangiomas slowly expand by incor
porating and modifying liver sinu
soids. As the slow enlargement occurs,
there is often an associated central
and subcapsular thrombosis followed
by fibrosis of vascular channels.
Hemangiomas larger than 4 cm
are said to be symptomatic,5 but only
two of our patients complained of
right upper quadrant pain. The pain
may be caused by thrombosis affect
ing the surface of the liver with asso
ciated focal fibrinous serositis. Pain
and hepatomegaly could also be ex
plained by the gradual enlargement of
the tumour with compression of ad
jacent organs, such as the gallbladder
and stomach. Liver function tests are
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not helpful in making the diagnosis.
Other tests may be misleading; a false
positive Casoni reaction incorrectly
suggested an echinococcal cyst in two
of our patients. The nonspecificity of
this test has been described previous
ly Plain roentgenograms were not
helpful in our patients. Calcification
in the region of the liver may be seen
in some cases Radionuclide scanning
and ultrasonography cannot reliably
distinguish giant hemangiomas from
secondary carcinoma; this is especially
so when the hemangioma is multifo
cal
Arteriographic findings were char
acteristic in three of our patients; ves
sels of normal size were displaced by
the lesion
There were no arterio
venous malformations, and prominent
lakes containing contrast material per
sisted into the venous phase.
The infusion computerized axial to
mogram showed early peripheral opa
cification and late filling of the central
area. This test may replace all invasive
tests in the future as it is quite specific
and is associated with minimal mor
bidity
Laparoscopy was not carried out in
any of our patients. It is diagnostic if
the tumour is situated in the periphery
of the liver
Liver biopsy should not be done
because of the danger of hemorrhage
from the tumour
. 7 -8

.4

The need for therapy has not been
clearly defined or objectively studied.
Operation is advocated for large, re
the danger of
sectable lesions
traumatic rupture and previously de
scribed cases of spontaneous rupture
lend support to this policy. The true
risk of rupture must be low, however,
since only a small number of cases
have been reported in the literature.
Radiotherapy has been recom
mended for lesions that are not re
sectable and appears to have some
value
; 15,16

17

. 18

. 2-9 1 0

. 6-11-12

. 13,14

. 14

.9

FIG. 3—Subcapsular hemangioma of
liver. Vascular spaces are separated by
fibrous septae (hematoxylin and eosin,
reduced by 57% from x 1000).
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FIG. 4—Periphery of hemangioma.
Liver parenchymal cells (P) show com
pression atrophy as enlarged sinusoids
(S) appear to be incorporated into heman
gioma (hematoxylin and eosin, reduced
by 57% from X975).
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CASE 8

A CASE
FOR METAMUCIL:

Acute Inflammation of Pancreatic Tissue
in a Meckel’s Diverticulum
R obert

H.

T aylor,

md , cm , frcs[c] and

D avid A. O wen ,

mb , b ch, mrc path, frcp [c]

Meckel’s diverticula are reported to
contain ectopic pancreatic tissue in
from 1% to 3% of cases studied.5,6
Acute inflammation localized to the
ectopic pancreatic tissue of such a
diverticulum and giving rise to acute
abdominal symptoms has not pre
viously been reported in the English
literature.
Case Report
A 29-year-old man presented with a
48-hour history of diffuse abdominal
pain. Several hours before presenta
tion, the pain localized to the right
lower abdomen and became more severe.
He had anorexia, mild nausea and loose
stools. There was no history of gastro
intestinal problems. He was a well-nour
ished young man. He was afebrile and
Les auteurs signalent ce qu'ils croient
his vital signs were normal. Abdominal
etre le premier rapport dans la
examination revealed a slight increase in
litterature de langue anglaise d'une
bowel sounds and marked rebound ten
inflammation aigue de tissu
derness in the lower abdomen, maximal
pancreatique ectopique dans un
just medial to McBurney’s point. Rectal
diverticule de Meckel. Un homme de
examination gave negative results. His
29 ans a ete vu souffrant de douleur
hemoglobin value was 15.9 g/dl and the
abdominale aigue; un diagnostique
leukocyte count 12.6 X 109/l with a
clinique d’appendicite aigue fut pose.
slight shift to the left. Urine specific
A la laparotomie, I'appendice etait
gravity was 1.027 and urinalysis showed
trace ketones. Serum and urine amylase
normal mais on observait un diverticule
levels were not measured. A diagnosis
de Meckel avec inflammation marquee
of acute appendicitis was made.
de la partie distale. L’examen
Laparotomy through a lower vertical
microscopique revela une inflammation
incision revealed a normal appendix. On
aigue limitee a du tissu pancreatique
the antimesenteric border of the ileum,
dans la paroi du diverticule. Une
60
cm proximal to the ileocecal junction,
adiponecrose etait presente. Les
there was a diverticulum 4 cm long and
mecanismes physiopathologiques
with a narrow base. The apex of the
possibles sont discutes.
diverticulum was swollen into an in
flamed, edematous, yellowish “knob”.
Meckel’s diverticulum is reported to The base of the diverticulum and adja
be present in about 2% of individ cent ileum were normal and there were
no enlarged lymph nodes. The narrow
uals.1 The majority of these individuals base
was crushed and ligated and the
are asymptomatic, but, occasionally, diverticulum
the stump was incomplications occur and make opera vaginated withexcised;
a
pursestring
suture. The
tion necessary. Such complications in patient made a smooth recovery.
clude hemorrhage, intussusception, di
verticulitis, obstruction and perfora Microscopic Findings
tion.2’3 The diverticulum can also be
The diverticulum was lined ex
the site of a neoplasm or form a com clusively
by mucosa of small bowel
ponent of a hernia.4,5
type. No patches of gastric mucosa
of either antral or acid-secreting type
were noted and there was no evidence
From the departments of surgery
of mucosal inflammation or ulcera
and pathology, University of British
tion. The wall of the diverticulum
Columbia and affiliated teaching
hospitals, Vancouver, BC
showed a well-defined submucosa and
two layers of muscularis propria. The
Accepted for publication Jan. 18, 1982
overall structure was thus that of a
Reprint requests to: Dr. R.H. Taylor,
congenital diverticulum (Meckel’s di
Rm. 622, Department of surgery,
verticulum).
Jean Matheson Pavilion, Shaughnessy
Sections through the yellowish area
Hospital, 4500 Oak St., Vancouver,
BC V6H 3N1
at the tip showed acute inflammation
656
VOLUME 25, NO. 6, NOVEMBER 1982 / THE

The authors report what they believe
is the first report in the English
literature of acute inflammation of
ectopic pancreatic tissue in a
Meckel's diverticulum. A 29-year-old
man presented with acute abdominal
pain and a clinical diagnosis of
acute appendicitis was made.
Laparotomy revealed a normal
appendix and a Meckel’s diverticulum
with gross inflammation at the
distal end. Microscopic examination
showed acute inflammation limited
to ectopic pancreatic tissue in the wall
of the diverticulum. Fat necrosis
was present. The possible patho
physiologic mechanisms are discussed.

and fat necrosis external to the mus
cularis propria (Figs. 1 and 2). This
was associated with recognizable pan
creatic tissue (Fig. 3). As is usual in
acute pancreatitis the ductules and
islands of Langerhans were more
prominent than the acinic tissue,
which was largely autodigested.
The microscopic appearances there
fore were identical with those of acute
pancreatitis seen in the normally situ
ated pancreas. These changes were not
secondary to luminal diverticular in
flammation.
Discussion
Ectopic pancreatic tissue (pancrea
tic heterotopia, aberrant pancreas, ac
cessory pancreas) has been found in
a variety of gastrointestinal organs:
esophagus, stomach, duodenum, com
mon bile duct, gallbladder, jejunum,
ileum, Meckel’s diverticulum and
within the mesentery.7’9 Such tissue
contains all the elements and architec
ture of the pancreas itself — exocrine
cells arranged into acini, ductules
and ducts entering onto the mucosal
surface of the organ and islands
of Langerhans with measurable endo
crine function.9’11 Why this displaced

FIG. 1—Apex of diverticulum. Nor
mal ileal mucosa (top). Acute inflamma
tory reaction in subserosal adipose tissue
(bottom) (hematoxylin and eosin, re
duced by 46% from x40 ).
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tissue is found in these ectopic loca
tions is not known but the two most
commonly held theories are, first, that
of lateral budding of the rudimentary
pancreatic ducts as they penetrate the
intestinal wall (tissue is separated,
carried along the length of the gastro
intestinal tract and subsequently
grows) and, second, of de novo forma
tion, since the embryonic digestive
tube is pluripotential and capable of
forming any of the accessory digestive
organs. Neither theory, by itself, satis
factorily explains the widespread and
specific locations.
Such ectopic tissue has been found
capable of undergoing all of the path
ologic changes seen in the pancreas
itself: benign and malignant neoplasms

of both exocrine and endocrine tissue
have been reported, and acute and
chronic inflammation including cyst
formation has also been docu
mented.911 Even cystic fibrosis has
been found in aberrant pancreatic tis
sue in a patient with this disease.10 All
reported cases of inflammation in ec
topic pancreas have occurred in struc
tures adjacent to the pancreas itself —
stomach, duodenum, common bile
duct and transverse mesocolon. In
some of these cases, the main gland it
self was also involved. Pancreatitis has
never been documented as occurring
in ectopic pancreatic tissue of the jeju
num or ileum, although, in 1946, Bar
bosa and colleagues9 reported a case
of pancreatic heterotopia with inflam

mation (including fat necrosis and
foreign-body reaction) in an omphalo
mesenteric cyst of the anterior abdom
inal wall of a 22-year-old man.
Meckel’s diverticulitis is not rare.
However, what makes our case unique
is the fact that the ileal mucosa of
the diverticulum was normal and not
involved in the inflammatory process.
The inflammation was limited to the
ectopic pancreatic tissue and there
was adjacent fat necrosis.
In considering the possible causes
of the acute pancreatitis, there are
only two reasonable explanations: ob
struction and ischemia. Filling of the
mouth of the diverticulum by a food
mass could cause obstruction to the
secretion of the pancreatic tissue and
inspissation leading to inflammation.
If this were the case, one might have
expected the ileal mucosa also to be
involved. An ischemic role in the
pathophysiology is plausible, particu
larly if there was an adhesion band
that might cause torsion or kinking.
However, no such band was present
and the patient had never been oper
ated on.
Whatever the cause of the pancrea
titis in this unique case, it was clearly
sufficiently severe to cause an acute
abdominal
condition
necessitating
emergency surgical intervention.
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FIG. 2—Edge of inflammatory mass shows fat necrosis (bottom right) (hema
toxylin and eosin, reduced by 25% from x 40).

FIG. 3—Fat necrosis (left) associated with surviving pancreatic ductules (top) and
island of Langerhans (right) (hematoxylin and eosin, reduced by 25% from x 100).
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Traumatic Diaphragmatic Hernias
a Report of 19 Cases
F ernando de O liveira , m d , F ernando J. O liveira , m d and A lber to Q u eiros , md
From an analysis of 19 patients
with traumatic diaphragmatic hernias
with respect to the type of injury,
associated injuries, clinical and
radiologic features, diagnosis, surgical
management and causes of death
and from a review of the literature,
the authors draw a number of
conclusions.
1. Careful clinical examination
coupled with an accurate interpretation
of the roentgenograms should detect
most cases of traumatic rupture
of the diaphragm.
2. Impairment of respiratory
function, possibility of strangulation
and incarceration of the abdominal
viscera demand early repair.
3. The choice of incision and
approach depends on the stage at
which the rupture is recognized
(early or late), the site of rupture and
the associated injuries.
4. Careful assessm ent of respiratory
function should be made in order
to prevent postoperative complications;
in som e cases respiration must be
assisted.
5. Although the mortality in
patients with traumatic diaphragmatic
rupture is still relatively high,
the deaths should not be related
to the rupture per se, or to its
repair, but rather to the associated
injuries.
A partir de I'etude de 19 patients
qui avaient une hernie diaphragmatique
traumatique et qui ont ete analyses
par rapport aux types de blessures,
aux lesions associees, aux caracteristiques cliniques et radiologiques,
au diagnostic, au traitement chirurgical
et aux causes de deces, ainsi que
d'uno revue de la literature, les
auteurs tirent plusieurs conclusions.
1.
Un examen clinique minutieux
associe a une interpretation precise
des radiographies devraient
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permettre de deceler la plupart
des cas de rupture traumatique
du diaphragme.
2. Une atteinte de la fonction
respiratoire et la possibility d’un
etranglement des visceres abdominaux
commandent une reparation immediate.
3. Le choix de I’incision et de
I'abord chirurgical depend du stade
atteint lors de la reconnaissance
de la rupture (precoce ou tardif), de la
localisation de la rupture et des
blessures associees.
4. L'evaluation minutieuse de la
fonction respiratoire est de mise
si Ton veut prevenir les complications
postoperatoires; dans certains cas,
la respiration doit etre assistee.
5. Bien que la mortality chez les
patients souffrant d’hernie
diaphragmatique traumatique
demeure relativement elevee, les
deces ne devraient pas etre
causes par rupture du diaphragme
ou par sa reparation, mais plutot
par les blessures associees.

Diaphragmatic hernias due to trauma
have been seen much more frequently
in the last two decades because the
number of road and work accidents
Table l-H e rn ia te d Viscera
Herniated organ

No. of ca ses

Stom ach
Spleen

15
8
6

Transverse colon
Liver
Jejunum and ileum
Greater omentum

3
2
2

Table I I - A ssociated Lesions
Associated lesion
Spleen
Colon
Liver
Stom ach
M esentery
Pancreas
Ileum
Lung
Extremities
R ib s
Pelvis
Skull

No. of cases
9
4
2
2
1
1
1
3
5
5
2
2
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has increased. The purpose of this
paper is to report our experience with
traumatic diaphragmatic hernias, to
discuss the most important diagnostic
aspects and to consider the surgical
management.
Patients and Findings
Nineteen patients with traumatic
diaphragmatic hernias were treated at
the University Hospital of Coimbra
between Jan. 1, 1970 and Dec. 31,
1979. There were 17 males and 2
females. Their ages ranged from 5 to
81 years.
In 17 patients the rupture was
caused by road accidents, 1 patient
had a fall from a great height and the
last patient had an accident with a
gun.
The diagnosis was made immediate
ly following injury in 17, but in 2
it was delayed 5 and 20 years respec
tively.
The symptoms were abdominal in
nine patients and thoracic in eight. In
two others respiratory insufficiency
was the most serious symptom.
In 11 patients paracentesis or peri
toneal lavage, or both, showed a hemoperitoneum. Eight patients arrived
at the hospital in a state of shock.
Plain films of the chest suggested
traumatic diaphragmatic hernia in 13
patients; in 12 of them there was a
pattern of intestinal air or fluid in
the chest, while in the other exagger
ated elevation of the right hemidiaphragm was observed. Confirmation
was obtained in five patients from
contrast roentgenograms. In the re
maining six patients the diaphragmatic
rupture was found only at operation,
because it was masked by other serious
injuries.
There were no instances of bilateral
rupture. Sixteen patients had a left
sided tear while 3 had rupture of the
right side. The size of the tears varied
between 5 and 10 cm in 6 patients
and was longer than 10 cm in 13.
The most frequently herniated or
gans were the stomach (15 times) and
the spleen (8 times) (Table I).
Associated injuries were frequent
(Table II), occurring in 17 patients. In
nine the injuries were limited to the
abdomen (Table III).
CANADIAN JOURNAL OF SURGERY

The interval between the accident
and operation ranged from a few
hours to 20 years. Of the 19 patients,
14 were operated upon within the first
24 hours; 3 were operated upon be
tween 24 and 72 hours and in the
other two the operation was per
formed 5 and 20 years respectively
after injury, when the diagnosis was
made. The surgical approach in 12
patients wqs by laparotomy; in 5 pa
tients a thoracoabdominal approach
was,necessary and in 2 a thoracotomy
was performed.
Five patients (26.3%) in this series
died (Table IV). The other 14 patients
have been followed up regularly from
1 to 10 years postoperatively; all are
alive and have no symptoms.
Discussion
In the most recently reported
series,1-4 as in ours, road accidents
were the most frequent cause of trau
matic rupture of the diaphragm. Indus
trial accidents and sports were next in
frequency.1"* In our series one rupture
was caused by a bullet.
The side of the rupture is more
commonly the left.1"3,5,6 because the
right hemidiaphragm is protected by
the liven It was also demonstrated by
Bekassy and associates1 that the right
hemidiaphragm is more resistant to
pressure than the left.
Diagnosis
The diagnosis is difficult because

Table Ill-Associated Injury
Site of injury

No. of cases

Abdomen alone
Abdomen + thorax
Abdomen + extremities
Abdomen + thorax + skull
Abdomen + thorax
+ extremities
Abdomen + extremities
+ pelvis
Abdomen + skull
+ extremities + pelvis

9
3
2
1
2
1
1

the patients generally have multiple
associated injuries, masking the clin
ical picture of diaphragmatic rupture.
In our series only two patients had
an isolated rupture.
The importance of early diagnosis
as well as early repair has frequently
been stressed.1-4'7 First, diaphragmatic
rupture greatly impairs respiratory
function;7 herniated viscera displace
and compress the lung, leading to ate
lectasis and hypoxia. Pneumonia,
bronchietasis and lung abscesses may
follow. Second, displacement of the
mediastinum to the opposite side, par
ticularly in patients with a consider
able herniation of viscera, may inter
fere with cardiac function. Finally, in
carceration or strangulation of viscera
may occur. Carter and Giuseffi8 re
ported that 90% of strangulated dia
phragmatic hernias are traumatic in
origin.
When the possibility of a traumatic
rupture of the diaphragm is high, we
believe the diagnosis can be established
preoperatively through careful clinical
examination and radiologic study of
the chest in frontal and lateral pro
jections.
The characteristic symptoms of dia
phragmatic injury, such as phrenic ex
acerbation, hiccups and pain in the
left shoulder, are seldom encountered.
But, on initial examination, the fol
lowing are suggestive: (a) the site of
injury, (b) pain in the lower chest,
(c) abdominal paradoxical respiration,
(d) a percussion splash or bowel
sounds in the chest and (e) dyspnea
(polypneic type) with cyanosis.
On some chest roentgenograms
clear signs of diaphragmatic rupture,
especially those that show a large hy
pertransparency, are found. However,
the signs we find more frequent
ly are those of atelectasis or hemo
thorax. These signs, associated with
the clinical picture, should make us
suspicious and should lead to the diag
nosis of traumatic diaphragmatic her
nia. Confirmation of diagnosis is ob
tained by roentgenographic study of
the digestive tract.

In our series, the chest film was
considered normal in 31.5% of the
patients. This percentage is similar to
that presented by Wise and associates9
(37.5%) and by Freeman and Fischer5
(33%) but it is rather greater than
that found by MacCune and asso
ciates3 (11%). More critical evaluation
of the films may lower the margin of
error and bring us closer to the values
reported by MacCune and colleagues.
Treatment
The treatment of traumatic dia
phragmatic hernia is exclusively sur
gical. The patient should be operated
upon as soon as possible; delay in
making a diagnosis and undertaking
treatment increases mortality. How
ever, the controversial points are the
choices of incision and approach. The
types of incision and approach chosen
vary with the stage at which the rup
ture is recognized (early or late), the
side of the rupture and with the asso
ciated injuries (particularly abdom
inal).
When the rupture is recognized
early, when it is on the left side and
intra-abdominal injuries are suspected,
laparotomy should be used. It was
our choice in 14 of the 17 patients.
When intrathoracic injuries exist, thor
acotomy associated with a laparotomy
is the approach necessary. In three
patients we had to use this combined
approach. In this case we prefer to
use separate incisions (laparotomy
plus thoracotomy) rather than a con
tinuous incision (thoracophrenolaparotomy). For right-sided ruptures,
right thoracotomy is preferable. For
our three patients who had a right
hemidiaphragmatic rupture we used a
combined approach: laparotomy plus
thoracotomy, in two patients because
the rupture had not been diagnosed
preoperatively, and in the other be
cause the patient had associated intra
abdominal injuries. When the ruptures
are recognized late, as happened in
two of our patients, thoracotomy is
the approach we prefer. In these cases,

Table IV Causes of Death (Five Patients)
Age, yr

Interval between
trauma and operation, h

45
80

4
6

24

3

50

72

33

6

Site of
associated injury

Time of death
after operation, d

Cause

Skull + lungs
Spleen + extremities
+ pelvis + skull
Spleen + colon + lungs

1

Brain damage

1
1

Liver + extremities

4

Brain damage
Cardiorespiratory
insufficiency
Cardiorespiratory
insufficiency
Pulmonary embolism

Mesentery + ileum + colon

14
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Sternectomie partielle pour tumeur metastatique avec
reconstruction par plaque de methylmethacrylate
Y.

GLOCK, MD,*

J.

HERREROS, MD,t

Les auteurs rapportent un cas de
sternectomie partielle pour carcinome
thyroi'dien metastatique. L’exerese
en monobloc a ete suivie d’une
reconstruction par plaque moulee de
methylmethacrylate.
Les tumeurs sternales sont rares
et I'operation a visees curatives
des metastases ne se justifie que si
I’etat general du patient le permet,
et qu’il s'agit d’une metastase unique
dont le cancer primaire a subi une
cure consideree comme radicale.
La chirurgie d'exerese large et en
monobloc repose sur une exploration
preoperatoire oil la tomographie axiale
sur ordinateur a une place
importante pour apprecier I'etendue
de la tumeur, et sur un contrdle
extemporane des marges de section.
La reconstruction par methyl
methacrylate presente I’interet d'un
montage rigide, par une substance
modelable extemporanement,
semi-transparente aux rayons X,
inerte et bien toleree par I'organisme.
En position sternale haute, le
moulage de methylmethacrylate
contribue a stabiliser la ceinture
scapulaire et assure une protection des
plans mediastinaux sous-jacents avec,
accessoirement, un effet esthetique
acceptable.
A case of partial sternectomy for
metastatic thyroid carcinoma is
reported. En bloc excision was
followed by reconstruction using a
molded plate of methylmethacrylate.
Sternal tumours are rare and
operations for cure of metastases
are justified only if the general
condition of the patient permits and
*P ro fesseu r adjoint, d ep a rtem en t de
chirurgie cardiovascu laire-thoraciqu e,
+resident IV, dep artem en t d e chirurgie
card iov a scu la ire-th o ra ciqu e. Xp r o f esse ur
adjoint, d ep a rtem en t d e chiru rgie
gen erate et % professeur a g reg e; directeur
du departem en t d e chiru rgie c a rd io 
vascu laire-thoraciqu e, C en tre H ospitalier
U niversitaire d e S h e rb ro o k e, S h erh roo ke,
PQ
A ccep te p o u r pu b lication le 24 fevrier,
1982
L es dem a n d es d e tires d part doivent
etre adressees au D r F .J . T eijeira,
Centre H osp italier U niversitaire d e
S h erb ro o k e, 3001 - 12e av en u e nord,
S h erb ro o k e, PQ J1 H 5N 4
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in the patient with a single metastasis
whose primary cancer operation
was a radical one.
Extensive en bloc excision is based
on preoperative investigation in which
computerized axial tomography
has an important place in delineating
the extent of the tumour and providing
accurate knowledge of the margins
of the section.
Reconstruction with methyl
methacrylate allows a rigid setting
with a material that can be molded,
is radiolucent, inert and well tolerated.
In the upper sternum it contributes
to the stability of the shoulder girdle
and protects the underlying mediastinal
structures in a cosmetically
acceptable way.
Si les tumeurs localisees au thorax
osseux sont rares, cedes a topographie
sternales sont exceptionnelles.1'8 Toute
tumeur sternale doit etre consideree
comme maligne jusqu’a preuve du
contraire.1,4'8'10 Apres cure radicale du
cancer primaire, la metastase, si elle
est unique, se traite chirurgicalement.11"14 Le bilan d’extension tumoral
s’est enrichi recemment de l’examen
par tomographie axiale sur ordinateur,
qui permet d’evaluer la profondeur
d'envahissement. Le diagnostic pathologique doit etre fait chirurgicalement
lors de 1’exerese qui est toujours large
et en monobloc.5'11,1419 Des lors, se
pose le probleme de la reconstruction
parietale. Dans les sternectomies partielles, la rigidite thoracique n’est pas
compromise;4,5,8’9’11,12’19 toutefois, le
comblement de la perte de substance
nous apparait justifie tant pour reconstituer un plan profond rigide capable
de proteger le mediastin18 que pour
stabiliser la ceinture scapulaire. L ’effet
esthetique est obtenu accessoirement.
A cette fin, le methylmethacrylate est
un materiel adequat.15,19,20 Nous decrivons un cas de sternectomie partielle
pour une lesion metastatique unique
d’un carcinome thyroi’dien, suivie
d’une reconstruction par plaque modelee de methylmethacrylate.
Observation
Une femme, agee de 64 ans, est
porteuse d’une neoplasie thyro'idienne
folliculopapillaire, decouverte a la

F.J. T e ije ir a ,

md§

suite de In stallation d’une paralysie
recidivante avec dysphonie. II s’agit
d’une masse thyro'idienne dominant a
gauche, multinodulaire, fixee, et legerement douloureuse. Le bilan biologique revele une glande euthyro'idienne et la scintigraphie montre une
heterogeneite de fixation avec des
zones froides au niveau du lobe gau
che. La recherche d’anticorps antithyroidiens est negative. Le diagnostic
pathologique ayant montre la nature
folliculopapillaire du carcinome et devant un envahissement important au
niveau des cartilages larynges, on rea
lise une laryngectomie totale avec evidemment jugulo-carotidien et thyro'idectomie totale. Les suites sont sim
ples. On decouvre, au decours du bilan
d’extension, une tumeur situee au ni
veau du manubrium sternal. C ’est pour
l’ablation de cette tumeur que la malade est confiee au departement de
chirurgie cardiovasculaire et thora
cique.
A l’entree, la malade presente une
cicatrice arciforme cervicale en rap
port avec la laryngectomie et la thyroi'dectomie. L ’orifice de tracheostomie permanente est situe un travers
de doigt au dessus du manubrium ster
nal. La cicatrice est nette. Cliniquement, la malade est en bon etat gene
ral. L ’examen met en evidence une
masse d’environ 8 cm de diametre
proeminente d’environ 2 cm sous la
peau (fig. la). Cette masse est molle,
pulsatile, sensible a la palpation, sans
thrill, ni souffle. L a peau en regard
est rouge et un peu inflammatoire. II
n’y a pas d’adenopathie sus-claviculaire. La masse est situee surtout du
cote gauche du manubrium. Le reste
de l’examen est negatif, l’auscultation
cardiopulmonaire est normale, l’auscultation de la masse n’objective pas
de souffle. Une scintigraphie thyro’idienne a l’iode-131, montre qu’il n’y
a pas de captation d’iode au niveau
de la masse manubriale. Par contre,
la scintigraphie au technetium-99m
montre une hyperfixation au niveau
de la portion superieure du sternum.
Les coupes tomographiques standards
du sternum (fig. 2) revelent une large
lesion osteolytique soufflant l’os, affectant essentiellement la moitie su
perieure et laterale gauche du manu
brium et s’etendant jusqu’au niveau du
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cartilage sternocostal de la premiere
cote gauche. L’extremite proximale de
la clavicule est respectee. La tomographie axiale du mediastin superieur et
du cou confirme la presence de cette
large lesion metastatique osteolytique
du manubrium sternal (fig. 3). Elle
permet de constater qu’il existe un bris
de la corticale anterieure et posterieure. II y a peu de masse tumorale
dans le mediastin anterieur en relation
avec 1 os sternal. Devant la chirurgie
radicale realisee au niveau cervical, il
est decide, en l’absence d’autres metastases, de realiser une resection de
la masse tumorale sternale avec re
construction.
La patiente est placee en decubitus
dorsal sous intubation par sonde
armee au niveau de la tracheostomie,
laquelle est separee du reste du champ
operatoire par un Op-Site sterile. Le
champ operatoire est large de fagon
a englober les deux seins de la malade
et a laisser toute la poitrine pour faire
face au probleme de recouvrement
cutane par d’eventuels lambeaux. L’incision est realisee de fagon a emporter
en monobloc la peau et les tissus recouvrant la tumeur. II s’agit d’une in
cision arciforme, concave en haut,
passant au pole superieur de la tumeur
et allant jusqu’au tiers moyen des clavicules droite et gauche. Branche sur
cette premiere incision, on realise une
incision concave vers le haut faisant
le tour de la masse tumorale et emportant une surface de 8 cm2 de peau.
A la partie inferieure de cette incision,
est branchee une incision verticale mediane. On decolle deux lambeaux lateraux emportant la peau, le tissu souscutane, l’aponevrose et le muscle
pectoral. Ces lambeaux sont sains bien
vascularises; ils sont chacun reclines
vers la droite et vers la gauche. Le
plastron sternal apparait; un lambeau
superieur est decline vers le haut, em
portant la peau, le tissu sous-cutane,
et les chefs d’insertion claviculaires et
sternaux des muscles sternaux cleidomastoi'diens droit et gauche. On fait
un deperiostage de la clavicule au
tiers moyen ainsi que de l’extremite
de la premiere cote a droite et a
gauche. Celles-ci sont sectionnees a la
scie de Gigli. Le pole inferieur de la
tumeur se situe 3 cm au dessus du
bord superieur de la deuxieme cote
et il est decide de la laisser en place.
On disseque le deuxieme espace inter
costal et une scie de Gigli est glissee
sous le sternum de fagon a sectionner
celui-ci transversalement. On controle
les vaisseaux mammaires internes
droits et gauches qui sont lies sous
la zone de resection claviculaire. Le
plan profond est libre de tout enva664

hissement mediastinal bien que la cor est solide (fig. 4). La plan de couverticale posterieure soit effondree. Le ture est fait grace a la suture sur la
fragment manubrial sternal emportant ligne mediane, apres decollement des
la premiere cote et le tiers interne de masses musculaires et aponevrotiques
clavicule est enleve en monobloc. On des grands pectoraux qui realisent un
constate que toutes les berges de la plan consistant et bien vascularise. Des
zone resequee sont libres d’envahisse- points de rapprochement sont faits
ment neoplasique. On se trouve alors dans le tissu sous-cutane et un surjet
en presence d’une perte de substance sous-cuticulaire ferme l’incision cutade la paroi thoracique mediane manu- nee sans tension. II est laisse en place
brio-sternale de 18 X 20 cm a com- un Hemovac retrosternal et presternal
bler. A l’aide d’un fil d’acier, on rea
lise d’abord l’osteosynthese de la cla
vicule avec la premiere cote. On fait
ensuite un moulage de methacrylate
qui est modele de fagon a donner le
relief d’une fourchette sternale correcte. Les berges de cette plaque ster
nale synthetique sont modelees de
fagon a s’arrimer sur la face externe
de la clavicule, de la premiere cote,
de la deuxieme cote et sur la table
externe du corps sternal restant. La
plaque de methacrylate est perforee
d’une serie d’orifices destines a passer
les fils d’acier qui sont successivement
fixes au niveau de la clavicule, de la
2— Incidences manubrio-sternapremiere cote, de la deuxieme cote les:FIG.
metastase osteolytique.
et du corps sternal. Le montage realise

FIG. 3— Coupe sternale et mediastinale a la tomographie axiale sur ordinateur: envahissement sternal avec effondrement des corticales anterieure et pos
terieure. Le sternum est indique par la
fleche.
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Fig. Ib
FIG. 1— (a) Preoperatoire:
tumeur
sternale vue a jour frisant. (b) Postopera
tiv e : cicatrice en Y avec bonne trophicite des lambeaux.

FIG. 4— Radiographic postoperatoire:
seuls se voient les fils d’acier fixant la
plaque semi-transparente aux rayons X,
aux berges osseuses.
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et on recouvre d’un pansement compressif. Au plan histologique, la masse
tumorale est un carcinome folliculopapillaire. Les suites operatoires sont
simples. La malade est sur pied le
lendemain de 1’intervention. Les drains
sont enleves en 24 heures. La peau
cicatrise sans probleme (fig. lb). La
malade sort au lOe jour avec une re
paration satisfaisante tant au plan de
la stability sternale qu’au point de vue
esthetique, sans depression liee a la
perte de substance et avec un relief
manubrial correct.
Discussion

T *

>
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Les tumeurs du thorax osseux sont
rares. Elies represented moins de 1%
de toutes les tumeurs malignes,13 et de
7% a 8% des tumeurs osseuses.6'8 Les
tumeurs sternales, quant a elles, comptent pour 3.7% a 15% des tumeurs
thoraciques osseuses,2,6'8'21 mais pour
seulement 0.6% a 0.9% de toutes les
tumeurs osseuses.6,8 Les tumeurs metastatiques du sternum dominent en fre
quence1'13 et represented 39.8% des
cas recenses par Kinsella et collaborateurs5 (67 cas sur 168). L’origine thyroi'dienne de la metastase sternale est
retrouvee dans 34% des cas de Kin
sella et collaborateurs5 (23 sur 67 cas).
Le premier rapport est celui d’Ollivier22 en 1868 qui soulignait le caractere pseudo-anevrismal de cette tumeur.23 La premiere resection revient
a von Eiselsberg en 1893.24
La symptomatologie associe de fa$on constante le binome “tumeur, douleur”. Une croissance rapide plaide en
faveur de la malignite.1,9 La douleur
peut preceder de plusieurs mois la le
sion osseuse decelable a la radiographie.13 Ces signes peuvent neanmoins
faire defaut.16 La caracteristique des
metastases osseuses de la thyroide et
des hypernephromes du rein est la
pulsatilite.4’9,12,22,23 Au niveau sternal,
la topographie de ces metastases est
surtout manubriale5 bien que le cas
de Baue11 necessita une resection ster
nale totale du fait d’un envahissement
du corps et du manubrium sternaux.
La masse tumorale est molle et la
pulsatilite ne s’accompagne pas de
thrill ni de souffle. En plus du bilan
radiologique standard et des tomogra
phies sternales precisant l’importance
de la lyse osseuse, certains auteurs
preconisent l’angiographie globale et
selective des arteres thyro’idiennes,
mammaires internes et intercostales
afin d’exclure un anevrisme aortique
et d’apprecier l’origine de la vascularisation en cas de tumeur vasculaire,
et pour en preciser l’abord chirurgical.10,25 La tomographie axiale sur

ordinateur nous est apparue tres utile
pour apprecier l’envahissement des
plans profonds. Son caractere non invasif et la fiabilite des images en font
un examen de choix dans le bilan des
tumeurs sternales.
Comme le note Campbell,14 l’indication operatoire en matiere de meta
stase repose, sur une bonne condition
generate du patient, l’unicite de la
metastase et la cure radicale du can
cer primaire, et la possibility de resequer sans mortality prohibitive. Ces
conditions etaient reunies chez notre
patiente.
L’intervention comporte toujours
deux temps operatoires: la resection
suivie de la reconstruction.12,16 En
ce qui a trait a la resection, l’unanimite est faite sur la necessity d’une exerese large, en monobloc, emportant
tous les plans concernes par le proces
sus tumoral. En cas de biopsie ou
d’envahissement, la peau est excisee et
les lambeaux conserves doivent etre
viables. La presence d’un pathologiste
s’impose afin de preciser l’integrite
de la marge de resection en cours
d’operation.5,6,9,10,12,14,16,25 Au niveau
sternal, les cartilages costaux adjacents sont a resequer ainsi que les tiers
internes des clavicules en cas de tu
meur manubriale.16
Le jugement du chirurgien ne doit
pas etre defavorablement influence
par la crainte de la perte de substance
creee26 car une excision partielle n’est
pas mieux que l’abstention.1
En matiere de sternectomie par
tielle, la reconstruction ne s’impose
pas, du fait de l’absence de trouble
ventilatoire par instability, et une sim
ple couverture musculo-cutanee peut
suffire.5,8,9,22 Nous pensons toutefois
que la creation d’un plan resistant
de protection mediastinal16 et a visee
esthetique est justifiee. Si la perte du
support claviculaire est minimise par
les insertions musculaires,11 il est sur
que la reconstitution d’un “arc-bou
tant anterieur” a la ceinture scapulaire
evitera les genes fonctionnelles et les
risques de lesions plexulaires.
Le materiel autogene a ete largement employe avec succes,2,5,12 mais
les caracteristiques actuelles des materiaux prothetiques en font d’excellents
substituts. En matiere de plastie ma
nubriale, le choix d’un materiel rigide
s’impose car, du fait de l’absence de
mouvement sterno-costal au niveau de
la premiere cote,14 on ne se heurte pas
a l’inconvenient d’un materiel rigide
fixe a une cote mobile, comme c’est
le cas a l’etage du corps sternal. Le
materiel de choix nous a paru etre le
methylmethacrylate utilise par les neurochirurgiens pour les cranioplasties et

adopte par certains chirurgiens thora
ciques.15,19,20 Facilement modelable en
extemporane, a la mesure et a la
forme de la perte de substance, ce
materiel est inerte et offre une excellente tolerance biologique. Sa semi
transparence aux rayons X n’hypotheque pas les possibilites de surveillance
radiologique des plans sous-jacents.
Sa mise en place avec fixation par fils
d’acier est facile.
Conclusions
Bien que la chirurgie des metastases
sternales soit souvent palliative, elle
peut neanmoins faire esperer des survies de plusieurs annees.14 Une repara
tion la plus anatomique possible s’im
pose alors. L’observation rapportee illustre les possibilites d’exerese et de
plastie des metastases uniques chez
des malades en bon etat general qui
ont subi une cure radicale de la tu 
meur primaire.
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Femoropopliteal Bypass:
Saphenous Vein and Expanded Polytetrafluoroethylene
Grafts
D.L. W ooster ,

m d , frcs [ c 1,*

The patency of 181 saphenous vein
and expanded polytetrafluoroethylene
(PTFE) femoropopliteal bypass grafts
was assessed during a follow-up that
ranged from 1 to 53 months after
operation. Significantly better patency
(P < 0.05) was noted with saphenous
vein (70%) than with PTFE (56%).
Life-table analysis at 30 months
demonstrated a cumulative patency of
50% for saphenous vein grafts versus
39% for PTFE, while at 53 months the
rates were 4P% and 33% respectively.
The PTFE gra .
-nded to occlude
earlier than sap 'ous vein grafts
but after the initial year, both types
of graft failed at a rate of about
5% a year. Patency was similar in
both groups when operation was
performed for claudication, but for
limb salvage operations saphenous
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vein patency was superior to PTFE.
Although the groups were similar in
constitution, a higher percentage of
patients in the PTFE group had
undergone previous vascular
operations.

La permeabilite de 181 pontages
femoro-poplites par greffe de veine
saphene ou par greffon de poly
tetrafluoroethylene expanse (PTFE)
a ete evaluee au cours d’examens de
surveillance qui se sont etales de
1 a 53 mois apres I’operation. Une
permeabilite significativement meilleure
(P < 0.05) a ete observee avec les
greffes de veines saphenes (70%)
comparativement au PTFE (56%).
L’analyse apres 30 mois a I’aide de
tables actuarielles a demontre un taux
cumulatif de permeabilite de 50%
pour les greffes de saphenes contre
39% pour le PTFE; apres 53 mois,
les taux etaient de 46% et de 33%
respectivement. Les greffons de PTFE
avaient tendance a s'obstruer plus
tot que les greffes de saphenes mais,
apres la premiere annee, les deux
types de greffons avait un meme taux
d'echec d'environ 5% par annee. Dans
les operations pour claudication, la
permeabilite etait similaire pour les
deux groupes, mais dans les
interventions visant a sauver un
membre, les greffes de veines
saphenes etaient superieures au
PTFE. Bien que les caracteristiques
des deux groupes aient ete semblables,
un plus fort pourcentage des patients
du groupe PTFE avaient deja subi
dans le passe des operations
vasculaires.

b sc* and

Femoropopliteal bypass is frequently
performed to relieve claudication, rest
pain and threatened limb loss. The
reversed saphenous vein is the stand
ard against which newer graft mate
rials are tested and remains the
most satisfactory conduit. Grafts
o f expanded polytetrafluoroethylene
(P T F E ) (G O RE-TEX; W .L. Gore &
Associates, Flagstaff, Ariz.) have been
advocated as the most satisfactory by
pass if the saphenous vein is absent
or inadequate for a femoropopliteal
bypass.1'3
The following retrospective review
o f our experience over a 3-year period
compares the patency o f the saph
enous vein graft with PTFE and dem
onstrates that PTF E is less than ideal
for below-knee femoropopliteal by
pass.

Patients
We reviewed the records o f 170
patients who underwent femoropopli
teal bypass during a 30-month period
(January 1977 to July 1979) and were
followed up between January 1977
and December 1979. The results of
bypass in 204 limbs were considered.
However, 23 limbs in which composite
grafts or grafts other than saphenous
vein or PTF E were used were ex
cluded. The results on the remaining
181 limbs were analysed. The same
181 grafts were also reassessed in May
1981.
The groups were compared with re
spect to age, indications for the pro
cedure, previous vascular operations,
inflow and outflow (run-off) status.
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patency and subsequent amputation R esu lts
up to December 1979. A random sub
Four subgroups were identified on
group defined the incidence of ciga the basis of patency or occlusion of
rette smoking. Diabetes, coronary ar saphenous vein or PTFE femoropoptery disease and cerebrovascular dis liteal bypass graft (Table I). These
ease were not correlated in this study. populations proved to be comparable.
The indications for bypass were The mean age of the patients was 65
grouped as “claudication alone” or years. Of a random subset of patients
“limb salvage”, which included rest 78% were smokers. Grafts had been
pain and gangrene. Bypass patency placed previously in 38 (21%) of the
was determined by clinical and Dop 181 limbs (Table I). Follow-up ranged
pler assessment and in some cases from 1 to 53 months in both groups.
defined by angiography regardless of Amputations resulted from 35 of the
the presence or absence of symptoms 68 occluded bypasses (51.5%) with
at follow-up. If a technical error was no significant difference noted be
recognized and remedied within hours tween saphenous vein and PTFE
of the initial procedure and resulted grafts. No difference with respect to
in a viable graft, the graft was con level of amputation was identified.
sidered patent. Later occlusion treated One graft infection occurred in the
by thrombectomy or graft revision, re PTFE group and two patients suf
gardless of outcome, was considered fered fatal arrhythmias in the peri
as a graft failure. If a patent graft operative period.
resulted it was followed up as a new
Significantly better (P < 0.05) pa
graft.
tency was noted in the saphenous
Inflow was assessed from the angio vein group for all bypasses as well
grams and was classified as “good’ as for distal (tibial) procedures (Table
if normal anatomy or minimal changes II). Overall patency for saphenous
were identified or “poor” if marked veins was 70% compared with 56%
stenosis or occlusion was noted. Run for the PTFE grafts. Life-table anal
off was defined as “good” if two or ysis demonstrated 50% cumulative pa
three vessels were patent or “poor” tency for saphenous veins versus 39%
if one small or no moderate-sized ves for PTFE at 30 months. Results were
sels were identified on angiography.
somewhat better if analysed after ex
Statistical analysis of the results clusion of those grafts that failed with
was carried out using the unpaired in the first month (54% versus 45%).
Student’s t-test.
The saphenous vein bypass still was
slightly superior. Follow-up to 53
months demonstr i a life-table cu
mulative patenc; rate of 46.4% for
saphenous vein grafts and 33.3% for
Table I I - Overall Patency Rates

Type of graft

All grafts,
no. (% )*

Distal (tibial)
grafts, no.
(% )*

59 (70)
25 (30)

6 (55)
5 (45)

54(56)
43 (44)

1 (14)
6 (86)

Saphenous vein
Patent
Occluded
PTFE
Patent
Occluded

FIG . 1— Cumulative patency by lifetable method to 48 m onths for long
saphenous vein (solid line) and poiytetrafluorocthylene grafts (broken line).

'Saphenous vein vs PTFE = P < 0.05.

Table l-Sap h e n o u s Vein and Polytetrafluoroethylene (PTFE) Groups.
Relation of Patient Age, Previous Grafts, Indication for Operation and Run Off Status
Patient
age, yr
Type of graft
Saphenous vein
Patent (n = 59)
Occluded (n = 25)
PTFE
Patent (n = 54)
Occluded (n = 43)

No. of
limbs
previously
grafted

Run-off
status

Indication
Claudication

Rest pain Good

Poor

Mean

Range

65
65

32-81
49-86

9
2

32
10

27
15

38
18

21
7

64
65

40-88
44-84

13
14

36
16

18
27

42
22

12
21

PTFE (Fig. 1 shows the follow-up to
48 months). Both saphenous vein
and PTFE grafts showed occlusions
throughout the study period. Polytetrafluoroethylene grafts occluded ear
lier than saphenous vein (52% versus
72% patency at 6 months). After the
initial year both grafts failed at a
rate of 3% to 5% per year. Aggres
sive attempts to maintain patency of
PTFE grafts with thrombectomy in
patients with good run-off and better
prospects for rehabilitation resulted
in 47 thrombectomies in 27 patients.
Twelve patent grafts resulted after one
to four thrombectomies, whereas 15
remained occluded after 27 attempts
at salvage (range 1 to 4). Occluded
saphenous vein bypasses were gener
ally not treated further unless limb loss
threatened. In such cases a technically
inadequate anastomosis was revised or
a new graft of prosthetic material was
used.
Although no difference in results
with the two conduits was apparent
when claudication was the indication
for surgery, patients operated on to
save the limb did better when saph
enous vein was used (Table I). The
run-off status did not affect patency
in those who had a saphenous vein
graft but those in the PTFE group
with good run-off did better than
those with poor run-off. Overall, the
run-off status was comparable in the
two groups. Inflow was comparable
and did not determine patency in
either group. Poor inflow was cor
rected by aortofemoral bypass when
necessary before the femoropopliteal
bypass was carried out.
D iscu ssio n

In general, an extended period of
observation involving hundreds of
cases is necessary to report on the
merits of a particular prosthetic graft
material. Various graft materials have
shown promising results at 2 years
only to fail later;2 therefore, we
believe that at least 5 years are nec
essary to assess a new graft accurate
ly.3'4 Despite this, many reports have
recently appeared describing patency
rates of 58% to 88% with PTFE
over short periods1'5 with minimal late
failures. In a few reports610 the re
sults were not as good, with 29% to
52% patency and continued late fail
ure. The data presented in our study
shows rather poor patency (39% at
30 months) for PTFE with ongoing
late failures at a rate of 3% annually.
Evans and associates11 found that most
failures with PTFE occurred in the
first 6 months and late failures at
1% per month.
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Polytetrafluoroethylene has certain
unique characteristics related to the
arrangement of nodules and fibrils of
Teflon. The graft is relatively resistant
to thrombosis and develops a thin
adherent neointima. It is resistant to
kinking and compression.12 Apart
from the material of the graft itself,
at least three other major variables
affect any interpretation of reports
regarding the efficacy and reliability
of the graft: (a) patient, (b) procedure
and (c) reporting of the results.
• Patient selection is an important
determinant of overall results, since
aggressive attempts to salvage limbs
with severe advanced disease will re
sult in poorer patency for any graft
or technique. Associated conditions
such as diabetes or smoking may sub
stantially affect the outcome. Gener
ally, severe signs and symptoms of
advanced ischemia are associated with
poorer patency rates13 and poor out
flow status correlates with occlu
sion,4’14 although not all reports sup
port these findings.615 In this study
patients with claudication did better
than those whose limbs were threat
ened, regardless of the type of graft
used. In the latter setting the patency
of saphenous veins was superior to

PTFE. Run-off status had a greater
effect on patency in the PTFE than
in the saphenous vein group. Doppler
studies may help delineate those in
whom graft patency could be ex
pected. Without full documentation
to allow comparison of patients, inter
pretation of graft patency and com
parison of various conduits will re
main inexact.
• Variation in technique of femoropopliteal bypass may have an im
pact on overall success; however, for
carefully performed operations the
most important factor is how far distally the anastomosis is carried out.
Below-knee anastomoses do less well
than above-knee7 and still more distal
anastomoses are even less reliable.2
In this study, 65% of distal grafts be
came occluded. In the PTFE group,
86% of the distal bypasses throm
bosed. This is similar to the 79% fail
ure rate reported by Suy and asso
ciates.16 A second aspect of technique
relates to aggressive thrombectomy or
revision in failed bypasses. The results
of this study may have been improved
by more aggressive revision of failed
bypasses as suggested by Veith and
associates.17
• The reporting of results varies

widely in different studies. Patency is
often defined by palpable pulses, Dop
pler studies or angiographic findings;
however, some reports base patency
on lack of symptoms or merely avoid
ance of amputation.1 This wide range
of criteria for patency certainly con
founds efforts to compare studies; in
deed, in this study not all patients with
failed grafts showed symptoms and
only 43% of those with occluded
grafts underwent amputation. More
over, some studies include as patent
those grafts that were patent after
thrombectomy for occlusion.3'8 In this
study any occlusion that occurred
after the first few hours constituted
graft failure and a subsequently pa
tent graft after thrombectomy was
considered as a new graft for follow
up. Such variations in definition may
be more important to the overall re
sults than the graft material itself.
Certain aspects of the timing of
graft occlusion have been presented
to support the relative value of a pros
thesis. Those grafts that become oc
cluded immediately after placement or
within 3 months of operation may re
flect technical errors2 whereas late oc
clusions (after more than 24 months)
may reflect distal progression of athe-
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rosclerosis.8 It has been suggested,
therefore, that occlusions in the inter
mediate range of follow-up more
clearly relate to thrombogenicity and
neointimal proliferation, with subse
quent stasis resulting from the char
acteristics of the graft itself.2’8 Those
studies showing few or no occlusions
after 6 months2,3 suggest that the flow
characteristics of PTFE make for
long-term patency. Other studies;*’6,8
including our own, show occlusion
even after 6 months; this may portend
less than optimal patency for PTFE.
However, on extended follow-up to
53 months the patency of PTFE
grafts parallels that obtained with
saphenous vein.
In general, no report has been able
to support the exclusive use of PTFE
and, in view of the short duration of
follow-up and multiplicity of factors
mentioned, this material cannot be
advanced as the conduit of choice if
saphenous vein is available. Vein is
much preferred for extended distal
bypasses; PTFE should not be used
electively in patients with claudication.
Polytetrafluoroethylene may be used
for limb salvage if a suitable vein is
not available, even though there is
potential for high occlusion rates in
the long term. Limb salvage may well

be successful with PTFE grafting be
cause not all failed grafts lead to am
putation and aggressive thrombectomy
of occluded grafts may clear some of
them. No increased incidence of graft
infection has been noted. The role of
PTFE in an above-knee segment in
patients with claudication or in ill
patients when a short operation is
desired remains to be assessed.
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Surgical Management of Left Ventricular
Pseudoaneurysms
R. L andymore,
Cardiac rupture usually results in
hemopericardium, tamponade and
death, but occasionally the rupture
is contained by the pericardium,
permitting the formation of a left
ventricular pseudoaneurysm. This
report describes a patient who
underwent successful removal of a
false aneurysm of the left ventricle
and discusses the surgical management
of left ventricular pseudoaneurysms.
Les consequences d'une rupture
cardiaque sont habituellement un
hemopericarde, une tamponnade et la
mort. Occasionnellement, la rupture
se limite au pericarde, ce qui entraine
la formation d'un pseudo-anevrisme
ventriculaire gauche. Cette
communication decrit le cas d'un
patient qui subit avec succes la
resection d'un faux anevrisme du
ventricule gauche. Le traitement
chirurgical des pseudo-anevrismes
ventriculaires gauches est discute.

Cardiac rupture following train nura
myocardial infarction usually r ult
in hemopericardium, tamponade i<
death. However, a small percen
of patients will survive acute rupty
of the left ventricle with the form
tion of a left ventricular pseudoaneu
rysm. This report describes a patien
who successfully underwent left ven
tricular pseudoaneurysmectomy an<
discusses the surgical management o
left ventricular pseudoaneurysms.

Case Report

md, frcs[c]

The admission chest roentgenogram
(Fig. 1) showed marked cardiac enlarge
ment compared with previous films.
Cardiac catheterization demonstrated
total occlusion of the left anterior des
cending coronary artery with an asso
ciated left ventricular pseudoaneurysm.
The transient ischemic attacks were
thought to be related to embolization
from the pseudoaneurysm because of the
temporal relation to the onset of the
attacks and the lack of clinical evidence
of carotid disease.
At operation the sternum was split
and the pericardium opened. A large
pseudoaneurysm extended from the re
gion of the interventricular septum to
the anterior chest wall (Fig. 2). No
attempt was made to manipulate the
pseudoaneurysm before initiating cardiac
bypass, to avoid dislodgement of ventri
cular thrombus into the systemic circula
tion. After cardiac bypass was established
with systemic hypothermia to 25°C, the
aorta was cross-clamped and the heart
arrested with a crystalloid cardioplegic

agent (potassium 20 meq/1) and topical
hypothermia. The pseudoaneurysm was
then mobilized. The sac of the false
aneurysm extended laterally towards the
left chest and was covered by a thin
layer of pericardium. It contained large
amounts of thrombus. After the dissection
was completed the false aneurysm was
removed and the ventricular cavity care
fully inspected for thrombus that might
have been dislodged during the manipula
tion (Fig. 3). A standard aneurysm repair
was then carried out using multiple
mattress sutures of 0-Prolene buttressed
with Teflon felt. A small transverse
aortotomy was created in the ascending
aorta to inspect the lumen for debris
that could have fallen through the aortic
valve during the procedure. After re
moval of air and rewarming, the patient
was weaned from cardiopulmonary by
pass without difficulty. The postoperative
course was smooth; histologic examina
tion confirmed the diagnosis of left
ventricular pseudoaneurysm.

Comment

Left ventricular rupture is the cause
of death in 4% to 8% of patients
after an acute myocardial infarction.1’3
Although cardiac rupture has been re
ported following ventriculotomy,4
trauma5 and endocarditis,6 it is usually
secondary to a transmural myocardial
infarction. Any portion of the ventri
cle may be involved but rupture most
commonly occurs through the anterior
free wall3,7 with 90% taking place
within 2 weeks of the acute infarc
tion.3-8
Cardiac rupture usually results in
FIG. 1— Marked left ventricular en
largement.
the formation of a hemopericardium

A 61-year-old man made a smooth
recovery from an acute anterior trans
mural myocardial infarction and was
discharged from hospital after 2 weeks.
One week later he suffered transient
ischemic attacks and was readmitted.
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FIG. 2—Large pseudoaneurysm ex
FIG. 3—Open left ventricular cavity
tending anteriorly towards chest wall. and margins of left ventricular pseudoClamp holds pericardium.
aneurysm.
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with the rapid onset of tamponade
and death. Occasionally, however,
pericardial adhesions, resulting from
postinfarction pericarditis, contain the
rupture, allowing the patient to sur
vive. A false aneurysm is then formed;
the walls consist of organized throm
bus and pericardium.3A,°
The formation of a left ventricular
pseudoaneurysm usually causes mild
left ventricular failure; the diagnosis
should be suspected when there is a
sudden increase in cardiac size. Other
patients may present with arrhyth
mias, emboli or rupture.11 The indica
tions for surgical intervention are si
milar for true and false aneurysms of
the left ventricle.12 In contrast to true
aneurysms, however, pseudoaneu
rysms will frequently enlarge and rup
ture resulting in death in 45% of
patients, suggesting that the diagnosis
is an indication for emergency opera
tion.2’13
Although the surgical repair is simi
lar for true and false aneurysms of
the left ventricle, particular care must
be exercised during the initial stages
of operation for left ventricular pseu
doaneurysms. The ventricular cavity
of a true aneurysm may contain or
ganized or fresh thrombus in some
cases.14,15 By contrast, virtually all
pseudoaneurysms contain thrombus
since the wall of the pseudoaneurysm
consists of thrombus and pericardi
um.3’9,10 The material removed from
the cavity of a pseudoaneurysm is not
unlike the layered thrombus found in
the wall of an abdominal aortic aneu
rysm and any attempt to dissect or
manipulate the false aneurysm before
establishing bypass and clamping the
aorta may result in embolization into
the systemic circulation, with resulting
neurologic injury. After completing
the dissection and opening the left
ventricle, the cavity should be care
fully inspected and any debris re
moved. It is also wise to open the
ascending aorta through a small trans
verse aortotomy to inspect the lumen
directly for thrombus that may inad
vertently have fallen through the aor
tic valve during manipulation of the
false aneurysm. The small aortotomy
may subsequently be used to remove
air from the heart. With these guide
lines the repair of left ventricular
pseudoaneurysms should be accom
plished without complication.
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Dynamic Peroneus Tendon Transfer
for Repair of the Unstable Ankle

The author considers the anatomic
basis and indications for a dynamic
peroneus brevis tendon transfer
to treat ankle instability and pain
caused by rupture of the lateral fibular
ligaments. He describes the surgical
technique. The peroneus brevis
tendon is passed through a tunnel
in the distal fibula and cuboid bone,
proximally and deep to the belly
of the short toe extensor muscle and
is looped back and sutured to itself.
Thirty-two patients with ankle
instability and pain of 10 years'
duration or acute ligamentous rupture
underwent dynamic peroneus brevis
tendon transfer in a prospective
study between Nov. 1, 1976 and
Oct. 31, 1981. Twenty-five of the
32 patients were available for
follow-up, which ranged from 15 to
57 months. The operation resulted
in improved activity in 80% and relief
of pain in 76%. There were three
complications: causalgia, infection
and numbness in one patient each.
The author believes this procedure
is worthwhile in active individuals
who have long-standing ankle pain and
weakness due to rupture of the
lateral ankle ligaments.
L'auteur se penche sur les fondements
anatomiques et les indications du
transfert dynamique du tendon
du court peronier lateral pour traiter
I’instabilite de la cheville et la
douleur causee par la rupture des
ligaments peroniers lateraux.
II decrit la technique chirurgicale.
Le tendon du court peronier lateral est
passe a travers un canal dans le peronier
distal et le cuboi'de, proximal et en
profondeur par rapport au ventre du
muscle extenseur du petit orteil,
puis retourne pour former une boucle
et suture sur lui-meme. Dans une etude
prospective qui s’est deroulee du 1er
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novembre 1976 au 31 octobre 1981,
32 patients qui souffraient depuis 10 ans
d'instabilite et de douleur de la
cheville ou qui ont eu une rupture
subite d'un ligament ont subi
un transfert dynamique du tendon
du court peronier lateral. Vingt-cinq
des 32 patients ont ete revus
aux examens de contrdle qui se sont
etendus de 15 a 57 mois. L’operation
a ameliore I’activite dans 80%
des cas et soulage la douleur dans
76%. Trois complications ont ete
enregistrees: causalgie, infection et
engourdissement chez un patient
chacun. L'auteur croit cette intervention
tres valable pour les personnes
actives qui souffrent depuis longtemps
de douleur et de faiblesse de la
cheville dues a la rupture de ligaments
peroniers lateraux.

Slight ankle instability in sports or
daily activities may be accepted by
some patients. Many, however, seek
ways to have their ankle disability cor
rected so that they can perform their
regular job properly or fully enjoy
sporting activities that require a stable,
pain-free, dependable ankle joint. Re
current trauma may weaken or rup
ture especially the anterior talofibular
ligament.1"3 In spite of supportive tap
ing or elastic bandages, further dam
age to this ligament may occur,4 re
sulting in a discrepancy between the
symptoms and the clinical stability of
the ankle joint.5 Severe anterolateral
tenderness, giving way in plantar
flexion and inversion without a severe
talar tilt are encountered.
The standard roentgenograms usu
ally give a normal appearance. Stress
films may show a talar tilt but the
findings are often normal.6 A slight
talar tilt at the talotibiofibular joint
may, however, be demonstrated more
easily by an arthrogram.7*8 In some
patients, tilting on stress even with
contrast medium in the ankle joint is
not shown. The anterior drawer sign
of the ankle can only be demonstrated
on roentgenograms if standard tech
niques are followed.9 If the ankle is
painful a local anesthetic can be used.
Anatomic Considerations

The anatomy of the lateral joint
ligaments has been well described by

Robichon and colleagues.10 Percy and
coworkers11 graded the lesions and
pointed out techniques for demon
strating the integrity of the ligaments.
Arthrography was used by Brostrom
and associates7 and stress tenograms
by Evans and Frenyo.12 Elmslie,13
Watson-Iones14 and Evans15 described
techniques for stabilizing the ankle
joint by creating a tenodesis. Sta
bility is provided only for a severe
talar tilt due to a rupture of the calcaneofibular ligament. They used the
peroneus brevis tendon, severing it
at the point of its main blood supply
at the musculotendinous junction. Pea
cock16 concluded that the blood ves
sels enter from the muscular origin
and are able to nourish the proximal
third of the tendon. Permanent dis
ruption of the central blood vessels
causes cellular death and eventually
disintegration of collagen bundles.
Therefore, the proximal blood supply
to the tendon must be preserved to
ensure restoration of tendon function
with minimal loss of collagen fibres.
Furthermore, elasticity is preserved
when the muscle remains attached to
the tendon. If a tendon transfer is to
be successful, these elements must be
left intact. Detachment of the tendon
should be carried out at its insertion
rather than at the site of its blood
supply at the musculotendinous junc
tion.
Indications for Dynamic
Peroneus Tendon Transfer

A surgical repair is indicated only
in patients with a history of continu
ous, intolerable instability and per
sistent pain. This instability must be
demonstrable on a plain roentgeno
gram or arthrogram. A talar tilt may
be present in both ankles, but when
there is also a history of injury, swell
ing, pain and giving way, then a mor
bid condition exists. The patient must
be unable to perform his job or con
tinue athletic activities after at least
6 months of conservative manage
ment.
An arthrogram may be contraindi
cated when there is a possible allergy
to the local anesthetic or the contrast
medium used. In these cases, a stress
test is done under direct vision at
operation. If the test result is positive
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and if the anterior talofibular ligament
cannot be adequately repaired, a dy
namic peroneus tendon transfer is
added.
No tendon transfer should be done
on patients who can perform satis
factorily with ankle support. A dyna
mic peroneus tendon transfer per
formed in a patient with arthritis of
the ankle or subtalar joint usually re
sults in an excessively stiff and pain
ful ankle, so the procedure is contra
indicated in such patients.
Surgical Technique and
Postoperative Care

An anterolateral incision is made
from the base of the fifth metatarsal
in a proximal direction anterior to
the lateral malleolus and curving pos
teriorly just proximal to the lateral
malleolus. The lateral cutaneous pe
roneal nerve should be located and
protected. The peroneus brevis tendon
is detached from the base of the fifth
metatarsal. Proximal and posterior to
the lateral malleolus, the peroneus
brevis tendon is identified and, with
care not to jeopardize its musculo

tendinous blood supply, is gently
pulled proximally out of its bed (Fig.
1). The musculotendinous portion is
protected while an oblique drill hole
is made, large enough to allow free
movement of the tendon, in the distal
fibula from the anterior distal side to
posterior proximal, close to the proxi
mal attachment of the talofibular liga
ment (Fig. 2). The edges are smoothed
by curette. A second drill hole is made
through the cuboid bone, initially
from a dorsal to plantar direction,
close to the insertion of the talofibular
ligament, then from the lateral aspect
to make a hole that will allow the
peroneus brevis tendon to be reat
tached in a loop to itself (Fig. 3). The
peroneus brevis tendon is now gently
pulled forward through the fibular
hole in a posterior to anterior direc
tion (Fig. 4) and then through the
cuboid tunnel from dorsal to plantar
and laterally through the side hole
(Fig. 5). The tendon is turned prox
imal and deep to the belly of the short
toe extensor muscle. It is long enough
to be looped back and sutured to
itself (Figs. 3 and 6). A plaster cast
is applied with the foot in a neutral

position. The cast is split anteriorly
to allow for swelling. Two weeks later
a walking cast is applied for another
month. Exercises are then started and
full activity is allowed 4 to 6 weeks
after removal of the cast.
Method of Analysis

After we had developed the prin
ciples of the procedure, we undertook
a prospective clinical study of patients
with chronic ankle problems (up to
10 years’ duration) and those with
acute athletic or work-related injuries.
All patients were reviewed by per-

FIG. 3— Diagram shows routing of
peroneus tendon.

/
PERONEUS
TENDON

FIG. 1—Incision anterior to lateral malleolus and removal
of peroneus tendon.

FIG. 2—Cadaver ankle shows hole drilled through fibula.
Hemostat is under intact anterior talofibular ligament, which
is either ruptured in acute or absent in chronic ankle lesions.

FIG. 4— Hole drilled through cuboid bone indicated by
tendon passer showing proximity of distal attachment of talo
fibular ligament. Peroneus brevis tendon has been pulled
through fibular hole.

FIG. 5— Peroneus tendon passed through hole in cuboid
bone exits laterally.
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sonal examination, questionnaire or
telephone. Between Nov. 1, 1976 and
Oct. 31, 1981, 32 patients (16 male,
16 female), who ranged in age from
13 to 53 years, underwent dynamic
peroneus tendon transfer. The patients
were taken at random. There were
three main groups: (a) 20 patients
with chronic instability; (b) 3 patients
with chronic instability and an acute

F I G . 6—Peroneus brevis tendon is
looped back and attached to itself with
Vicryl suture.

episode of severe sprain or rupture;
(c) 9 patients with recent acute liga
mentous rupture without previous in
jury or handicap. These patients had
profuse hemorrhage and needed im
mediate repair.
All patients with chronic problems
were fully investigated; arthrograms
and stress studies were included. In
six patients no arthrogram could be
done so a stress test was performed
under direct vision at operation. Six
teen patients had a positive talar tilt
sign (5° or more) indicating lateral
laxity.17 Of the 32 patients, 25 were
available for follow-up which ranged
from 15 to 57 months.

There were three complications:
causalgia in one patient, infection in
one and numbness of the fourth and
fifth toes in one. This last patient was
not handicapped. The patient with
causalgia also had moderate arthritis
of his ankle. The patients with causal
gia and infection and patient no. 22
(Table I) with stiffness were the only
three who had to reduce some activi
ties to avoid irritating their ankle.
Five of six patients with normal
arthrographic findings were operated
upon on the basis of their symptoms;
they were able to increase their ac
tivities.

Findings

Discussion

Nineteen patients (76%) were able
to increase their activity as a result of
the operation, in 3 activity was the
same and 3 were less active (Table I).
Twenty patients (80%) had complete
relief of pain, 1 was unchanged and
4 had residual pain. Twenty-one pa
tients had stronger ankles and 3 felt
their ankle was weaker. Seventeen pa
tients said they would consider a simi
lar operation on the other ankle and
8 would not. Overall, 20 patients
thought the operated ankle was better,
2 that it was the same and 3 that it
was worse.

The principal pathologic features in
most of our cases appear to be a
rupture of the anterior talofibular lig
ament, in some a rupture of the an
terior talofibular and calcaneofibular
ligaments and, in one, a complete dis
ruption of all the lateral fibular lig
aments. The procedures for tenodesis
of the ankle joint, described by Watson-Jones14 and Evans15 have been suc
cessful in our hands only in obvious
cases with severe talar tilting; even
then, there were often complaints
of residual weakness. Watson-Jones’
technique is aimed at repair of both

Table 1-Results of Peroneus Brevis Tendon Transfer
Postoperative results
Patient
no.

Sex

i
2
3
4

M
M
F
M

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

F
F
M
F
M
M
F
M
M

M
F
M
F
F
F
F
M
F
F
F
F

Age,
Yf
22
25
18
35
13
20
33
36
45
28
13
29
22
26
27
53
17
20
15
15
33
17
31
14
16

Occupation

Talar tilt
on arthrogram*

Ankle
stronger

Pain

Motion

+

Yes
Yes
No
Yes

Relief
Relief
Worse
Same

Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Relief
Relief
Relief
Relief
Relief
Worse
Relief
Relief
Relief
Relief
Relief
Worse
Relief
Relief
Relief
Relief
Relief
Worse
Relief
Relief
Relief

Better
Better
Stiff
Better but
stiff
Better
Stiff
Stiff
Same
Stiff
Stiff

Fireman
Labourer
Student
Electrician
Figure skater
Clerk
Labourer
Housewife
Labourer
Labourer
Figure skater
Labourer
Labourer
Labourer
Teacher
Physician
Student
Student
Student
Figure skater
Teacher
Student
Clerk
Student
Student

+
+
-

Normal
-

++
Severe
Severe
Severe
-

Severe
++
++
+
-

+
+
+

Normal
Severe
+
-

+
+

Better
Better
Stiff
Same
Stiff
Better
Better
Stiff
Better
Stiff
Stiff
Better
Better
Stiff

Activity

Overall
assessment

Patient would
consider operation
on other ankle

More
More
Less

Better
Better
Same

Yes
Yes
No

More
More
More
More
More
More
Less
More
More
More
Same
More
Same
More
More
Same
More
More
Less
More
More
More

Better
Better
Same
Better
Better
Better
Worse
Better
Better
Better
Better
Better
Worse
Better
Better
Better
Better
Better
Worse
Better
Better
Better

Yes
Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes
No
Yes
No
Yes
Yes
No
Yes
Yes
No
Yes
Yes
No

*+ = tilt of 5°, ++ = tilt of more than 5”.
— = arthrogram not done due to allergic reactions.
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ligaments, the anterior talofibular and
the calcaneofibular ligaments, and this
is a rather difficult procedure to per
form. The tendon often is not long
enough. Evans’ technique fails to pro
tect or replace the anterior talofibular
ligament, but when there is obvious
tilting of the ankle joint due to com
plete disruption, some benefit will be
derived from such a tenodesis. The
dynamic peroneus transfer, in con
trast, has been a very satisfying pro
cedure in patients with less severe in
stability. This is due to the continued
activity of the peroneus brevis tendon.
Since it is possible for a transferred
tendon to function properly through
a pulley as described for the thumb
by Lipscomb and associates18 there is
no reason why a transferred tendon
should not function properly when a
tunnel is created through a bone such
as the fibula. The peroneus brevis
muscle remains functional by sliding
through the fibular tunnel and stabil
izes the ankle during activity, such as
running and skating, when a load is
put on the ankle joint.
The patency of the fibular tunnel
is demonstrated by a cortical border
seen on the roentgenogram (Fig. 7).
Inversion of the operated ankle is only
a few degrees less than that of the
other ankle.
Occasionally, adhesions are formed
in the bony tunnel; tenodesis is the
result of these. The adhesions were
removed by tenolysis in two instances.
Because of excessive stiffness in three
of our cases, the cast is now worn for
only 4 weeks; this resulted in earlier
walking and no undue stiffness.
The statement of Ruth:19 “If the
physician decides against operative

treatment or immobilization in plaster,
he should first have proof that the
ligaments are intact and that the ankle
is stable”, covers a wide field of ankle
injuries and appears to be slightly
idealistic. Many patients do not want
a cast or an operation because they
feel that their ankle is “just sprained”.
Those patients first must have a dis
ability before they will seek help and
immobilization with a cast is by then
no longer effective.
Before repair, residual disability is
present in at least 33% of patients
and abnormalities of the ankle can be
found in 60% of patients with pre
vious ankle injuries.20 According to
Freeman,21 cast immobilization for a
minimum of 6 weeks is satisfactory in
most cases.
Repair of a ruptured ligament19 or
reinforcement, or both, by the tech
niques described by Elmslie,13 WatsonJones,14 Evans,15 Chrisman and Snook22
and Gillespie and Boucher23 have been
used. Some are simple, others com
plicated. All are designed as a teno
desis.
The advantages of the dynamic pe
roneus tendon transfer can be sum
marized as follows:
• The new route of the peroneus
brevis tendon runs in the same direc
tion as that of the anterior talofibular
ligament.
• During the healing period, as
with any muscle at rest, the peroneus
brevis contracts to its shortest posi
tion; therefore, the tendon transferred
will obtain its shortest possible length
due to its active elasticity during this
healing period.
• Ankle mobility in plantar and
dorsiflexion is not impaired.
• The stability of the subtalar joint
is greatly improved and provides a
marked increase in the patient’s re
liance on the ankle joint in plantar
flexion.
• Eventually a capsule is formed
around the distal part of the tendon
which becomes a natural reinforce
ment of the ankle capsule.
• The musculotendinous blood
supply is intact allowing for rapid
healing and return of function.
The dynamic peroneus tendon
transfer is a worthwhile procedure for
active individuals to improve long
standing ankle pain and weakness due
to rupture of the anterior talofibular
ligament and to prevent these prob
lems in recent injuries.
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Factors Affecting Rehabilitation following
Aortocoronary Bypass Procedures
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Two hundred and ten men were referred
consecutively to a rehabilitation
program following aortocoronary
bypass surgery. The program involved
exercise tolerance testing 8 and 20
weeks postoperatively, with an
intervening 12-week exercise program.
A retrospective analysis of data showed
50% of these patients to be on no
medication throughout their
rehabilitation and the others on
medications likely to affect cardiac
performance. Factors likely to
influence exercise tolerance such
as age, medication and extent of
revascularization were subjected to
multivariate analysis in these two
cohorts of patients. Age (up to
60 years) and the extent of
revascularization did not appear to
influence exercise tolerance.
Following the 12-week exercise
program, patients in both groups had
improved significantly (P < 0.01), but
the initial and final performance of the
cohort of patients requiring cardiac
drugs was significantly poorer than
those on no medication (P < 0.01).
Deux cent dix hommes ont ete diriges
consecutivement vers un programme
de readaptation apres pontage
aorto-coronarien. Le programme
impliquait une epreuve d'effort aux
8e et 20e semaines apres I'operation
avec, dans I'intervalle, un programme
d'exercice de 12 semaines. Une analyse
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retrospective des donnees a revele
que 50% de ces patients ne prenaient
aucun medicament durant le
programme de readaptation aiors que
les autres recevaient une medication
susceptible de modifier leur
performance cardiaque. Pour ces deux
cohortes, les divers facteurs capables
d'influencer I’epreuve d'effort tels
que I’age, la medication et I'etendue
de la revascularisation ont ete soumis
a une analyse de covariance. L'age
(jusqu'a 60 ans) et I'etendue de la
revascularisation n'ont pas semble
affecter I’epreuve d'effort. Apres 12
semaines du programme d'exercice,
les patients des deux groupes s'etaient
ameliores significativement (P < 0.01)
mais les performances initiate et
finale du groupe necessitate des
medicaments cardiotropes etaient
significativement plus faibles que
celles des patients qui n'avaient pas
de medication.

The saving and restoring to health
members of society, whose labours
are indispensable in a State, may well
be ranked among the more important
services done to the community.
The History of the Royal Infirmary,
Edinburgh, 1788

The factors that affect the outcome
of rehabilitation following cardiac sur
gery include those that are physical,
psychosocial and associated with the
health care system, and the patient’s
perception of health and level of phy
sical fitness.1’3
Of patients who undergo aortocoro
nary bypass surgery, 80% to 90%
experience a prompt improvement in
their symptoms and approximately
70% are rendered free of pain.4’7
However, many who are physiologic
ally capable of returning to work, do
not, for a variety of reasons. Studies
dealing with the effects of revascular
ization upon work status report a rate
of return to work ranging from 83%
to less than 50%.712 Recently, Danchin and associates13 analysed the
working status of 1217 men after
aortocoronary bypass surgery. They
noted that 24% had never returned
to work, 56% were working at 6
months after the operation and 66%
at 2 years. Thereafter the proportion
declined progressively to 56% and

GREENFIELD, B SC

53% at 4 and 5 years respectively.
Whether a structured rehabilitation
program and demonstration of physi
cal improvement to aortocoronary by
pass patients through exercise toler
ance testing, regular supervised exer
cise sessions and education is likely to
influence return to work has not, as
yet, been addressed.
Description of Postoperative
Rehabilitation Program

The cardiovascular rehabilitation
program at the Toronto General Hos
pital is continuous from the time of
operation until the patient returns to
an optimum level of vocational and
avocational activity. It extends over
a period of 20 weeks and is arbitrarily
divided into four stages.
Immediately after Operation

This stage includes the usual post
operative physiotherapy chest routine.
When the patient is allowed out of
bed he is taught to take his own pulse
rate and is incorporated into a daily
calisthenics and walking program. At
the time of discharge he is given an
exercise routine compatible with car
diovascular status and level of fitness.
It includes some simple calisthenics
and walking.
Early Postoperative Rehabilitation

During this phase the patient is en
couraged to exercise daily to the pre
scription provided before discharge
and is asked to record pre-exercise,
postexercise pulse rates and any un
toward symptoms experienced. At 4
weeks after discharge, the program
may be expanded.
Intermediate

Six to 8 weeks after operation a
multistage, steady state, exercise tol
erance test (T-l) is carried out using
a treadmill and a modification of the
protocol described by Balke and
Ware.14 Exercise testing is to 85%
of the age-adjusted maximum or is
symptom-limited. A 12-lead electro
cardiogram monitors cardiac status
throughout the test and in the post
exercise recovery period. With this
test, an assessment of work capacity
and limiting factors is made and an
extrapolation of the maximum at-
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tained oxygen uptake at peak work
load is recorded. Based upon the re
sults a conditioning heart rate (85%
of that achieved on the test) is pre
scribed for each patient. All patients
attend a supervised exercise program
lasting 12 weeks followed by a second
exercise tolerance test (T-2) using the
same protocol and recording methods.
During this phase a six-subject educa
tional program and a program for
spouses are conducted.
L ate Rehabilitation

Upon completion of the 12-week
exercise and education program pa
tients may continue to attend the
physician-supervised exercise sessions
or may continue to exercise to a pre
scribed heart rate in a program of
their choosing.
Subject Selection

Of those who have undergone aor
tocoronary bypass surgery 210 men
have been referred consecutively into
this rehabilitation program and con
stitute the patient population of the
study. No patient who was referred
has been excluded. The age range,
mean age, age distribution and extent
of revascularization are shown in Figs.

1 and 2. We recognize that in a pro
portion of instances, not yet deter
mined, complete revascularization of
all vessels might not have been pos
sible for technical or other reasons.
Results

A comparison of parameters that
indicate an improvement in the level
of physical fitness (resting heart rate,
resting blood pressure and estimated
attained oxygen uptake at peak work
load) are shown in Tables I and II.
The mean resting heart rate dimin
ished significantly (P < 0.001, twotailed Student’s r-test) over the 12week intermediate phase. Since each
test was terminated at 85% of an ageadjusted maximum (or was symptomlimited) the heart rate at peak work
load between the two tests is not sta
tistically significant. Similarly, as
might be expected, the mean systolic
blood pressure at peak workload did
not alter significantly. Over the 12week period between the two tests
the improvement in the mean exercise
tolerance for all patients was highly
significant (P < 0.001). When this
improvement in aerobic capacity is
considered against age, regression
analysis demonstrates a clear negative

linear correlation with increasing age
at T-l and T-2. The younger the pa
tient the greater the potential im
provement in aerobic capacity in the
age range studied (30 to 70 years). A
significant (P < 0.025) age by test
interaction is present, that is, the rela
tion between attained oxygen uptake
at peak workload depends upon which
tolerance test is considered. For each
year of increment at T-l there is a
decrement in exercise tolerance of
0.302%. At T-2, although there is an
overall improvement in performance,
this decrement increased to 0.456%/y r
causing a tendency for the “best
straight” lines to converge. It should
be recognized that age is merely a
single factor amongst many to be con
sidered in the assessment of exercise
tolerance following aortocoronary by
pass surgery (Fig. 3).
When aerobic capacity between T-l
and T-2 is compared against the ex
tent of revascularization it can be
seen that a numerical improvement
in all categories occurs (Table III). A
patient who had six lesions bypassed
early in 1978 is one of the highest
achievers in the program, leads an ex-

/ .
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A

*
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Table 1 -M e a n H e a rt R ate (beats/m in)
H e a rt rate
Resting
M a x im u m (a t peak
w o rklo ad )

First te s t

S econd test

P value

77.1

72.3

< 0 .0 0 1

139.8

140.6

NS

4
i

N S = not significant.

Table I I —Blood Pressure (mm Hg)
Blood pressure
R esting systolic
R esting diastolic
M a x im u m systolic (at
peak w orkload)
M a x im u m diastolic (at
peak w orkload)

fir s t test

Second test

P value

125.3
80.0

121.2
7 6 .9

< 0 .0 0 1
< 0 .0 0 1

165.3

167.7

NS

82.4

7 9 .6

< 0 .0 1

i
FIG. 1— Age distribution of 210 men
who underwent coronary artery bypass
surgery. Age ranged from 30 to 69 years
(mean 52.4 years).

Table I l l - M e a n O xygen U ptake (ml/kg - min)
(A ttained) by N um ber of B ypass G rafts in 2 1 0 M e n
N o. of
g rafts

N o. of
patients

First
test

Second
te s t

1
2
3
4
5
6

35
68
81
22
3
1

21.9
20.3
22.1
20.9
23.8
46.0

2 5 .3
25.1
2 7 .0
2 4 .5
24.7
4 9 .5

22.1

2 6 .2

s< P value
NS
0.0001
0.0001
NS

i

—

< 0 .0 0 1

FIG. 2— Extent of revascularization.
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tremely active avocational life and is
capable of exercising at high levels for
prolonged periods. This particular pa
tient has been followed at intervals
since 1978, has continued to exercise
assiduously, has been exercise toler
ance tested on six separate occasions
and has improved upon his initial high
performance.
Correlation of Exercise Tolerance
with Medication

Analysis of data showed that the
population fell into two cohorts of
comparable size: Patients (group 1)
who throughout their rehabilitation
were taking no medication likely to
influence cardiac performance and pa
tients (group 2) taking medications
likely to influence cardiac action.

FIG. 3—Age and exercise tolerance.
TI = first tolerance test, decrement is
0.302 %/yr, T2 = second tolerance test,
decrement is 0.456%/yr.

Within group 2 there were three sub
categories: (a) patients who started
the program taking a cardiac medica
tion and who finished using the same
medication (Fig. 4a), (b) those who
started with a medication that was
changed before the rehabilitation pro
gram was complete (Fig. 4b) and (c)
those who started with no medication
but who were given a cardiac drug
before the completion of the 12-week
program (Fig. 4c). When the mean
oxygen uptake of groups 1 and 2 is
compared at the time of the initial ex
ercise tolerance test it can be seen that
the group requiring no medication
started off at a higher level of physical
fitness than those who were deemed
to require medication (mean oxygen
uptake group 1, 22.9 ml/kg-min vs.
group 2, 19.9 ml/kg-min). This dif
ference is statistically highly signif
icant (P < 0.001). After 12 weeks of
prescribed exercise both groups im
proved by a statistically significant
margin although the discrepancy be
tween them was maintained at the
time of T-2 (mean oxygen uptake
group 1, 28.2 m l/kg -min vs. group 2,
23.6 ml/kg*min). All four groups
were subjected to two-way analysis of
variance. Group 1 differed significant
ly from the three other subgroups
(P < 0.001). The differences between
the three subcategories (Fig. 4) were
not statistically significant. Group by
test interaction did not demonstrate
any significant difference in the rate
of improvement.
It could be hypothesized that the
superior performance of those on no
medication might have resulted from
a preponderance of younger patients
in group 1. However, the distribution
of the two groups by decades is com
parable (Table IV).

Return to Work

When 147 patients had completed
the program we decided to survey
employment patterns following sur
gery and a questionnaire was distrib
uted. Twenty-three patients were lost
to follow-up and 4 had died (one pa
tient had been killed in a car acci
dent). Ninety-three patients responded
to the questionnaire (78% compli
ance); 80 (86%) had returned to
work. The time frame within which
these patients resumed work is shown
in Table V; 68% had returned to
work within 12 weeks and 39.8%
had returned to work within 4 weeks
of surgery. The majority (92.5%) had
returned to their preoperative occupa
tion. Of the 13 patients (14%) who
did not return to gainful employment,
8 gave reasons for leaving their job,
4 of them citing age as the deciding
factor for early retirement, the other
4 citing fear of returning to work,
excessive physical demands of the oc
cupation, medical advice and angina
as their reasons for not returning.
Discussion

We realize that our study has a
number of imperfections. The cohort
of male patients being reported rep
resents a biased population in that
they are patients who possess the
motivation to become involved in a
rehabilitation program and there is
no control group for comparison. It
might also be argued that the im
provement in aerobic capacity seen
over the 12-week rehabilitation pe
riod in the various subgroups (Fig. 4)
might represent an improvement that
could have occurred without a re
habilitation program. Such argument
can only be refuted by a carefully

Table IV-A ge versus Medication*
Age group, yr
51-60
41-50
30-40

Patients
No medications,
16 (7.6)
n = 103 (49%)
Medications,
n = 107 (51%)
4 (1.9)
'Figures in brackets are percentages.

FIG. 4—Exercise tolerance and med
ication over 12-week period. Group 1
(103 patients [49%]) = taking no med
ication influencing cardiac performance.
Group 2 (107 patients [51%]) = (a)
taking same cardiac medication through
out, (b) taking different cardiac medica
tion at end of program, (c) taking no
medication at beginning but taking car
diac medication before end of program.

No. of patients
%

61-70

26 (12.4)

48 (22.9)

13 (6.2)

31 (14.8)

53 (25.2)

19(9)

Table V-Retum to Employment : Time Frame,
Range 1 to 150 Weeks
Time, wk
1-4
4-12
12-52
37
27
12
40
28
13
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conducted prospective study and by
making comparison of an active treat
ment group with a control group,
carefully matched for habitus, social
status, educational level, type of oc
cupation, severity of disease and car
diovascular function. These arguments
notwithstanding, the study provides an
insight into the rate of improvement
in exercise tolerance that can be ex
pected in patients who undergo aorto
coronary bypass surgery and some of
the factors that might affect it.
That those patients requiring car
diac drugs started their rehabilitation
at a much lower level of exercise tol
erance than those who were consid
ered not to require such drugs is not
surprising. It might be speculated that
the second group represents patients
whose cardiovascular function is poor
er and who require cardiac medication
as a consequence. The medication it
self could play a part in altering a
patient’s exercise tolerance and capa
city although often such drugs are
prescribed in the hope of improving
performance, recognizing that some
(eg.. /2-blockers) interfere with the
heart-rate response to exercise. How
ever, the poorest group (group 2c)
started the rehabilitation program with
no medication and so the influence of
chemical interference on response in
this group cannot be incriminated. In
this group there was a “training effect’’
comparable to all other groups, albeit
at a lower level.
In contrast to the findings of
Barnes and associates,7 of the factors
likely to influence eventual outcome
in terms of aerobic capacity, the ex
tent of revascularization did not ap
pear to be an important factor, al
though, in the group of 35 patients
who had a single-vessel bypass, statis
tical analysis did not reveal a signif
icant difference between the results of
T-l and of T-2.
Despite potential criticisms of the
study, we believe that a structured re
habilitation program for patients who
have undergone aortocoronary bypass
surgery, with serial exercise tolerance
testing, an intervening exercise regi
men prescribed by a knowledgeable
physician and an education program
for both patients and their spouses is
important if these patients are to
achieve maximum recovery at an op
timum rate following surgery, taking
into consideration such factors as vo
cational and avocational exercise re
quirements, cardiovascular status and
the medical management of cardio
vascular impairment. It is probable
that a rehabilitation program such as
we have described improves the con
680

fidence of patients in their ability to
work and in their work capacity by
reducing apprehension and by dem
onstrating a work capacity beyond
their occupational requirement. Such
an approach facilitates advice con
cerning return to work at an optimal
time to patients more prepared and
receptive to such advice.
Conclusions

Maximum aerobic power can be in
creased by a structured exercise pro
gram for patients who have undergone
aortocoronary bypass surgery. Im
provement in aerobic power is accom
panied by a decrease in the resting
heart rate and blood pressure. Educa
tional and psychological support pro
grams for both patients and spouses
are valuable adjuncts to an exercise
program following aortocoronary by
pass surgery. This investigation has
provided a step in the attempts to
clarify the many factors involved in
rehabilitation of patients after aorto
coronary bypass procedures. This
study might be considered a pilot one,
providing direction for further re
search in this area.
The authors would like to record their
indebtedness to Dr. W.G. Bigelow, with
out whose foresight and support this
rehabilitation program would not have
come into existence and Mr. Henzel
Jupiter and Mr. Hau Lei for their as
sistance in analysing the data.
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NOTICES
Trauma Care ’83

The second national symposium on
the comprehensive management of
the critically injured patient, spon
sored by the John C. Lincoln Hospital
& Health Center, Phoenix, Arizona,
will be held Jan. 9-13, 1983, at the
Scottsdale Hilton Hotel in Scottsdale,
Arizona.
Trauma Care ’83 will be a forum
for exploring a variety of trauma
management techniques, including
management of pregnant, pediatric
and geriatric patients. Other topics
will include management of hepatic,
vena caval, splenic and pancreatic in
juries as well as discussions on anti
biotics and anesthesia.
Dr. Jeffrey A. Singer, program
chairman for the symposium, said that
“the major goal of the symposium is
to provide an exchange of knowledge
and techniques for broad-based and
selective management of the critically
injured patient”. Original papers are
currently being sought for presenta
tion. with particular interest in those
concerning new approaches to trauma
care.
Featured speakers at the symposium
will be noted physicians and surgeons
in the field of trauma, including Dr.
Alasdair Conn, director of field pro
grams, Maryland Institute for Emer
gency Medical Systems; Dr. Howard
Champion, director of surgical critical
care services, Washington Medical
Center; and Dr. John Stafford, direc
tor of emergency medical services,
Arizona Department of Health Ser
vices. Also featured will be members
of the Lincoln Hospital, such as Dr.
Michael Krentz, director of emergen
cy services; Dr. Rosalie Deckert, as
sociate director of critical care med
icine; Dr. Nelson Faux, director of
prehospital systems; and Dr. David
Elliott, critical care specialist.
continued on page 694
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Annular Pancreas with Coexistent Ampullary
Carcinoma in an Elderly Woman
E nsor T ransveldt ,

md ,*

R oger G. K eith , md , frcs , frcs [c ], facs ,* J ames F onger ,
M urray M. F isher , md , fr c p [c ] |

The authors report the first known
case of annular pancreas with
coexistent ampullary carcinoma.
Obstructive jaundice occurring
in an 80-year-old woman was caused
by the neoplasm rather than the
congenital anomaly. Although the
annular pancreas did not obstruct
the duodenum, it did account for
an unusual appearance of the neoplasm
on air contrast roentgenography
of the upper gastrointestinal tract.
The two lesions were successfully
treated by radical pancreaticoduodenec
tomy. The woman has been
disease-free for more than 24 months.
Les auteurs decrivent le premier cas
connu de pancreas annulaire avec
carcinome ampullaire coexistant. Chez
une femme de 80 ans est apparu
un ictere par obstruction cause par la
neoplasie plutot que par la malformation
congenitale. Bien que le pancreas
annulaire n’ait pas obstrue le duodenum,
il etait responsable de I’aspect
inhabituel de la radiographie a
contraste gazeux des voies
gastro-intestinales superieures.
Les deux lesions furent traitees
avec succes par pancreaticoduodenectomie. Cette femme est
exempte de maladie depuis plus
de 24 mois.

Annular pancreas is a rare congenital
anomaly that presents in adults as fre
quently as in children. Most often the
lesion causes duodenal obstruction, al
though associated peptic ulcer, pan
creatitis and jaundice have been de
scribed.1’3 The oldest patient ever to
present with an annular pancreas is
reported here. The coexistence of am
pullary carcinoma has not been re
corded before.

m d * and

copic examination stenosis of the duo
denal lumen was noted 10 cm beyond
the pylorus. A biopsy specimen taken
from this site showed normal duodenal
mucosa. No other lesion could be iden
tified beyond the stenosis because the
duodenoscope could not be passed into
the distal duodenum. Therefore, endos
copic retrograde cholangiopancreatogra
phy was not feasible.
Upper gastrointestinal air contrast
roentgenography revealed a large intra
luminal filling defect at the junction of
the second and third parts of the duo
denum. In addition, consistent narrow
ing was noted at the middle of the second
part of the duodenum (Fig. 1).
The patient refused to undergo percu
taneous transhepatic cholangiography
but agreed to operation. An annular
pancreas was found to be completely
encircling the midportion of the second
part of the duodenum (Fig. 2). The duo
denum was patent through the anomaly
but the luminal diameter was less than
2 cm. A large intraluminal tumour was
palpated beyond the annular pancreas,
at the junction of the second and third
parts of the duodenum. Duodenotomy
identified a large carcinoma arising
from the ampulla of Vater, displaced
distally by the annular pancreas (Fig. 3).
The tumour and the annular pancreas
were resected en bloc by a radical pan
creaticoduodenectomy.
Histologic examination showed that
the tumour was a moderately differen
tiated adenocarcinoma of the ampulla of
Vater. Peripancreatic lymph nodes were
not involved. The annular pancreas was
FIG. 1—Stenosis of supra-ampullary histologically normal. The patient re
second portion of duodenum and large mains well and free from recurrent
filling defect at junction of second and malignant tumour 24 months after her
operation.
third parts of duodenum.

painless jaundice, had lost 10 kg in
weight and experienced intermittent stea
torrhea. Hepatomegaly was noted on
abdominal examination. Results of
hematologic investigations were normal.
Biochemical evaluation showed abnormal
serum levels as follows: total bilirubin
was 124.8 iimol/l. conjugated bilirubin
97.5 umol/l, alkaline phosphatase 309
lU/dl, total protein 7.7 g/dl and albumin
3.4 g/dl. All other liver enzyme, serum
amylase and glucose levels and pro
thrombin and partial thromboplastin
times were normal.
Ultrasonography showed dilated intrahepatic biliary radicles and gallbladder,
without calculi. A scan of the liver using
technetium-99m was normal. At endos-

Case Report

An active 80-year-old woman had

From the departments of *surgery and
t medicine, University of Toronto,
Toronto, Ont.
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FIG. 2—Second part of duodenum.
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FIG. 3—Duodenum with ampullary
Annular pancreas encircling supra-am
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carcinoma distal to annular pancreas.
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Discussion

In our case the presenting sign of large periampullary lesion by the con
intermittent jaundice suggested a peri stricting annular pancreas.
There have been 250 reported cases ampullary neoplasm rather than bili
Surgical treatment in this case con
of annular pancreas. The majority of ary obstruction by the congenital
these have been in adults.4 Although anomaly. Ultrasonographic examina sisted of radical pancreaticoduodenec
the condition is congenital, symptoms tion demonstrated acalculous dilata tomy in spite of the patient’s advanced
of duodenal obstruction may be de tion of the biliary tract without defin age. The results have been gratifying.
In such a case with metastatic spread,
layed as long as the duodenal lumen
ing the level of obstruction. The ste- we advise biliary bypass by cholecysis not encroached upon by pancreatic
nosing anulus precluded definitive en
inflammation within the encircling doscopic evaluation and biopsy of the tojejunostomy or choledochojejunosanomaly and is not compromised by tumour. Unfortunately, percutaneous tomy and gastric decompression by
peptic ulceration of the proximal duo transhepatic cholangiography was un gastrojejunostomy.
denum. Prior to our case, the oldest acceptable to the patient. The level of
patient reported with symptoms refer- the biliary obstruction was confirmed References
rable to an annular pancreas was 75 only by examining the surgical speci
1. B eachley MC, I ANkau CA j r : Symptoma
years old.5
tic adult annular pancreas. Am J Dig Dis
men which showed dilatation of the
1973; 18: 513-6
intrapancreatic portion of the bile 2. M acG regor AM, G reen BJ, Stern MA:
The presentation of annular pan duct, with stenosis only at the level
Symptomatic annular pancreas in the adult.
creas and jaundice has been reviewed of the ampullary carcinoma.
Br J Surg 1969; 56: 713-5
3.
M
oore TC: Annular pancreas, common-duct
by Morrell and Keynes.6 They found
The radiographic appearance of the
compression and cholelithiasis. A M A Arch
15 cases; of these 1 had liver disease upper gastrointestinal tract with air
Surg 1956; 73: 1050-4
due to alcoholism, 4 had common bile contrast examination was unusual in 4. L loyd-J ones W , M ountain JC , W arren
KW: Annular pancreas in the adult. Ann
duct stones and 10 had pancreatitis. that the polypoid tumour presented in
Surg 1972; 176: 163-70
The association of an? ular pancreas the third part rather than the more 5. Seliger G, G oldman A: Symptomatic an
nular pancreas in a 75-year old man. Am
and carcinoma of the ampulla of typical site in the second part of the
Gastroenterol 1973; 60: 185-90
V ater has not previously been re duodenum (Fig. 1). This position was 6. JM orrell
MT, K eynes WM: Annular pan
corded.
creas
and jaundice. Br 1 Surg 1970: 57:
created through displacement of the
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BOOK REVIEW
ESSENTIALS OF ANORECTAL SUR
G ER Y. Stanley M. Goldberg, Philip
H. Gordon and Santhat Nivatvongs.
389 pp. Illust. J.B. Lippincott Com
pany o f Canada, Toronto, 1980.
Price not stated. ISBN 0-397-50417-9.

Management of minor disorders of anus
and rectum has long been overlooked
in most training programs in general
surgery. The knowledge provided in these
areas in the popular textbooks is gen
erally scanty and often the postoperative
management of anorectal problems is
learned by following the regimen pre
scribed by the surgeon. Goldberg and
Nivatvongs from the University of Min
nesota and Gordon from McGill Univer
sity have performed a commendable task
in covering these neglected areas. Their
text is augmented by 300 illustrations,
including a large number of neatly
drawn figures by Martin E. Finch.
The text comprises 30 chapters, cover
ing every conceivable anorectal problem
from prolapse of rectum to perianal endometrioma. It is preceded by a fore
word which describes the history of
anorectal surgery both in Europe and
North America. In it, William C. Bern
stein highlights the landmarks and de
velopment of anorectal surgery from an
cient Egypt to modern times with the
formation of the American Board of
Colon and Rectal Surgery. The topics
688

and the chapters are arranged in a meth
odical manner. After describing the ana
tomy and physiology of rectum and anal
canal, the authors follow with diagnosis,
postoperative management of anorectal
wounds and principles of anesthesia in
anorectal surgery. The following chapters
are devoted to a discussion of common
anorectal problems and end with compli
cated rectal problems including benign
and malignant tumours of the rectum,
rectal prolapse, anal incontinence and
rectovaginal fistula.
Throughout the text the authors have
concentrated on developing a scientific
basis for understanding and managing
anorectal problems. The pathogenesis of
anorectal prolapse and fistulas is de
scribed clearly with the help of original
diagrams taken from Parks’ classic
paper. The chapter on anorectal physiol
ogy describes in great detail mechanisms
of anal continence, with reference to re
cent studies, and provides an exhaustive
list of references to support the con
cepts outlined. Similarly, in dealing with
hemorrhoids, a good description of path
ogenesis is followed by a rational scheme
of practical management. In the chapter
on rectal cancer the correlation between
pathology and prognosis is described in
detail to provide a basis for an appro
priate selection of operation.
Throughout the book the authors have
emphasized the benefits of a jack-knife

or prone position both for endoscopic
examination of rectum and for thera
peutic procedures. In fact, in all the
illustrations of the perineum the patient
is in the prone position. It takes a
conventional surgeon some time to re
verse his anatomical concepts. In their
enthusiasm for the prone position the
authors recommend it for perineal exci
sion of the rectum in an abdominoperi
neal operation. This approach obviously
precludes a synchronous abdominoperi
neal excision of rectum which the au
thors have chosen not to include in the
options. In postoperative management
the authors recommend dehydrating the
patient to avoid the need for catheteriza
tion. I do not think the rationale for
this approach would be acceptable to
most practising surgeons.
This is an excellent book that should
be read by all general surgeons and
trainees in general surgery and proctol
ogy. It will also be a very useful refer
ence book for medical students. The
authors are to be congratulated for pro
viding an excellent collection of rather
neglected but much needed information.
T.A. K h a n ,

m

s c , m d , f r c s , f r c s [c ]

Department of surgery,
University of Manitoba,
Health Sciences Centre,
Winnipeg, Man.
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Tuberculous Dactylitis: a Rare Entity
E.P. U rovitz ,

Tuberculous dactylitis is a rare
musculoskeletal infection, but as
emigration from developing countries
increases it is likely to be seen
more frequently. The author reports
the case of a 23-year-old man with
this condition. The radiologic features
of tuberculous dactylitis include
soft tissue swelling, periostitis with
bone expansion and cortical
destruction, diffuse uniform infiltration
and localized osteitis.
The major role of surgery is to
provide tissue for diagnosis and
to allow for the removal of caseous
avascular tissue to promote
distribution of drugs into surrounding
tissues. An important aspect in
the rehabilitation of these patients
is early motion to prevent joint
contracture and subsequent ankylosis.
La dactylite tuberculeuse est une
infection musculo-squelettique rare;
toutefois, avec I'emigration croissante
des pays en voie de developpement,
elle est susceptible d'etre rencontree
plus frequemment. L'auteur decrit
un cas de cette maladie chez un
homme de 23 ans. Les caracteristiques
radiologiques de la dactylite
tuberculeuse associent inflammation
des tissus mous, periostite avec
expansion osseuse et destruction
corticale, infiltration uniforme diffuse
et osteite localisee.
Le role principal de la chirurgie
consiste a aller prelever du tissu
pour le diagnostic et a permettre
I’enlevement du tissu caseeux
avasculaire dans le but de favoriser
la distribution des medicaments
dans les tissus adjacents. Un aspect
important de la readaptation de ces
patients est leur mobilisation precoce
afin de prevenir la contracture des
articulations et I'ankylose subsequente.

The increasing number of people
emigrating to Canada from developing
third world countries has resulted in
a continuing rise in the incidence of
musculoskeletal tuberculosis despite
From the orthopedic division,
Scarborough Centenary Hospital,
Scarborough, Out.
Accepted for publication Apr. 26, 1982
Reprint requests to: Dr. E.P. Urovitz,
2877 Ellesmere Rd., Ste. 7G,
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md , frcs [c ]

effective chemotherapy.1 Nevertheless,
tuberculosis of the hand remains an
uncommon manifestation and tuber
culous dactylitis (affecting only the
phalanges) is rare.2 The following re
port of a case of reactivated tuber
culous dactylitis serves to illustrate
the clinical, radiologic and therapeutic
principles involved.

Case Report
In November 1980, a 23-year-old man
was seen, complaining of a 1-year history
of progressive swelling of and drainage
from the left index finger. In 1976,
while in India, he had experienced pain
and swelling of the proximal interphalangeal joint of the left index finger and
a diagnosis of tuberculosis had been
made. Subsequently, he underwent a
proximal interphalangeal joint arthro
desis. In October 1979, he had injured
his finger playing football and a roent
genogram was interpreted as showing a
fracture near the fused joint. He was
treated with a splint but continued to
complain of pain and swelling. He emi
grated to Canada in April 1980. Approx
imately 6 weeks before this presentation
he had noted the development of a sinus
over the radial aspect of the middle
phalanx. He also complained that he had
lost 1 to 2 kg in weight but denied any
history of pyrexia, nocturnal sweats,
cough, sputum or pleuritic chest pain.
The hand had a tender, fusiform
swelling involving the middle phalanx
and the distal interphalangeal joint of
the index finger. A small sinus over the
radial aspect of the middle phalanx
drained a minute quantity of seropurulent fluid. The proximal interphalan
geal joint was fused and painless. The
range of motion of the distal inter
phalangeal joint was from 45° to 10° of
flexion.
A roentgenogram (Fig. 1) revealed a
decreased cartilage space at the proximal
interphalangeal joint, diffuse soft tissue
swelling and multiple radiolucencies and
cortical thinning involving the middle
phalanx. The cartilage space of the distal
interphalangeal joint was maintained.
Routine blood tests gave normal results
and the biochemical profile was normal.
Drainage fluid was sterile on routine,
fungal and tuberculous culture. A chest
roentgenogram revealed no evidence of
tuberculosis.
To make a definitive diagnosis, an
open biopsy of the middle phalanx was
performed through a dorsolateral inci
sion; the sinus was erased. At operation
the dorsal cortex of the middle phalanx
was found to be replaced by grey
ish-brown gelatinous granulation tissue
which surrounded the extensor mech

anism. A few small sequestra lay in this
tissue, and these and the tissue itself
were curetted to normal bone. The distal
interphalangeal joint appeared to be free
of disease, so arthrotomy of this joint
was not performed. The proximal inter
phalangeal joint was solidly fused.
The histopathologic findings (Fig. 2)
were consistent with tuberculosis and
the diagnosis of tuberculous dactylitis was
confirmed when Mycobacterium tuber
culosis grew on tissue culture. Postoperatively, the patient was given a
combination of isoniazid (150 mg/d),
ethambutol (15 mg/kg daily) and rifam
pin (600 mg/d). Active motion of the

FIG. 1— Index finger showing loss of
cartilage space at proximal interphalan
geal joint and multiple radiolucencies in
middle phalanx with cortical thinning.
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distal interphalangeal and metacarpopha
langeal joints was started 10 days after
the biopsy and debridement.
Six months after operation the swell
ing was much reduced and there was no
drainage. Range of motion of the distal
interphalangeal joint was the same as
before operation.

definition of true dactylitis, however,
cases of tuberculous dactylitis number
only 22.
Several features of our case are
worth emphasizing as they illustrate
several clinical and radiographic as
pects mentioned in past reviews. Frost7
stated that a history of trauma was
Discussion
common in tuberculous dactylitis al
Tuberculosis of the hand is uncom though Mason4 disagreed.
In our patient, the football injury
mon; only 159 cases have been re
ported in the five largest series.2'6 The probably contributed to the activation
majority of these were tuberculous of a tuberculous synovitis of the prox
tenosynovitis. According to Leung’s6 imal interphalangeal joint.
There is often no associated pul
monary lesion; this has been noted by
both Robins5 and Feldman and asso
ciates2 and in our case. Feldman and
colleagues2 noted that the commonest
radiologic features of tuberculous dac
tylitis were soft tissue swelling, perio
stitis with bone expansion and cortical
destruction, diffuse uniform infiltra
tion (honeycombing) and localized
osteitis. Unlike pyogenic sepsis, tuber
culosis rarely incites much sclerosis
or new bone formation. It should be
emphasized that these are general
characteristics and departures from
them are quite frequent. Sequestra
and pathologic fractures may also oc
cur. Many of the features stressed by
Feldman were present in our case and
were possibly overlooked at the initial
FIG . 2— Granulation tissue of middle
presentation following injury.
phalanx
demonstrating inflammatory
The treatment of tuberculous dac
infiltrate and Langhans giant cells (hema
toxylin and eosin reduced by 54% from
tylitis involves a combined medical
X 250).
and surgical approach. The poor re

sponse to conservative therapy alone
has been mentioned by Bickel and col
leagues,3 Kanavel8 and Mason,4 al
though these reports represent experi
ence in an era before the advent of
the newer antituberculous chemother
apy. The major surgical procedures
include: (a) open biopsy to obtain suf
ficient pathologic tissue for diagnosis
and (b) removal of avascular tissue to
promote the distribution of drugs into
surrounding tissues.
Prolonged immobilization has ad
verse effects upon joint capsule and
ligaments leading to stiffness; early
motion is now recognized as superior
to lengthy immobilization for this dis
order.6
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Permanent Subcutaneous Vascular Access:
the Chemo Shunt
J . J . L a ir d , m d , f a c s , f r c s [ c ]

A technique is described for providing
permanent painless vascular access
in patients receiving chemotherapy
for malignant disorders. In 55 patients
with no suitable vascular access, a
permanent subcutaneous vascular
access site was created in the upper
anterior chest wall utilizing a Silastic
dome and attached tubing. The drugs
to be given are injected into the
dome, the solution passes through the
tubing and empties into the superior
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vena cava. When not being used
the system is filled with heparin
solution. There have been no instances
of infection either primarily or in
the long term. In some patients the
access site has been used for 2 V2
years and the technique has met with
enthusiastic patient response. The
author has termed this technique
the chemo shunt.
On decrit une technique permettant
d’etablir une voie d’acces vasculaire
indolore et permanente chez les
patients qui recoivent une
chimiotherapie anti-cancereuse. Chez
55 patients qui n’avaient pas de voie
d’acces vasculaire adequate, un acces
vasculaire sous-cutane permanent

a ete cree dans la partie anterieure
et superieure de la cage thoracique,
a I’aide d’un reservoir a coupole de
Silastic attache a une tubulure. Les
solutions de medicaments sont
injectees sous la coupole, passent
dans le tubulure et sont evacuees
dans la veine cave superieure. Pendant
qu’il est au repos, le systeme est
rempli d’une solution d’heparine. On
n’a enregistre aucune infection ni
en debut d’utilisation, ni a long terme.
Chez certains patients, cette voie
d’acces est utilisee depuis 2 V2 ans
et la technique a regu un accueil
enthousiaste de la part des patients.
L’auteur a nomme cette technique le
"chemo shunt” (derivation pour
chimiotherapie).

VOLUME 25, NO. 6, NOVEMBER 1982 / THE CANADIAN JOURN AL OF SU RGERY

Many patients with cancer receive
chemotherapy either as primary or as
adjunctive treatment with operation
or radiotherapy, or both. Of the many
chemotherapy regimens, most are in
termittent and long term, lasting over
a number of months or years. Unfor
tunately, most of the drugs used ir
ritate the veins into which they are
injected. As a result, phlebitis and
sclerosis develop at the vascular ac
cess site. Administration then becomes
difficult, and painful and frightening
to the patient who is already anticip
ating the unpleasant side-effects of
the therapy.
This paper outlines a technique for
providing permanent vascular access
without pain. It was carried out on
55 patients over a 3-year period.
Patients

From Jan. 1, 1979 to Dec. 31, 1981
at Metropolitan General Hospital in
Windsor, Ontario, in conjunction with
the regional unit of the Ontario Can
cer Foundation, chemotherapy divi
sion, 55 patients (19 men, 31 women,
5 children) had implanted into the sub
cutaneous layer of the upper anterior
thoracic wall an apparatus that pro
vides permanent vascular access. All
patients had cancer and were receiv
ing chemotherapy, most on a long
term basis. In each patient peripheral
venous access was no longer available.
The ages of the patients ranged from
the teens to the 80s. Cancers included
lymphoma, leukemia and those of

breast, bowel and lung. There were
no contraindications to the use of
this apparatus because of age or type
of cancer.
T echnique

The materials used for this appara
tus include: Heyer-Schulte tubing (cat.
no. 850-1225; A.H.S. Medical Special
ties, Mississauga, Ont.) (Raimondi
peritoneal catheter). This is a springreinforced silicone catheter with a
distal slit valve (Fig. 1), which pre
vents blood reflux and clotting. The
spring reduces the possibility of kink
ing or folding and makes the entire
catheter visible on the roentgenogram.
It is provided with a straight threaded
connector, to join to a Heyer-Schulte
injection dome (cat. no. 350-9000).
The dome is approximately 1.5 cm
in diameter, with a mesh embedded in
its base to prevent needle puncture. A
standard protocol for use of this sys
tem has been made for cancer clinic
staff and the “IV team”.
Preoperative assessment included a
hemogram and coagulation profile.
All procedures were done on an out
patient basis under local anesthesia.
Valium may be given intravenously
as a sedative. Children are usually ad
mitted to hospital and the procedure
is done under general anesthesia.
The patient is placed in a semisit
ting position with the arm at the side.
Two incisions are used. The first, 2
cm long, is placed below the medial
end of the third rib. A subcutaneous

pocket is created above this incision;
some denervation of the skin is
achieved for future needle puncture
(Fig. 2).
A second incision, 3 to 4 cm long,
is made below the clavicle, overlying
the deltopectoral groove. The cephalic
vein or a branch is isolated and pro
vides access to the central venous sys
tem, via the subclavian vein. The in
jection dome is placed in the pocket
created in the medial incision. A fine
Silastic tube, attached to the dome, is
run through a tunnel created between
the two incisions. This tube is intro
duced through the cephalic and sub
clavian veins into the superior vena
cava, just proximal to the heart. If
the vein in the deltopectoral groove
is not readily available, an introducer
in the subclavian vein will allow the
tube to be placed in the superior vena
cava. All attachments of the apparatus
are secured with cotton ties. The com
plete system is checked for patency
and function at the end of the pro
cedure via a percutaneous puncture
into the dome. It is then filled with
heparin solution (1:1000), as it is
after each use. Antibiotics are not
given routinely, either locally or systemically.
The material to be injected goes
into the dome through a 25-gauge
needle and thus to the superior vena
cava. A chest roentgenogram is not
routinely obtained to confirm that the
catheter is correctly placed but may
be used to confirm the position of
the Silastic tubing in the superior vena
cava (Fig. 3).
D iscu ssion

FIG. I— Original
used.

dome

and

tubing

FIG. 2— Cutaneous landmarks drawn
on skin before insertion.

FIG. 3— Dome and tubing in position.

All equipment inserted into the pa
tient is made of Silastic. The tubing
used in our first six patients did not
contain a finely coiled wire and in
some was placed over the clavicle. As
a result, three of these tubes cracked
and leaked within 3 months of inser
tion. However, there has been no
trouble since we started to use tubing
with coiled wire inserted below the
clavicle. There have been no infec
tions, either primarily or in the long
term, following multiple uses of this
system for chemotherapy. The follow
up of these patients is carried out by
the cancer clinic staff.
Patients generally are not operated
upon until they have a leukocyte
count greater than 1 X 10V1 and a
platelet count greater than 25 X 109/1.
Four domes have been replaced,
two because of leakage from the in
jection area and two because of overlying ulceration. All had been used
for more than 10 months.
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Is Aminoglutethimide an Alternative to Adrenalectomy
for Metastatic Carcinoma of the Breast?
E r n e s t E . St e r n s ,

m d , f r c s [ c ], f a c s , C h a r l e s E . B ir d , m d ,
K e n n e t h W . M a c k ie , m d , d m r d , f r c p [ c ]

Aminoglutethimide inhibits steroid
synthesis by the adrenal gland and
the peripheral conversion of androgens
to estrogens. As such it has been
recommended in the place of
adrenalectomy for the treatment of
advanced breast cancer. Amino
glutethimide with hydrocortisone was
given to 19 women with metastatic
cancer of the breast whose disease
was progressive, who would otherwise
have undergone adrenalectomy
and whose potential for response
was good. Four patients could not
tolerate the drug and seven failed
to respond. Eight women had an
objective response, complete in two
and partial in four. In two patients
the disease stabilized. The period
of treatment ranged from 11 to
26 months but three patients are still
on treatment after 26 months. The
authors conclude that aminoglute
thimide has a place in the management
of women with advanced breast
cancer who satisfy the criteria for
hormone manipulation.
[.’aminoglutethimide inhibe la
synthese des steroides par les glandes
surrenales, ainsi que la conversion
peripherique des androgenes en
oestrogenes. Telle quelle, on I'a
recommandee en remplacement de la
surrenalectomie dans le traitement
du cancer du sein au stade avance.
L'aminoglutethimide associee a
I'hydrocortisone fut administree a
19 femmes porteuses d’un cancer
metastatique du sein en evolution qui
auraient autrement subi une
surrenalectomie et dont les possibilites
de reponse etaient bonnes. Ouatre
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patientes n’ont pu supporter le
medicament et il y eut sept echecs
therapeutiques. Huit femmes eurent
une reponse objective, complete
dans deux cas et partielle dans quatre.
Chez deux patientes, la maladie
se stabilisa. La periode de traitement
variait de 11 a 26 mois mais
trois patientes sont toujours sous
traitement apres 26 mois. Les
auteurs concluent que I’aminoglutethimide a une place dans le
traitement du cancer du sein au stade
avance chez les femmes qui
rencontrent les criteres etablis
pour la manipulation hormonale.

patients with metastatic carcinoma of
the breast, the investigational use to
date indicates that the response to the
drug at least equals that of adrenalec
tomy4 and hypophysectomy.5 Amino
glutethimide must be combined with
steroid replacement and most inves
tigators have used dexamethasone to
this end. Unfortunately, aminoglute
thimide accelerates the metabolism of
dexamethasone and some of the man
agement problems of this combination
may be ascribed to this interaction.
To avoid this problem, hydrocortisone
has been advocated as a form of
steroid replacement.6

At least one third of all patients with
metastatic carcinoma of the breast
will demonstrate an objective response
when subjected to adrenalectomy.
This number is increased in women
with a previous response to hormone
manipulation or who have estrogen
receptor-positive tumours, or both.1
However, many patients are denied
this form of management for very
valid reasons. The operation is asso
ciated with a mortality of between
2% and 7% and with serious com
plications.2 At best the response rate
is 50%. Finally, after adrenalectomy
the patient is permanently dependent
on exogenous steroids and this often
complicates chemotherapy when there
is a relapse.
An alternative to adrenalectomy is
the biochemical suppression of adre
nal steroid production. Aminoglute
thimide was first marketed as an anti
convulsant but was withdrawn because
it inhibited steroid production. This
inhibiting activity was subsequently
applied to the management of patients
with carcinoma of the breast.3 The
advantage of “medical adrenalectomy”
is obvious. The morbidity and mortal
ity of surgery are avoided, the inhibi
tion of steroid production is reversible
following the relapse of disease and
complications of the use of this drug
are relatively minor and usually self
limited. The patient with a limited life
expectancy who might well refuse ma
jor surgery is more inclined to accept
a drug treatment program.
Although aminoglutethimide is not
available for the routine treatment of

Patients and Methods

We used aminoglutethimide and hy
drocortisone in 19 women (age range
32 to 71 years, mean 48 years) with
advanced breast cancer who had un
dergone a previous oophorectomy or
who were postmenopausal. All had
previously undergone hormonother
apy. The interval between the time of
diagnosis and the identification of sec
ondary disease (disease-free interval)
ranged from 0 to 132 months. These
women would have been considered
for surgical adrenalectomy and were
selected for aminoglutethimide ther
apy because they had the greatest po
tential for response — a previous re
mission after hormone manipulation,
a disease-free interval longer than 24
months or, in those tested, an estrogen
receptor-positive tumour. In selecting
these 19 women, we chose those with
secondary tumours in soft tissue and
bone preferentially; patients with lym
phatic pulmonary involvement, exten
sive hepatic metastases or central
nervous system disease were excluded.
Before aminoglutethimide and hy
drocortisone treatment was begun, the
extent of the disease was documented.
All surface tumours were photo
graphed and measured. Hematologic
and biochemical profiles were estab
lished, including a complete blood
count and measurement of serum al
kaline phosphatase, lactic dehydro
genase and calcium levels. Chest and
skeletal roentgenograms as well as
radionuclide scans of the bones and
liver were also obtained. Whenever
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secondary hepatic lesions were sus
pected, ultrasonography was per
formed. Measurable metastases were
evaluated at 3-month intervals and
general assessments were carried out
every 6 months or as determined by
the course of the disease.
Aminoglutethimide was adminis
tered in doses of 250 mg four times
daily, and hydrocortisone in 20-mg
doses morning and evening. When
aminoglutethimide was discontinued,
hydrocortisone was administered for
48 hours longer. There were no cases
of hypothalamic-pituitary-adrenal un
responsiveness when hydrocortisone
was withdrawn.
Assessment of Response
Patients were considered to have a
complete response to treatment when
clinical, radiologic or biochemical de
terminations confirmed the disappear
ance of all evaluable metastases and
skeletal films demonstrated the pres
ence of sclerosis or reossification. A
partial response was defined as a de
crease by at least 50% of all measur
able lesions and a failure of new sec
ondaries to appear. The patient was
considered to have stable disease
when no demonstrable change in any
of the detectable metastases occurred
and the patient remained subjectively
well during the course of treatment.
Since the patients were entered into
the study only when they had docu
mented progressive disease, the failure
of the disease to progress for a period
of more than 3 months was considered
to be an effective form of palliation.
Progression of disease was present
when any of the metastatic deposits
failed to regress or stabilize and there
was deterioration in the general con
dition of the patient.
Results

Treatment had to be discontinued
in 4 of the 19 women because of in
tractable side-effects. Fifteen patients
were therefore available for assess
ment. Treatment has been terminated
in 12 patients and 3 continue to re
ceive aminoglutethimide and hydro
cortisone.
Eight patients responded and seven
did not. The mean age, disease-free
interval and survival time from diag
nosis to death between responders and
non-responders is given in Table I.
The disease-free interval and total sur
vival was longer in responders. The
site of metastatic disease is given in
Table II. There was no difference be
tween the two groups.
696

All 15 patients had received hor
monotherapy previously. Seven of the
eight responders had demonstrated an
objective response while only four of
the seven non-responders had had a
remission.
Failure to respond to aminoglute
thimide and hydrocortisone was evi
dent within 6 weeks. Only one patient
was maintained on treatment for more
than 24 weeks. This woman had a
slowly progressive tumour and while
she was subjectively improved for 9
months she had no objective evidence
to indicate a response to the drug.
Of the eight responders (Table III)
two had complete remission, which
continues after 26 months. Four had
a partial response, the longest for 26
months and that patient continues in
remission. In two patients the disease
stabilized, one of these women had
complete disappearance of her chest
wall disease but radiographs demon
strated no change in her osseous me
tastases.
Side-Effects
Only 5 of the 19 patients reported

no side-effects of treatment. The most
common complaints were drowsiness
in nine patients, nausea and vomiting
in five and skin rash in four. The
other symptoms reported were non
specific and may not have been re
lated to use of the drug. Most of the
effects were self-limited and disap
peared spontaneously without treat
ment. Of the five patients who com
plained of nausea and vomiting, four
had intractable symptoms. Change in
the dosages of both aminoglutethimide
and hydrocortisone was ineffective.
The condition was controlled only by
discontinuing therapy.
Discussion

Although the management of meta
static breast cancer is an important
entity in breast cancer treatment and
hormone manipulation is paramount,
aminoglutethimide has not been
strongly promoted and the drug is
available only for investigational use.
Although its use in this condition was
first reported in 1973, there have been
few reported studies. Most of the ear
lier investigators used dexamethasone

Table 1-Results of Aminoglutethimide Therapy in 15 Patients
Disease-free
Age, yr
interval, mo*
Group
No.
Mean
Range
Mean
Range
Responders
8
49
34-62
37
0-102
Non-responders
7
45
32-66
26
0-57
*Time from diagnosis to demonstration of secondary disease.
tTime from diagnosis to death.
+Four patients still alive at 38 to 142 mo.
§Two patients still alive at 79 and 97 mo.

survival, mot
85*
61 §

Table II—Site of Metastatic Disease
Group
Responders
Non-responders

No.
8
7

Osseous
6
7

Visceral
6
6

Nodal
2
2

Chest
wall
2
2

Table Ill-Responders
Nature of
response
Complete
Complete
Partial
Partial
Partial
Partial
Stable
Stable

Age,
Disease-free
Duration of
interval, mo
treatment, mo
Vf
52
0
26*
41
21
26*
34
26
11
62
24
12
38
102
26*
59
54
25
45
42
12
58
29
16
'Continues in remission on aminoglutethimide and hydrocortisone.
tStill alive.

Total
survival, mo
38t
98t
83t
89
142+
112
54
68
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for steroid replacement so the results
may not be comparable to those in
studies in which hydrocortisone was
used.
Santen and Wells8 recently reviewed
the mechanism of action of aminoglutethimide and reported the largest
series to date. Of 52 patients, 4 had
complete remission lasting for an
average of 25 months and 11 had a
partial response for a mean duration
of 10 months. Ten patients had stable
disease for 8 months.7 From their
findings and our results it appears that
the more complete the response the
longer is its duration. The responses
are also more predictable in patients
who have estrogen receptor-positive
tumours. It is obviously impossible to
do a comparative study on medical
and surgical adrenalectomy but the
evidence to date suggests that the re
sults of aminoglutethimide therapy are
as good or better than those of adre
nalectomy or hypophysectomy. The
advantages of the drug are important
since surgical morbidity and mortality
are eliminated. It is of interest that
two of four patients reported by San
ten and Wells who had an objective
response to adrenalectomy had further
partial remission when aminoglute
thimide was administered after re
lapse.4 It has also been reported8 that
a 12-week trial of aminoglutethimide
will accurately identify those patients
who will subsequently respond to sur
gical adrenalectomy.
There are several complications of
aminoglutethimide therapy. Drowsi
ness and skin rash in other studies,
though not in ours, prompted the ter
mination of treatment in an appreci
able percentage of patients.4 Pancyto
penia and hypothyroidism have also
been reported. Four of our patients
experienced nausea and vomiting of
such severity that drug had to be dis
continued. This has not been previous
ly reported as an important sideeffect. Complications generally occur
in three quarters of the patients but
treatment has to be terminated in less
than 20%.
The results of our small series agree
with those of previously reported
studies indicating that aminoglute
thimide is effective in women with
metastatic cancer of the breast. In
those who tolerate the drug it appears
to be an effective substitute for adre
nalectomy with longer remissions in
those with complete response.
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Editorial comment.—The paper by
Sterns and colleagues discusses their
experience with aminoglutethimide as
a substitute for adrenalectomy in the
treatment of 19 patients with meta
static cancer of the breast. This form
of therapy is certainly at the fore
front of current management efforts
and may have something to offer.
Four of the 19 women (21%) were
unable to tolerate the drugs, 8 (42%)
responded to the drug and 7 (37%)
did not. This simple descriptive re
sult cannot and should not be com
pared with results that would be
achieved by adrenalectomy, hypophy
sectomy or any other endocrine rou
tine proposed for the management of
advanced breast cancer patients. The
data presented in this study do not
support a conclusion that aminoglute
thimide therapy should or could be
used as an alternative to surgical adre
nalectomy, despite the intuitive feeling
that such therapy would be desirable
when contrasted with the fairly serious
nature and unpredictable results of
adrenalectomy. The only way by which
adrenalectomy and aminoglutethimide
therapy can be compared is by a ran
domized clinical trial; without it, a
valid comparison would be exceeding
ly difficult.

Professor,
Department of biostatistics.
McMaster University,
Hamilton, Ont.
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Melanoma: the Management of Local Recurrence
and In-transit Metastasis
J ean C outure ,

Following the primary treatment of
melanoma, subsequent appearance
of local recurrence and in-transit
metastasis remains one of the most
difficult problems faced by surgeons.
In managing the disease at this
stage, it is important to realize that,
because of a favourable immune
reaction in some patients, the disease
may remain localized for many
months or years. Consequently, local
control should be attempted in the
best possible manner when the disease
is confined to a specific region and
there are no signs of dissemination.
Methods of local control include
local surgical procedures, local and
systemic chemotherapy, immuno
therapy, radiotherapy, amputation and
isolation-perfusion. After reviewing the
literature and based upon personal
experience, the author found that
hyperthermic isolation-perfusion can be
effective in the management of
local recurrences of melanomas and
in-transit metastasis.
Le traitement des recidives locales
du melanome et des metastases
en transit qui accompagnent souvent
cette maladie demeure un des
problemes les plus difficiles en
chirurgie.
Dans I’etablissement d'un plan
de traitement, on doit tenir compte
du fait que, chez certains patients,
a cause d'une reaction immunitaire
favorable, la maladie peut demeurer
localisee pendant plusieurs mois
ou annees. En consequence, un
traitement local approprie doit etre
propose lorsque la maladie demeure
localisee et s'il n’y a pas de signes
decelables de metastases.
Les diverses modalites therapeutiques
comprennent le traitement chirurgical
fait localement, la chimiotherapie
locale et systemique, I’immunotherapie,
la radiotherapie, I’amputation, et
la perfusion regionale. Apres avoir
revu la litterature sur ce sujet
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et suite a une certaine experience
personnelle, I'auteur est d’avis
que la perfusion regionale realisee
sous hyperthermie est efficace dans
le traitement des recidives locales
et des metastases en transit du
melanome.

The surgical management of mela
noma has always been a challenge.
Although results of surgical treatment
have improved, many problems re
main unsolved, one of them being the
management of stages II and IIIA
melanomas (classification of the M.D.
Anderson Hospital and Tumor Insti
tute). In stage II, local recurrence
occurs within or adjacent to the scar
of a primary lesion; stage IIIA is de
fined as regional in-transit disease or
“satellitosis” without clinical or mi
croscopic evidence of metastasis in
the regional lymph nodes.
In this paper, I review some of the
factors in the natural behaviour of
melanomas that are important in the
management of local and regional dis
ease and I describe the various meth
ods of treatment that can be used at
these stages.
Natural Behaviour of Local and
Regional Melanomas

For the surgeon, the occurrence of
stages II and IIIA disease comes as a
surprise; often, the primary tumour,
sometimes rather small, has been ex
cised widely and prognosis has been
considered good. Then local recur
rences develop quite rapidly, frequent
ly within 6 months of the primary
operation, to the distress of the sur
geon, the patient and family. In most
instances, such a poor outcome could
not have been predicted. Following
the classical works of Clark and asso
ciates1 and Breslow2,3 it was hoped
that the level of invasion and the tu
mour thickness might be helpful in
predicting not only the patient’s sur
vival but also the percentage of local
recurrences or in-transit metastases.
Recent papers on the subject4-6 have
established the good prognostic value
of this method as far as survival is
concerned but have failed to predict
with enough accuracy the percentage
of patients-in whom stages II and IIIA
disease will develop.

It must be realized that many pa
tients with local and regional disease
are also suffering from metastatic dis
ease, and, consequently, cannot bene
fit from local or regional treatment.
Fortunately, there are more favour
able situations, however distressing, in
which patients are afflicted with very
extensive local and regional disease
that remains localized for a long time.
Therefore, effective control of the dis
ease at this stage is of the utmost im
portance as this can bring about a
cure in some patients. This period of
localization is specific to melanomas;
it has been postulated that an immune
reaction is present in some cases. Ac
cording to Lewis7,8 and others,9 some
patients are in a temporary phase of
resistance which is due to a hosttumour reaction. Tumour antibodies
have been identified, which, in the
opinion of these authors, protect the
organism from systemic disease. It
has also been demonstrated that, once
the antibodies disappear from the cir
culation, there is a breakdown of the
immune reaction and the patients de
velop systemic disease quite rapidly.
It is then obvious that, in a number
of patients, local and regional control
should be attempted when the immune
reaction, if present, keeps the disease
confined to a specific region and there
are no signs of dissemination.
Treatment of Stages II and
IIIA Disease

Several methods have been pro
posed in the treatment of melanomas
at these stages.
Surgical treatment of recurrences
varies from local excision to wide, ra
dical excision of local disease and in
transit lesions. Although only a small
number of patients will survive 5 years
following aggressive local treatment,
most will enjoy a longer survival than
patients treated by more conservative
local surgery. Of 35 patients reported
by Karakousis and associates,10 there
were 10 long-term survivors following
radical local treatment; the survival
time among those who died from the
disease following aggressive local
treatment was 28 months compared
with 13.5 months for patients treated
by conservative means.
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In a group of 170 patients reported
by Conrad,11 17% achieved 5-year dis
ease-free survival following local ex
cision of recurrences. Similar results
were reported by Mehnert and Heard12
and Jones and associates,13 in whose
studies the 5-year survival was less
than 25%.
Chemotherapy administered by lo
cal intratumoral injection or systemically occasionally gives temporary
improvement. Some partial regressions
have been observed with alkylating
agents but there is usually no lasting
benefit. The use of DTIC (dimethyltriazeno-imidazole carboxamide) and
BCNU (bischloroethyl nitrosourea)
has given a response rate of 20% to
25%, but the effects are temporary.14
Evidently, systemic or local chemo
therapy does not yield a high rate of
success in local and regional disease.
Immunotherapy has been used ex
tensively following the report of Mor
ton and colleagues15 that 90% of pa
tients receiving bacille CalmetteGuerin intratumorally showed regres
sion of the lesions; the regression rate
in noninjected lesions was 17% and
25% of patients remained free of dis
ease for 1 to 6 years. However,
most10,16 claim that only a third of the
injected nodules will regress.
Jewell and associates16 reported
24% tumour regression in 244 pa
tients with stages II and IIIA mela
nomas treated with a crude acellular
homogenate of allogeneic melanoma
cells. Isolated reports have claimed
prolonged survival after local or sys
temic immunotherapy, but there are
no figures that show a meaningful in-

F IG . 1— R ecurrent m elanom a and
satellite nodules in 62-year-old woman
operated on 6 m onths before fo r primary
tum our in right calf (Clark’s level III1).

crease in the 5-year survival in pa
tients with local and regional disease.
Irradiation has been considered in
effective in the treatment of melano
mas in general. Occasionally, good
results are reported, but they are usu
ally temporary and do not affect long
term survival in patients with stages
II and IIIA melanoma.
Amputation was thought to be the
treatment that would give the best re
sults in cases of local and regional
disease, but the results have been dis
couraging.17"20 Since less than one third
of patients with melanoma have long
term survival, surgeons generally have
been reluctant to recommend amputa
tion for the management of a disease
with a high probability of metastatic
spread. It still is being done occasion
ally but the results do not justify
the very radical amputation that is
sometimes required.
Isolation-perfusion, suggested by
Creech and associates21 in 1958, has
been used extensively by some investi
gators in the treatment of melanomas.
It is designed to deliver a high dose
of the chemotherapeutic agent, in this
case melphalan, to a tumour-bearing
region in an extremity previously iso
lated from the systemic circulation.
This is achieved by cannulating the
artery and vein, and establishing a
temporary extracorporeal circuit using
a pump oxygenator containing a heat

F IG . 2— Lower leg following hyper
therm ic isolation-perfusion perform ed
8 days previously. T here is extensive
edem a and m arked regression of som e
m alignant nodules.

exchanger. The isolation is almost
complete with the addition of a tour
niquet above the occluded vessels, so
that systemic toxicity is avoided.
Results to date have demonstrated
clearly the value of isolation-perfusion
in treating melanomas at stages II and
IIIA and its superiority over other
methods at these stages of the disease.
Local control can be achieved in more
than 50% of cases.22"26 Moreover, the
5-year survival has been greatly im
proved with this treatment in a way
that was totally unexpected. When in
terpreting the reported results, one has
to take into account the addition of
heat to the technique in later years.
According to Stehlin and associates,23
the improvement in local control and
5-year survival are due largely to hy
perthermic perfusion; in 73 patients
with stages II and IIIA disease, the
5-year survival was 22% with normothermic perfusion, but increased to
more than 50% in 30 patients who
underwent hyperthermic perfusion.
Other groups using hyperthermic per
fusion have not achieved as high a
5-year survival rate, but local control
has been just as good.22'25,26
The increase in the 5-year survival
with isolation-perfusion cannot be ex
plained only by a local effect, other
wise one would expect the same re
sults following amputation, which
eliminates tumour completely, as with
regional perfusion in patients with
stages II and IIIA disease. Therefore,
there must be some systemic effect,
which, according to Stehlin, can be
explained by the immune response re
sulting from destruction of distal dis
ease and increase of the cytotoxic ac
tivity of plasma and lymphocytes
against the patient’s own melanoma
cells.
Our experience with 13 patients
who had stage H or IIIA disease has
been similar; complete or partial re
gression of tumour occurred in 50%
of the cases and, as a consequence,
amputation was not indicated in any
case. The only three living patients
belong to a group of six patients sub
jected to hyperthermic perfusion. Figs.
1, 2 and 3 show the results in one of
these cases.
Most complications are minor and
are associated with some local tissue
reaction and edema; major complica
tions can occur in 1% to 2% of the
cases and manifest themselves by
some tissue necrosis, which can be
extensive and may lead to amputation.
Fortunately, such a procedure was re
quired only three times in Stehlin’s
series of 185 hyperthermic perfu
sions.23 Mortality is what would be
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expected in any major surgical pro
cedure and has been reported to be
about 1% to 2 %. Systemic toxicity
is rare, because isolation of an ex
tremity is usually quite satisfactory
and leakage of the drug is minimal.
Discussion

Of the modalities proposed for
treatment of stages II and IIIA mela
nomas, isolation-perfusion is the treat
ment of choice. Depending on local
conditions, other methods may be em
ployed if available. The place of im
munotherapy is yet to be determined.
However, because of the immune re
sponse to some melanomas there is
promise that further research will
make it possible to obtain better re
sults with local or systemic immuno
therapy.
For many surgeons, local excision is
the most popular form of treatment.
The success rate is not high but if it
is done early and radically it can be
almost as good as that of radical am
putation; for this reason there are few
indications, if any, for radical amputa-

tion in melanomas of stages II and
IIIA.
Isolation-perfusion is not used in
most centres, partly because of the
technical problems involved and be
cause it is not universally accepted.
Although initial results of treatment
of stage I melanomas of the extrem
ities by regional perfusion were good
and in many instances superior to the
conventional surgical treatment,22'24,56
skepticism remains, mainly because of
the lack of randomized series compar
ing both treatments. For this reason,
the results of treatment of stage I
melanomas by isolation-perfusion have
been questioned, at least as far as
5-year survival is concerned. However,
most investigators agree that isolationperfusion as an adjuvant to surgical
treatment carries a much lower recur
rence rate than surgical treatment
alone. In our institution, there were
five local recurrences in 20 stage I
melanomas (level III or higher) treated
by wide excision of the primary tu
mour with or without node dissection,
but only one recurrence in 15 mela
nomas at a comparable stage when
isolation-perfusion was added.
Consequently, if isolation-perfusion
has any value in preventing local recurences, it should be of value in the
treatment of stages II and IIIA mela
nomas. I believe our results and
those reported in the literature, espe
cially since the addition of hyperther
mia, demonstrate the superiority of
this modality over other methods pres
ently available.
Summary

Local recurrences and in-transit metastases, as seen in stages II and IIIA
melanomas, are the most important
problems faced by surgeons in the
treatment of this disease. Of the mo
dalities available for treatment of
melanomas at these stages, hyperther
mic isolation-perfusion, either alone
or as an adjunct to surgical treatment,
is recommended.
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Use of Vitallium Prosthesis to Relieve Jaundice
in Patients with Obstruction at the Bifurcation
of the Hepatic Duct
P aul H . N il o f f , m d ,

Fourteen patients with hepatic duct
obstruction were treated by inserting
a Vitallium prosthesis through the
strictured area. Eleven had proven
cholangiocarcinoma; in 3 a definitive
diagnosis was not obtained. Jaundice
was relieved and patients were
afforded good palliation. Obstruction
of the prosthesis has not been a
problem and the absence of external
drainage tubes has been a factor
in improving the quality of life of
these patients. The simplicity of the
operation is emphasized.

E. J o h n H in c h e y , m d ,
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treated by the insertion of a Vitallium
prosthesis. In 11 patients (6 men, 5
women) the stricture was due to chol
angiocarcinoma. These patients ranged
in age from 49 to 87 years (mean 65
years). Tumour could not be proven
by biopsy of the bile ducts in three
patients; one patient proved to have
a Candida infection of the duct and
two patients are presumed to have had
sclerosing cholangitis. Three of the
patients with cholangiocarcinoma had
associated gallstones.
Surgical Technique

Ouatorze patients souffrant d'une
obstruction des canaux hepatiques ont
ete traites par I'insertion d'une
prothese Vitallium dans la partie
retrecie. Onze de ces malades avaient
un cholangiocarcinome demontre;
chez les 3 autres, un diagnostic
definitif n’a pu etre etabli. L'ictere
fut soulage et les patients
beneficierent d'un bon traitement
palliatif. II n'y eut pas de probleme
d'obstruction de la prothese et
I'absence de tubes de drainage externe
a contribue a ameliorer la qualite de
vie des patients. Les auteurs
soulignent la simplicity de cette
operation.

Since cholangiocarcinomas are usually
slow-growing tumours, long survival
as well as effective palliation can be
achieved by adequate surgical decom
pression.1-5 To this end a Vitallium
prosthesis (Fig. 1) has been designed
to relieve obstruction in tumours of
the proximal hepatic ducts that cannot
be resected.

The common bile duct is opened
distal to the tumour. A Bake’s dilator
is used to create a passage through
the tumour and proximal obstructed
intrahepatic ducts and the prosthesis
is inserted to maintain decompression
of the biliary tract. This prosthesis
has a flange by which it is sutured to
the common bile duct to maintain its
position. It also has a small opening
into which a tiny catheter is inserted
temporarily, so that cholangiograms
can be taken and the biliary tract
can be decompressed during the im
mediate postoperative period (Fig. 2).
The gallbladder, if present, is always
removed to avoid the complication of
cystic duct obstruction by tumour.
The prosthesis was inserted through
the strictured area into the obstructed
right hepatic duct in all our patients.

f r c s [c 1

of metastases rather than the effects
of biliary obstruction (Table I).
Reoperation was necessary twice —
once to advance a tube that had mi
grated distally and once to clean a
prosthesis that was obstructed by fib
rin mixed with Candida fungus col
onies. No recurrence occurred follow
ing treatment with amphotericin B.
Tubes retrieved at autopsy were free
of concretions. Survival in the 11 pa
tients with cholangiocarcinoma ranged
from 2 to 34 months (median 18
months). Only one patient received
radiotherapy and she lived 24 months.
Discussion

The procedure of choice for the
treatment of carcinoma of the hepatic
ducts is surgical resection as described
by Longmire and associates1 and
Evander and associates.6 This is rarely
feasible; reported series are small and
follow-up is short.7-10 Resection is lim
ited by invasion of portal venous and
arterial structures when the tumour is
situated in the porta hepatis. Extensive
surgical procedures in this area are
associated with high mortality and
morbidity.
Since these tumours tend to grow
slowly, with many patients surviving
a year or longer, the major problem
for the surgeon is to provide palliation
for the intense jaundice and associated
itching. A number of methods to es-

Results

All patients had good palliation
with relief of jaundice and pruritus,
and those with malignant disease died

Patients

During the past 14 years, 14 pa
tients with biliary obstruction at the
hepatic duct bifurcation have been

o
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FIG. 1—Three sizes of Vitallium
prosthesis. Note flange for securing to
bile duct.

FIG. 2— Postoperative cholangiogram.
Dye injected through catheter shows
early filling of left duct with slower
filling of right ductal system.
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tablish biliary drainage are now avail
able. For the elderly or the patient
who is considered a high operative
risk, percutaneous placement of cath
eters through bile-duct tumours can
be carried out to establish external
drainage or combined internal and
external drainage.1113 The percutane
ous placement of a permanent pros
thesis through a tumour without an
external catheter has also been re
ported.14,15 Occlusion or dislodgement, or both, of the catheters is not
uncommon.12 A number of options are
open to the surgeon at operation if
the tumour is not resectable. Terblanche and associates16 have reported
good results with a U-tube made of
firm plastic which prevents obstruc
tion due to the pressure of advancing
tumour. This tube has the advantage
of being fixed so that it cannot be
dislodged and can be replaced by
“railroading” should it become ob
structed.
Cameron and associates15 have used
transhepatic Silastic stents in 20 pa
tients with malignant strictures, 10 of
which involved the bifurcation of the
bile duct. Five patients survived more
than 1 year and two for more than 2
years. This catheter can easily be
changed should obstruction occur. In
ternal drainage with cholangiojejuno
stomy, as described by Longmire and
associates1 and Ragins and associates,17
may be used. We have performed this

operation when insertion of a metal
prosthesis was impossible.
Placement of a Vitallium tube
through a cholangiocarcinoma which
has been dilated with Bake’s dilators
offers the most effective palliation.
Our experience confirms that of
others,4,5'18 that decompression of the
right ductal system alone is usually
sufficient to relieve jaundice. Obstruc
tion of the tube has occurred only
once — by a “fungus ball”. Two pa
tients have had tubes in place for 5
and 14 years respectively without
cholangitis or jaundice. The use of
metal prostheses for the repair of
biliary strictures is sometimes com
plicated by obstruction by concretions.
One might speculate that in patients
with stricture following operation for
gallstones, the bile is of a different
composition from that in patients
with cholangiocarcinoma.
We believe that the absence of ex
ternal drainage tubes has been a factor
in the improved quality of life of
these patients.
The gross appearance of cholangio
carcinoma and sclerosing cholangitis
is similar and histologic proof of the
diagnosis of bile-duct carcinoma high
in the porta hepatis may be difficult
to obtain. One would hesitate to carry
out an extensive procedure for a nonneoplastic lesion in this area. Insertion
of the Vitallium prosthesis is relatively
simple and, in our hands, effective as

shown in two long-surviving patients
who must have non-neoplastic lesions.
Recent studies suggest that radiotherapy9,i9,2o an(j chemotherapy21-22 may be
effective in treating cholangiocarcino
ma. If this proves to be true then the
combination of a Vitallium prosthesis
and adjuvant therapy should be a de
sirable method of treatment.
The operation is simple. It is not
much more extensive than exploration
of the common bile duct. The proce
dure is well tolerated and is particu
larly useful in elderly and poor-risk
patients who are candidates for oper
ation.

*
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T a b le I — H isto lo g ic D ia g n o s is and O u tco m e in 1 4 P a tie n ts w ith O b stru ctio n
at the Bifu rcation o f the H e p atic D u c t T re a te d b y In se rtio n o f a
Vitallium P r o s t h e s is
P a tien t
no.
1

Age,
yf

Sex

77

M

H isto lo g ic d ia g n o s is
A d e n o c a rc in o m a o f h e p atic duct

F ollow -up
S u r v iv e d 1 yr

2

57

F

C a rc in om a of bile duct

S u r v iv e d 3 4 m o

3

87

M

C a rc in o m a of h e p atic duct

S u r v iv e d 2 mo. G e ne ral deterioration

4

74

M

C a rc in o m a o f h e p atic duct

S u r v iv e d 2 3 m o. D ie d o f hepatic

I

m e ta sta se s
5

62

F

C a rc in om a of bile duct.
H e p atic m e t a st a se s

S u r v iv e d 7 mo. D ie d o f m e t a st a se s

6

61

M

C a rc in o m a o f bile duct

S u r v iv e d 7 mo. E x te n sio n o f tum our
w ith m e ta sta se s. D ie d o f g a s tr o 
intestinal h e m orrh a ge

7

72

F

C a rc in om a of bile duct.

8

52

M

C a rc in o m a o f bile duct

S u r v iv e d 18 m o. D ie d o f m e t a st a se s

9

72

F

C a rc in om a o f bile duct.

A sy m p to m a tic for 11 m o. R e c u rre n t

H e p a tic m e ta sta se s

L ym ph -n od e m e t a st a se s

S u r v iv e d 9 m o

jaundice due to e x te n s io n o f tum our
b e yo n d p ro sth e sis. S u r v iv e d 2 0 m o

10

49

F

C h o la n gio ca rcin o m a

S u r v iv e d 2 4 m o

11

56

M

C h o la n gio ca rcin o m a

S u r v iv e d 2 6 m o

12

73

M

N o t is s u e d ia g n o s is of

A liv e and w e ll (16 mol. T ub e replaced

n e o p la sm

after 8 m o d ue to o b stru ctio n by
fu n g u s

13

64

F

G landular s tru c tu re s in

14

62

M

N o t is s u e d ia g n o s is of

fib ro u s tissu e
n e o p la sm
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A liv e a nd w e ll at 5 yr
A liv e and w e ll at 14 y r
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USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
Daily Oo m
(grama)

Type of Infection

ACTION
In v itro studies in dicate th a t the bacterial action o f CLAFORAN (cefotaxim e sodium ), a
se m isyn th e tic ceph alosporin a ntib iotic, results fro m in h ib itio n o f cell w a ll synthesis.

INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxim e sodium ) m ay be indicated fo r th e tre a tm e n t of in fectio ns
caused b y susceptible strains o f the designated m ic ro -o rg a n is m s in the diseases listed
be lo w :
Low er respiratory tract infections: pneum onia and lu ng abscess caused by
S trepto coccus pne u m o n ia e (fo rm e rly D iplococcus pne um o niae), other S trepto cocci
(excluding[Enterococci, e.g.,S. faecalis), S taphylococcus aureus (penicillinase and
non -p e n icillin a se producing), Escherichia co/i. H e m o p h ilu s influenzae, (includin g
a m p icillin -re sista n t strains), and unspecified K lebsiella species.
Urinary tract infections: caused by Escherichia coli, unsp ecified Klebsiella species
(in c lu d in g K. pne u m o n ia e ), Proteus m irabilis, in d o le -p o s itiv e Proteus, Serratia
m arcescens and S taphylococcus epiderm idis. Also, u n co m plicated gonorrhea caused
b y N. gon o rrh o e a e in clu d in g pen icillin-resista nt strains.
Bacteremia/Septicem ia: caused by Escherichia coli, unsp ecified Klebsiella strains and
S e rratia marcescens.
Skin infections: caused by Staphylococcus aureus (penicillin ase and non-penicillinase
pro d u cin g ), S. epiderm idis. G roup A Streptococci, Escherichia co/i, Proteus m ira b ilis
and in d o le -p o sitive Proteus.
Intra-abdom inal infections: caused by Escherichia coli, and unspecified Klebsiella
species.
Gynecological infections: including pelvic in fla m m a to ry disease, e n d o m e tritis and
pe lvic c e llu litis caused by E. coli. G roup A S trepto cocci and S taphylococcus
e p id e rm id is, anaerobic bacteria including unspecified Peptococcus and
P eptostreptococcus strains and som e strains o f Bacteroides fra g His. In several cases,
a lth o u g h clin ica l cures w e re achieved, bacteriological fo llo w -u p was not available.
C linical experience w ith CLAFORAN in anaerobic in fe c tio n s is lim ited. CLAFORAN has
been used w ith some success in w o u n d and in tra -a b d o m in a l infections aga inst some
strains o f un id e n tifie d Bacteroides and anaerobic cocci.
CLAFORAN has been sh o w n to be active against som e strains o f Pseudom onas.
In th e tre a tm e n t of in fectio ns encountered in im m unosup pre ssed and granulocytopenic
patie nts, results of therapy w ith cefotaxim e have no t been im pressive.
CLAFORAN shou ld not be considered in the tre a tm e n t o f enterococcal in fectio ns, i.e.
Strep, faecalis.
S pecim ens fo r bacteriologic culture should be obtained p rio r to therapy in o rd e r to
iso late and id e n tify the causative organism s and to d e term ine th e ir suscep tibilities to
CLAFORAN. Therapy m ay be in stituted before results o f susce p tib ility studies are
kn o w n ; a n tib io tic trea tm ent should be re-evaluated once these results becom e
available.

CONTRAINDICATIONS
CLAFORAN is contraind icated in patients w h o have show n hype rsen sitivity to
c e fo ta xim e sodium , the cephalosporin, or the p e n ic illin g ro u p s o f antibiotics.

WARNINGS

Before th e ra p y w ith CLAFORAN is in stituted, it m ust be determ ined w h e th e r th e patient
has had p revio us hype rsen sitivity reactions to cefota xim e, cephalosporins, penicillins
o r o th e r drugs. CLAFORAN should be given w ith cau tio n to patients w ith Type 1
h y p e rs e n s itiv ity reactions to penicillin. A n tib io tic s , in c lu d in g CLAFORAN s h ou ld be
ad m in iste re d w ith cautio n to patients w h o have d e m onstrated som e fo rm o f allergy,
p a rtic u la rly to drugs. If an allergic reaction to CLAFORAN occurs, the drug s h ou ld be
d isco n tin u e d and the p.atient treated w ith th e usual agents (e.g. epinephrine,
a n tih ista m in e , pressor am ines o r corticosteroids).

PRECAUTIONS
Pregnancy: The safety o f CLAFORAN (cefotaxim e s o d iu m ) in pregnancy has n o t been
established. C onsequently, use o f the drug in pregna nt w o m e n requires th a t the likely
b e n e fit fro m th e drug be w e ighe d against the possible risk to th e m oth er and fetus.
Nursing M others: CLAFORAN is excreted in hum an m ilk in lo w concentrations. Caution
s h o u ld be exercised w h en the drug is adm inistered to n u rs in g m others.
Pediatric Use 'r he safety and effectiveness o f CLAFORAN in in fan ts and c h ild re n have
n o t ye t been established. It has, however, been used in c h ild re n at a dosage range o f
100-150 m g /k g /d a y in 2-4 d iv id e d doses.
Kidney: A lth o u g h CLAFORAN rarely produces alte ra tio n s in kidney function, evaluation
o f renal status is recom m ended, especially in severely ill p atie nts receiving high doses.
P atients w ith m arkedly im paire d renal fu n c tio n shou ld be placed on the special dosage
sched ule recom m ended und er DOSAGE AN D ADM INISTRATIO N, because norm al
doses in these in dividuals are likely to produce excessive serum conce ntration o f the
m eta bolite s.
P rolonged use o f CLAFORAN m ay result in the o v e rg ro w th o f nonsusceptible
org a n ism s. Constant obse rvatio n o f the pa tie n t's c o n d itio n is essential. If superinfection
occurs, th e ra p y should be discontinued and app ro p ria te m easures taken.
P o sitive d ire c t C oom b's test is know n to deve lop in in d iv id u a ls durin g tre a tm e n t w ith
th e ceph a lo sp o rin g ro u p o f antibiotics, in cluding c e fo ta x im e sodium .
In la b o ra to ry tests a false positive reaction to glucose m ay occur w ith reducing
substances bu t not w ith the use o f specific glucose oxyda se m ethods.

ADVERSE REACTIONS
The m o st freq uent adverse reactions encountered are:
Local (5% ) - injection site in fla m m a tio n w ith in traveno us a d m in istratio n. Pain,
in d u ra tio n and tenderness after in tram uscula r in jection .
Hypersensitivity (1.8%) - Rash, pruritus, fever.
G astrointestinal (1.7%) - C o litis (not pseu dom em brano us), diarrhea, nausea, and
v o m itin g . A fe w cases o f pseu dom em branous c o litis have been reported.
Hem ic and Lymphatic System - M ild reversible leukopenia, granulocytopenia and
th ro m b o c y to p e n ia have been reported. Som e patie nts deve loped positive direct
C o o m b 's te st durin g tre a tm e n t w ith CLAFORAN (cefo taxim e sodium ).
G enitourinary System - M oniliasis, vaginitis.
Central Nervous System (0.2%) - Headache.
Liver - Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline
pho sphatase levels have been reported.
Kidney - Increased serum creatinine and BUN have o c casionally been observed.

SYMPTOMS AND TREATMENT OF OVERDOSAGE
S ince no case o f overdosage has been reported to date w ith CLAFORAN, no specific
in fo rm a tio n on sym pto m s o r trea tm ent is available. T reatm e nt o f overdosage should be
s y m p to m a tic.
DOSAGE AND ADMINISTRATION
CLAFORAN (cefotaxim e sodium ) m ay be adm in iste re d in traveno usly or
in tra m u s c u la rly after reco n stitu tio n (see table w ith recom m en ded m ode o f
re c o n s titu tio n according to route o f a dm in istratio n). Dosage and route o f ad m in istratio n
s h o u ld be determ ined by suscep tibility of th e causative organism s, severity o f the
in fe c tio n and cond itio n o f the patient.

Froqooftcy and Root*

Uncomplicated Gonorrhea

1

1 gram IM (single dose)

Uncomplicated infections
such as pneumococcal
pneumonia or acute urinary
tract infection

2

1 gram every 12 hours
IM or IV

Moderately severe
infections

3-4

1 gram every 6-8 hours
IM or IV

Severe infections

4-6

1 gram every 4-6 hours
IM or IV

Infections commonly
needing antibiotics in
higher dosage
(e.g., septicemia)

6-8

2 grams every 6-8 hours IV

Life-threatening infections

up to 12

2 grams every 4 hours IV

THE M A X IM U M DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
A d m in is tra tio n o f CLAFORAN should be continued for a m in im u m o f 48 to 72 hours
after the patient defervesces o r after evidence of bacterial eradication has been
obtained; a m in im u m o f 10 days o f treatm ent is recom m ended fo r infections caused by
G roup A beta-hem olytic S trepto cocci in order to guard against the risk o f rheum atic
fever or g lo m e ru lo n e p h ritis ; freq uent bacteriologic and clinical appraisal is necessary
du rin g therapy o f chronic u rin a ry tract infections and m ay be required fo r several
m onths after therapy has been com pleted; persistent infections m ay require prolonged
treatm ent. Doses less than those recom m ended s h o u ld n o t be employed.
DOSAGE FOR PATIENTS W ITH IMPAIRED RENAL FUNCTION
In patients w ith estim ated creatinine clearance o f less than 20 m l/m in /1 .7 3 m 2 the dose
o f CLAFORAN m ust be halved (see PRECAUTIONS). If serum creatinine values alone are
available, the fo llo w in g fo rm u la (based on sex, w e ig h t and age o f the patient) m ay be
used to conve rt these values in to creatinine clearance.
Males:

Weight (kg) x (140 - age)

Females:

0.85 x above value

72 x serum creatinine

RECONSTITUTION
The fo llo w in g table is p rovid ed as a guide for reconstituting CLAFORAN (cefotaxim e
sodium ) fo r both in tram uscula r and intravenous adm inistration.
APPROXIMATE
AMOUNT OF
APPROXIMATE
AVERAGE
DILUENT TO
WITHDRAWABLE
CONCENTRATION
BE ADDED
VOLUME
STRENGTH
(ml)*
(ml)
(mg/ml)
Intramuscular
500 mg vial
2
230
2.2
3.4
300
1 g vial
3
2 g vial
5
6.0
330
Intravenous
500 mg vial
10
10.2
50
1 g vial
10
10.4
95
10
180
2 g vial
11.0
•Shake to dissolve.
Parenteral drug products s h ou ld be inspected visu ally fo r particulate m atter and
d iscoloration p rio r to a d m in istratio n. Solutions o f CLAFORAN range fro m lig h t ye llo w
to amber, depending on conce ntration and diluent used. The dry p ow der as w e ll as
solutions tend to darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted o nly w ith Sterile W ater fo r
Injection in accordance w ith the volum e s recom m ended in the preceding table.
For intravenous bolus use: 500 m g, 1 gram and 2 gram vials shou ld be reconstituted
w ith at least 10 m l o f any o f the solutions recom m ended under COMPATIBILITY/
STABILITY.
For intravenous infusion use: 1 o r 2 gram s o f CLAFORAN m ay be reconstituted
with 50 or 100 ml of any of the solutions recommended under COMPATIBILITY/STABILITY.

ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxim e sodium ) should be in jected w e ll w ith in the body
o f a relative ly la rge m uscle such as the upper outer quadrant o f the butto ck (i.e., gluteus
m axim us); aspiration is necessary to avoid inadvertent injection in to a blood vessel.
Intravenous: The in traveno us route is preferable fo r patients w ith bacterem ia, bacterial
septicem ia, o r other severe o r life-threatening infections, or fo r patients w h o m ay be
p o o r risks because o f lo w ered resistance resulting from such de b ilita tin g c o n d itio n s as
m a ln u tritio n , traum a, surgery, diabetes, heart failure, o r m alignancy, particu la rly if
shock is present o r im pending.
For bolus a d m in is tra tio n a solu tio n containing 1 gram or 2 gram s o f CLAFORAN can be
in jected over a period o f three to five m inutes. Using an infusion system , it m ay also be
given over a lo nger period o f tim e th ro u g h the tu b in g system by w h ich the patie nt m ay
be receiving o ther in traveno us solutions. Butterfly® or scalp vein type needles are
preferred fo r th is type o f in fusion. However, durin g in fusion o f the solution containing
CLAFORAN, it is advisable to discontinue tem p ora rily the a d m in istratio n o f other
solutions at the same site.

COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxim e so d iu m ) m ay be reconstituted w ith any o f the fo llo w in g and
should be used fresh ly prepared:
Sterile W ater fo r Injection
Sodium C h loride Injectio n B.P.
5% D extrose Injection B.P.
Dextrose and S o dium C h loride Injection
C om pound S odium Lactate Injection B.P.
If a solution m ust be stored, o n ly the solution prepared w ith Sterile Water fo r Injection
m ay be kept und er refrig era tion (belo w 5°C) fo r not lo nger than 24 hours. A n y unused
solutions shou ld be discarded.
CLAFORAN is com p a tib le w ith 1% lignocaine. O nly fresh ly prepared solutions should
be used. CLAFORAN solu tio n s e x h ib it m axim um s tability in the pH 5-7 range.
A solution o f 1 gram o f CLAFORAN in 14 ml o f Sterile Water fo r Injection is isotonic.
S olutions o f CLAFORAN m ust not be adm ixed w ith am inoglycoside solutions. If
CLAFORAN and am ino glycosides are to be adm inistered to the sam e patient, they m ust
be adm inistered separately and not as a m ixed injection.

DOSAGE FORMS
CLAFORAN (cefotaxim e sodium ) is supplied as a sterile, w h ite to pale ye llo w pow der, in
vials containing 500 m g, 1.0 gram and 2.0 gram s o f cefotaxim e sodium (expressed as
acid on a d ry basis).
CLAFORAN in the dry state shou ld be stored at room tem perature (below 30°C),
protected fro m lig h t and heat. S o lution s of CLAFORAN range fro m lig h t ye llo w to
amber, depending on conce ntration and the dilu e n t used. The solutions tend to darken
depending on storage co n d itio n s and should be protected fro m elevated tem p era tures
and excessive light.
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